"experiment","description","EFOType","EFOValue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","organism part","breast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","phenotype","monolayer control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","cell line","MCF10A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","phenotype","mid transepithelial electrical resistance"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","phenotype","plateau transepithelial electrical resistance"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10070>","Transcription profiling of human MCF10A cells through Differentiation on Transwells","phenotype","low transepithelial electrical resistance"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10233>","Transcription profiling by array of human PMA-activated MM6 cells with cyclin T1 knockdown","RNAi","control shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10233>","Transcription profiling by array of human PMA-activated MM6 cells with cyclin T1 knockdown","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10233>","Transcription profiling by array of human PMA-activated MM6 cells with cyclin T1 knockdown","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10233>","Transcription profiling by array of human PMA-activated MM6 cells with cyclin T1 knockdown","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10233>","Transcription profiling by array of human PMA-activated MM6 cells with cyclin T1 knockdown","cell line","MM6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10233>","Transcription profiling by array of human PMA-activated MM6 cells with cyclin T1 knockdown","RNAi","cyclin T1 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","organism part","trabecular bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","cell type","osteoblast like cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","Compound treatment","bone morphogenetic protein 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10311>","Transcription profiling of human osteoblast transcriptome in resting and induced primary cells","Compound treatment","dexamethasone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","disease","liver carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","genotype","TMPRSS6 mutant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","cell line","HepG2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","genotype","TMPRSS6 wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10591>","Transcription profiling by array of human HepG2 cells with overexpression of TMPRSS6 or its mutant version","genotype","empty vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","cell line","HS5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","growth condition","CD14-postive monocytes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","cell type","stromal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","growth condition","no CD14-positive monocytes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10595>","Transcription profiling by array of human bone marrow stromal cells lines cultured with monocytes to investigate interactions in the hematopoietic microenvironment","cell line","HS27a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10289>","Transcripton profiling by array of human wild type and siRNA silenced SDHB HepB3 cells","cell line","Hep3B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10289>","Transcripton profiling by array of human wild type and siRNA silenced SDHB HepB3 cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10289>","Transcripton profiling by array of human wild type and siRNA silenced SDHB HepB3 cells","RNAi","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10289>","Transcripton profiling by array of human wild type and siRNA silenced SDHB HepB3 cells","disease","hepatocellular carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10289>","Transcripton profiling by array of human wild type and siRNA silenced SDHB HepB3 cells","genetic modification","stable transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10289>","Transcripton profiling by array of human wild type and siRNA silenced SDHB HepB3 cells","RNAi","SDHB siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10406>","Transcription profiling of human sinus mucosa from cystic fibrosis, chronic rhinosinusitis patients and controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10406>","Transcription profiling of human sinus mucosa from cystic fibrosis, chronic rhinosinusitis patients and controls","disease","chronic rhinosinusitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10406>","Transcription profiling of human sinus mucosa from cystic fibrosis, chronic rhinosinusitis patients and controls","organism part","sinus mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10406>","Transcription profiling of human sinus mucosa from cystic fibrosis, chronic rhinosinusitis patients and controls","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10406>","Transcription profiling of human sinus mucosa from cystic fibrosis, chronic rhinosinusitis patients and controls","disease","cystic fibrosis and chronic rhinosinusitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","Compound treatment","N-methyl-N'-nitro-N-nitrosoguanidine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15236"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell type","lymphoblastoid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15036"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15510"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15590"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15385"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15226"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15268"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15227"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15213"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15223"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15242"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15245"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","MT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15072"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15038"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15029"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15215"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15061"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15386"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","TK6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15221"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15324"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10313>","Transcription profiling of human lymphoblastoid cell lines that are part of the NIHPDR exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to identify novel predictors of resistance to DNA damaging agents","cell line","Coriell GM15224"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","passage","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","individual","donor 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","time","3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","growth condition","TGFb3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","time","0 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","individual","donor 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","growth condition","BMP2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","individual","donor 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","time","21 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","individual","donor 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","time","1 day"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","time","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","individual","donor 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10315>","Transcription profiling of human MSC isolated from human bone marrow aspirates differentiated to chondrocytes with BMP2 or TGFbeta-3, vs undifferentiated MSC sampled at multiple time points","individual","donor 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","phenotype","gefitinib resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","cell line","A431_GR"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","age","85 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","disease","epidermoid carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","organism part","epidermis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","phenotype","gefitinib sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10696>","Transcription profiling by array of human wild type and gefitinib-resistant A431 cancer cells","cell line","A431_wt"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","stimulus","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","stimulus","cigarette smoke"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10718>","Transcription profiling of human NHBE cells exposed to whole cigarette smoke (FULL flavor) - TIME series","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","individual","DP31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","cell type","dental pulp stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","age","14 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","passage","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","individual","DP28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","passage","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10444>","Transcription profiling of human dental pulp stem cells in long term culture","individual","DP2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10479>","Transcription profiling by array of human HUVECs induced by bg-CAT","cell type","HUVEC cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10479>","Transcription profiling by array of human HUVECs induced by bg-CAT","passage","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10479>","Transcription profiling by array of human HUVECs induced by bg-CAT","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10479>","Transcription profiling by array of human HUVECs induced by bg-CAT","Compound treatment","PBS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10479>","Transcription profiling by array of human HUVECs induced by bg-CAT","Compound treatment","bg-CAT"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","clinical treatment","two days post-chemotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","organism part","buccal mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","clinical treatment","pre-chemotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BRENC3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","clinical treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BRENC2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BRENC1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10746>","Transcription profiling by array of human patients with acute myeloid leukemia and chemotherapy-induced oral mucositis","individual","BREN22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","phenotype","hormone independent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","cell line","MCF-7:2A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","cell line","MCF-7:5C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","phenotype","estrogen dependent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10879>","Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","ESR1 siRNA control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","time","18 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","BT474"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","BT474EI"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDAMB231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MT3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","CAMA1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","time","72 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","control for ESR1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","mir-221/222 mimic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1806"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","ESR1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","DU4475"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDAMB361.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","control for mir-221/222 inhibitor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","CAL51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","KPL1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDA231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","ZR75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","control for mir-221/222 mimic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","Compound treatment","mir-221/222 inhibitor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","UACC893"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","CAL148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDA435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","T47D"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDA361"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","EFM192A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDAMB415"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1937"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","AU565"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDA468"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDAMB468"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","UACC812"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","SW527"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","EFM19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDA175"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","BT549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HS578T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","SKBR3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","BT474.tb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1954"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","T47D1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1419"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1569"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1395"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDAMB453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HDQP1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","CAL120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","EVSA1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","JIMT-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","CAL851"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","BT5491"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MFM-223"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1500"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","SKBR31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC2218"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","CAL1201"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1428"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","ZR75-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","BT483"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MDA436"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","MCF 10A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10890>","Transcription profiling of human breast cancer cell line profiles","cell line","HCC1143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","Clinical info","no tumor cells in bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","disease","pulmonary adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","Clinical info","tumor cells in bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10799>","Transcription profiling of human primary lung adenocarcinomas","individual","AC 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10821>","Transcription profiling by array of human transfected D10-positive germinal center B cells to investigate LMP1-mediated gene expression changes","genotype","empty vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10821>","Transcription profiling by array of human transfected D10-positive germinal center B cells to investigate LMP1-mediated gene expression changes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10821>","Transcription profiling by array of human transfected D10-positive germinal center B cells to investigate LMP1-mediated gene expression changes","cell type","germinal center B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10821>","Transcription profiling by array of human transfected D10-positive germinal center B cells to investigate LMP1-mediated gene expression changes","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10821>","Transcription profiling by array of human transfected D10-positive germinal center B cells to investigate LMP1-mediated gene expression changes","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10821>","Transcription profiling by array of human transfected D10-positive germinal center B cells to investigate LMP1-mediated gene expression changes","genotype","LMP1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10780>","Transcription profiling of human histologically normal breast tissues reveals proliferative genes dominate malignancy-risk gene signature","organism part","breast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10780>","Transcription profiling of human histologically normal breast tissues reveals proliferative genes dominate malignancy-risk gene signature","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10780>","Transcription profiling of human histologically normal breast tissues reveals proliferative genes dominate malignancy-risk gene signature","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10780>","Transcription profiling of human histologically normal breast tissues reveals proliferative genes dominate malignancy-risk gene signature","histology","Unremarkable breast ducts,Unremarkable breast ducts (Normal)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10780>","Transcription profiling of human histologically normal breast tissues reveals proliferative genes dominate malignancy-risk gene signature","disease","breast carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10780>","Transcription profiling of human histologically normal breast tissues reveals proliferative genes dominate malignancy-risk gene signature","histology","Invasive ductal carcinoma (IDC),invasive ductal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","disease","acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","clinical history","favorable prognosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","cell type","T cell,T-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","cell type","B cell,B-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10820>","Transcription profiling of human peripheral blood monocytes from acute lymphoblastic leukaemia patients to search for new biomarkers for the monitoring of the minimal residual disease of ALL","clinical history","poor prognosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","organism part","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","cell line","KMH2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","cell type","B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","disease","Hodgkins lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","cell line","L1236"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","cell line","L428"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","cell line","patient-derived cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10831>","Transcription profiling of human HL cell line associated gene expression changes compared with CD10+ GC B cells","cell line","L591"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","Clinical info","Breast cancer distant metastasis; Lung tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","disease staging","metastasis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","disease","breast carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","Clinical info","Breast cancer distant metastasis; Non-lung tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","organism part","non-lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11078>","A six-gene signature predicting breast cancer lung metastasis","individual","Breast Cancer Met-16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","Clinical info","allograft,deceased donor,post transplant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","clinical history","deceased donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","time","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","clinical history","living donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","Clinical info","allograft,living donor,post transplant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","time","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","Clinical info","allograft,deceased donor,pre transplant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","time","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","time","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11166>","Transcription profiling of human kidney allografts - local regulation and clinical impact of complement gene expression in deceased and living donor kidney allografts","Clinical info","allograft,living donor,pre transplant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","growth condition","oxidative stress"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","cell line","U937"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","time","18 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","Compound treatment","curcumin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10896>","Transcription profiling of human monocytes (U937 cell line) to assess the impact of curcumin on monocytes exposed to oxidative stress","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","cell type","continuous cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","disease","melanoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","generation","less than 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","genotype","BRAF wildtype; NRAS wildtype"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","growth condition","melphalan and temozolomide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","genotype","BRAF Mutant; NRAS wildtype"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","genotype","BRAF Mutant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","genotype","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","growth condition","melphalan"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10916>","Transcription profiling of human-melanoma derived cell lines response to chemotherapy","genotype","BRAF wildtype; NRAS mutant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Weiss Grade","high"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","disease","adrenocortical carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","organism part","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","9.2 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.775 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","biopsy site","left"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","266 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","tumor_stage","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","biopsy site","right"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","50 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","disease","adrenocortical adenoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","Cushing syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","5.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","tumor_stage","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Weiss Grade","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","tumor_stage","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","virilization and microcephaly"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","12.468 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","3.2 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","<10 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","<10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","12 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","1690.4 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","not available years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","16.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Weiss Grade","low"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","87 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","2.7 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","11.1 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.364 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","1805 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","18.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","60 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","5.342 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","10.5 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","aldosteronoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","hyperaldosteronism"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","14.9 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","1.1 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","17.2 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","left adrenal mass"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","tumor_stage","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","15.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","25.2 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","3.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","1305 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","right adrenal mass"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","2.233 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","35.1 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy for renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","organism part","adrenal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","360 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","15 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy for pheochromocytoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy for ACA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","57 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","6.2 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","180 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","9 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","1.512 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","116 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","7.2 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","19 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","2890 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","2.781 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","16 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","2.011 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","520 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","8.868 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","12 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","Liver tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","8.5 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","Conn's syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","1.3 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","tumor_stage","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","history of adrenocortical carcinoma with lung, liver and bone metastises 1 year prior"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","1.233 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","460 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","9.8 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.942 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","253 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","7 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","95 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","2.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","23.6 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","3.3 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","65 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","hypertension"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","22 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.625 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","right adrenal tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","2440 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","right pheochromocytoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","12.5 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy for metastatic lung carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","12.1 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","2310 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","2.068 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","110 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","2.721 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","biopsy site","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","1.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","7.6 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","4.334 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","78"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","450 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","Increased testosterone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.477 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","right flank pain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.121 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","1.203 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","tumor of left hepatic lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.619 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","10.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","history of adrenocortical carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","1.658 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","17 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","4.753 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","2540 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.899 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","history of adrenal mass"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","2300 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","26 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","4.95 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","174.5 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","abdominal pain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","45 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","Cortisol secreting tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","660 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","13 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy for multinodular cortical hyperplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","4.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","31 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","adrenalectomy for pheochromocytoma (Multiple Endocrine Neoplasia, Type IIA)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","212 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","10 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","1.732 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","8.7 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","397 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","elevated serum aldosterone and DHEA-S"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","22.4 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Clinical info","bilateral adrenal masses"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","4.2 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","8.2 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","2.2 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Mitotic rate of tumor","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","900 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","18 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Last Follow Up","0.09 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Diameter","8.5 centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","400 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10927>","Transcription profiling of human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10)","Tumor Mass","16 grams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","developmental stage","child"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","cell type","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Patient2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","sampling time point","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","disease","meningococcal sepsis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","sampling time point","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","cell type","lymphocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Patient4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Control-c"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Control-a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Control-b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","sampling time point","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Patient6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Patient3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Patient1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","sampling time point","72 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11755>","Transcription profiling of human pediatric meningococcal sepsis patients reveals dynamic changes in NK-cell and cytotoxic molecules","individual","Control-d"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","cell line","SH-SY5Y"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","organism part","peripheral ganglion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","Compound treatment","nicotine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11208>","Transcription profiling of human model neuronal cell lines after chronic nicotine exposure","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","family history","No"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 3875delGTCT"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","disease","high grade serous carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","organism part","oviduct"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","Clinical info","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 1293del40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","family history","yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","Clinical info","menstrual phase: follicular"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","Clinical info","menstrual phase: luteal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","family history","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 185delAG"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 5382insC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 A1959T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA2 C5910G"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1/2 wildtype"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA2 6174delT"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","genotype","BRCA1 917delTT"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10971>","Transcription profiling of human non-malignant fallopian tube epithelium and high grade serous carcinoma.","age","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","individual","121704"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","cell type","naive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","individual","11405"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","cell type","central memory T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","individual","12805"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","individual","12405"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","individual","120604"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11057>","Transcription profiling of human memory T cell subsets from peripheral blood.","cell type","effector memory T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","cell line","FL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","organism part","amnion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","Compound treatment","dimethyl sulfoxide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","time","10 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","time","22 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-10979>","Transcription profiling by array of human amnion epithelial FL cells treated with the carcinogen BPDE at low concentration","Compound treatment","benzo[a]pyrene diolepoxide 0.05 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11045>","Transcription profiling by array of human kidney and liver","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11045>","Transcription profiling by array of human kidney and liver","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11045>","Transcription profiling by array of human kidney and liver","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11045>","Transcription profiling by array of human kidney and liver","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","cell line","MCF7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","Compound treatment","estradiol 10 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11352>","Transcription profiling by array time series of human MCF7 breast cancer cells treated with estradiol","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","Infection","HRV-16 rhinovirus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","organism part","nose"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","cell type","epithelium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","time","-14 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","Infection","negative control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","time","2 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11348>","Transcription profiling of human nasal epithelium from subjects infected with HRV-16 rhinovirus vs sham infected","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","stimulus","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","disease","meningeal tuberculosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","cell type","macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","stimulus","tuberculosis extract"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","disease","pulmonary tuberculosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11199>","Transcription profiling of human macrophages to identify tuberculosis susceptibility genes","disease","latent tuberculosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","disease","prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","cell line","abl"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","Compound treatment","17beta-hydroxy-5alpha-androstan-3-one"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","time","16 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","Compound treatment","siRNA control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","Compound treatment","androgen receptor siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","cell line","LNCAP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11428>","Transcription profiling of human LNCaP and abl cells treated with androgen or androgen receptor siRNA","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","individual","donor 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","growth condition","staphylococcal superantigen SEI"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","growth condition","staphylococcal superantigen SEB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","individual","donor 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","individual","donor 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11281>","Transcription profiling by array of human peripheral blood mononuclear cells treated with staphylococcal superantigens SEB and SEI","growth condition","untreated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","cell type","glioma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","Compound treatment","enzastaurin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","cell line","U251"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","Compound treatment","dimethyl sulfoxide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","time","10 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11285>","Transcription profiling by array of human U251 cells treated with DMSO or enzastaurin","time","18 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","cell type","monocyte derived dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","growth condition","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","growth condition","Candida albicans"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11309>","Transcription profiling  by array of human APECED patients in vitro monocyte-differentiated dendritic cells vs. healthy controls","disease","autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","Compound treatment","estrogen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11324>","Transcription profiling by array of human MCF cells treated with estrogen","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","Compound treatment","phorbol 12-myristate 13-acetate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","genotype","negative control shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","cell line","MM6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","genotype","cyclin T1 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","cell type","lymphocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","cell line","Jurkat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11462>","Transcription profiling of human MM6 cells response to cyclin T1","Compound treatment","lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11440>","Transcription profiling by array of human HT29 colon cancer cells to investigate the role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate","phenotype","methotrexate resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11440>","Transcription profiling by array of human HT29 colon cancer cells to investigate the role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate","cell line","HT29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11440>","Transcription profiling by array of human HT29 colon cancer cells to investigate the role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11440>","Transcription profiling by array of human HT29 colon cancer cells to investigate the role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate","disease","colon cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11440>","Transcription profiling by array of human HT29 colon cancer cells to investigate the role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate","phenotype","methotrexate sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","cell type","macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","stimulus","interferon gamma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","disease","ankylosing spondylitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","stimulus","negative control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient 42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Control #5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11886>","Transcription profiling of human macrophages from ankylosing spondylitis patients reveals interferon-gamma dysregulation","individual","Patient #3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","stimulus","exercise"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","developmental stage","late pubertal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","time","30 minutes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","developmental stage","early pubertal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","10 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","time","0 minutes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","stimulus","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","11 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","17 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","15 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11761>","Transcription profiling of human peripheral blood mononuclear cells after a brief bout of exercise alters gene expression PBMCs from early- and late-pubertal males","age","12 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","cell line","GM5659"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","Compound treatment","ascorbic acid 100 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11919>","Transcription profiling by array of human vitamin C-induced gene expression in GM5659 skin fibroblasts","Compound treatment","ascorbic acid 2-phosphate 100 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","Clinical info","not inflamed,not-inflamed"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","disease","interstitial cystitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","organism part","bladder"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","Clinical info","ulcer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 04"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 02"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 09"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 07"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 05"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11783>","Transcription profiling by array of bladder tissue of patients with interstitial cystitis","individual","Patient: 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","Compound treatment","trovafloxacin 100 micrograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","cell type","hepatocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","Clinical info","Reason for liver resection: liver metastasis of kidney carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","Clinical info","Reason for liver resection: liver adenoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","Clinical info","Reason for liver resection: liver metastasis of colorectal cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11941>","Transcription profiling by array of human primary hepatocytes treated with trovafloxacin","Clinical info","Reason for liver resection: liver metastasis of mammary carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","individual","subject 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","organism part","bladder"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","growth condition","proliferating medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","cell type","urothelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","disease","interstitial cystitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","individual","subject 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","growth condition","differentiating medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","individual","subject 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","disease","stress incontinence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","individual","subject 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","individual","subject 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11839>","Transcription profiling by array of human female interstitial cystitis urothelial cells after inducing differentiation","individual","subject 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","cell type","natural killer cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","source","healthy donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","treatment","NKAES"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","treatment","high dose IL2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12198>","Primary NKcells vs. NKAES-derived NK cells vs. NKcells stimulated by low/high dose IL2 after 7days of culture","treatment","low dose IL2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12090>","Transcription profiling by array of human chromophobe renal cell carcinoma and oncocytoma","organism part","renal tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12090>","Transcription profiling by array of human chromophobe renal cell carcinoma and oncocytoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12090>","Transcription profiling by array of human chromophobe renal cell carcinoma and oncocytoma","disease","chromophobe renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12090>","Transcription profiling by array of human chromophobe renal cell carcinoma and oncocytoma","disease","oncocytoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","Infection","Francisella tularensis novicida"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","Infection","uninfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12108>","Transcription profiling of human monocytes infected with Francisella tularensis","Infection","Francisella tularensis Schu S4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12113>","Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer","disease","pancreatic cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12113>","Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer","organism part","pancreatic tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12113>","Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12113>","Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12113>","Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer","xenograft","athymic nude mouse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12113>","Transcription profiling by array of human pancreatic tumours in xenografts to investigate the antitumor activity and molecular effects of the novel Hsp 90 Inhibitor, IPI-504, in pancreatic cancer","Compound treatment","IPI504"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","cell line","HIGK"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","Infection","Porphyromonas gingivalis and Streptococcus gordonii"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","organism part","gum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","passage","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","cell type","keratinocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","Infection","Streptococcus gordonii"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","Infection","sham infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12121>","Transcription profiling by array of human gingival epithelial cell responses to a complex microbiome","Infection","Porphyromonas gingivalis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12251>","Transcription profiling of human ulcerative colitis samples reveals a predictive response signature to infliximab treatment in ulcerative colitis","disease","ulcerative colitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12251>","Transcription profiling of human ulcerative colitis samples reveals a predictive response signature to infliximab treatment in ulcerative colitis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12251>","Transcription profiling of human ulcerative colitis samples reveals a predictive response signature to infliximab treatment in ulcerative colitis","Clinical info","no response to Infliximab"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12251>","Transcription profiling of human ulcerative colitis samples reveals a predictive response signature to infliximab treatment in ulcerative colitis","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12251>","Transcription profiling of human ulcerative colitis samples reveals a predictive response signature to infliximab treatment in ulcerative colitis","Clinical info","response to Infliximab treatment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","Infection","LCMV-WE"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","organism","Macaca mulatta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","disease","viral hemorrhagic fever"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","Infection","uninfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","disease","no"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","Infection","LCMV-ARM and LCMV-WE"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","Infection","LCMV-ARM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12254>","Gene expression associated with liver metabolism during viral hemorrhagic fever","time","day 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11959>","Transcription profiling by array of human SK-N-AS neuroblastoma xenograft tumor reveals anti-IGF-IR antibody h10H5 induces a unique response","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11959>","Transcription profiling by array of human SK-N-AS neuroblastoma xenograft tumor reveals anti-IGF-IR antibody h10H5 induces a unique response","xenograft","nude mouse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11959>","Transcription profiling by array of human SK-N-AS neuroblastoma xenograft tumor reveals anti-IGF-IR antibody h10H5 induces a unique response","cell line","SK-N-AS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11959>","Transcription profiling by array of human SK-N-AS neuroblastoma xenograft tumor reveals anti-IGF-IR antibody h10H5 induces a unique response","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11959>","Transcription profiling by array of human SK-N-AS neuroblastoma xenograft tumor reveals anti-IGF-IR antibody h10H5 induces a unique response","disease","neuroblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-11959>","Transcription profiling by array of human SK-N-AS neuroblastoma xenograft tumor reveals anti-IGF-IR antibody h10H5 induces a unique response","Compound treatment","IGF-IR monoclonal antibody - 10H5 5 milligrams per kilogram"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","cell type","oocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","Clinical info","male cause of infertility"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","age","greater than 35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","cell type","mixed somatic cell types"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12034>","Transcription profiling of human oocytes","organism part","mixed"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","time","1 day"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","cell type","osteoblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","individual","patient 3206"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","organism part","trabecular bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","growth condition","mineralisation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","individual","patient 3205"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","time","10-14 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","individual","patient 3080"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","time","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","growth condition","grown to confluence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","time","0 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12264>","Transcription profiling by array of human trabecular bone osteogenic cells","individual","patient 3002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","individual","3080"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","sampling time point","early cell adhesion (MD1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","sampling time point","post full confluence (MD5)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","individual","3205"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","sampling time point","full confluence (MD4)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","sampling time point","semiconfluence (MD3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","individual","3002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","sampling time point","early differentiation (MD2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12265>","Transcription profiling of human osteogenic cells derived from bone marrow and trabecular bone - II","individual","3206"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease","ovarian cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","genotype","BRAF: mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","histology","micropapillary feature: negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","not available,stage IIIb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","organism part","ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","Clinical info","low malignancy potential"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","genotype","BRAF/KRAS: wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","histology","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage IIIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","Clinical info","malignant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","not available,stage IC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","histology","micropapillary feature: positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","high grade,stage Ia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","organism part","peritoneum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","not available,stage Ia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","genotype","KRAS: mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","high grade,stage IIIa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","genotype","ERBB2: mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","low grade,stage Ia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","not available,stage IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","low grade,stage IIa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","low grade,stage IIB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","not available,stage IB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","not available,stage IIB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 2,stage IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 2,stage IIIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","genotype","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","high grade,stage IIIb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","genotype","BRAF/KRAS/ERBB2: wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","high grade,stage IC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","organism part","other"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 2,stage IIIb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","low grade,stage IIIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 2,stage IIIa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage IIIb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","low grade,stage IIIa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage IC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 2,stage IIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage IIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage III"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","low grade,stage IIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","high grade,stage IIIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12172>","Transcription profiling of human Low Malignancy Potential (LMP) and serous tumours","disease staging","grade 3,stage IIIa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism part","dorsolateral prefrontal cortex,neurons from dorsolateral prefrontal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","cell type","neuron"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism part","cerebellum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","not specified years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","sex","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","strain","NMR-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism part","cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","organism part","dorsolateral prefrontal cortex,endothelial cells from dorsolateral prefrontal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","cell type","endothelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","clinical history","history of schizophrenia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12293>","Evolution of neuronal and endothelial transcriptomes in primates","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","cell type","B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","time","24 hours,3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","cell line","EREB2-5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","phenotype","EBNA2 expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","phenotype","Notch2-IC expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","time","3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","phenotype","Notch1-IC expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","phenotype","CAT expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","time","3 days,8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","time","0 hours,3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12355>","Transcription profiling of human time points after induction of Notch1-IC, Notch2-IC or EBNA2 in EREB2-5 cells - detection of Notch1-IC, Notch2-IC and EBNA2 target genes in human B cells","time","3 days,4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","disease","Alagille syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","cell type","lymphoblastoid cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","Clinical info","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","JAG1 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","ethnicity","Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","23.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","disease","Cornelia de Lange Syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","Clinical info","severe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 1546_1547insG / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","ESCO2 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","not available years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","ethnicity","race unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","disease","Roberts syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 1444_1447delAGAG / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","0 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","10 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","under 5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","7 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 4606C>T / Nonsense"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","3.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","19.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 961delA / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","14.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 2969delG / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","10.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","ethnicity","Arab"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 4002_4005del4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 1902_1903insA / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","6.7 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","8.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 2494C>T / nonsense"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","6.9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 6407insA / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 1934delA / Nonsense"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","0.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 5167C>T / Nonsense"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","11.9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 150delG / Nonsense"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","0.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 3048_3051delATTA / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","ethnicity","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","13 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","14 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","6.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","1.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","12 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","18.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 742_743delCT / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 2449_2450insG / Frameshift"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","genotype","NIPBL mutation: cDNA 4193C>G / Nonsense"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","5.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12408>","Transcription profiling of Cornelia de Lange Syndrome proband derived cell lines reveals defective cohesin in cdls mediates gene expression with characteristics of transcription factor and insulator activity","age","5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","organism part","endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","Compound treatment","estradiol and medroxy progesterone acetate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","developmental stage","post menopausal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","Compound treatment","tibolone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","Compound treatment","estradiol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","Patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12446>","Transcription profiling of human hormone-treated postmenopausal patients","individual","nr 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","Clinical info","site of relapse: brain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 12 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","organism part","primary breast tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","Clinical info","site of relapse: other"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 15 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 53 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 5 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 25 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 6 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 23 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 14 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 35 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 24 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 8 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 21 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 11 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 9 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 61 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 22 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 16 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 28 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 73 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","Clinical info","site of relapse: local"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 20 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 17 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 10 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 30 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 54 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 0 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 32 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 29 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 4 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 48 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","Clinical info","site of relapse: brain and other"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 49 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 47 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 44 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 7 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 39 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 18 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 97 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 19 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 36 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 33 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 42 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 60 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 13 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 99 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 3 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 50 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 64 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 37 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 26 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 94 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 115 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 27 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 34 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 40 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 83 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 38 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 69 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 1 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 55 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 46 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 43 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 31 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 58 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 107 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12276>","Transcription profiling of human primary breast tumors","clinical history","survival: 85 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","disease","T cell leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","Compound treatment","17-allylamino-17-demethoxygeldanamycin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","cell line","TaY-E10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","cell line","MT4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","Compound treatment","17-(dimethylaminoethylamino)-17-demethoxygeldanamycin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12287>","Transcription profiling of human adult T cell leukemia cell lines to investigate the biological pathways of Hsp90 inhibitors","cell line","MT2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","histology","IIA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","organism part","nasopharynx"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T1N0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease","nasopharyngeal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","cell type","epithelium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T1N1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","histology","IIB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T2N2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T3N0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T2N1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","histology","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T3N1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12452>","Transcription profiling of human nasopharyngeal carcinoma vs control","disease staging","T3N2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12886>","RNAi profiling of by array of human hepatocellular carcinoma cells silenced for Wilm's Tumor 1 gene expression","disease","hepatoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12886>","RNAi profiling of by array of human hepatocellular carcinoma cells silenced for Wilm's Tumor 1 gene expression","cell line","PLC/PRF/5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12886>","RNAi profiling of by array of human hepatocellular carcinoma cells silenced for Wilm's Tumor 1 gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12886>","RNAi profiling of by array of human hepatocellular carcinoma cells silenced for Wilm's Tumor 1 gene expression","RNAi","WT1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12886>","RNAi profiling of by array of human hepatocellular carcinoma cells silenced for Wilm's Tumor 1 gene expression","RNAi","control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","protocol type","lithium heparin tube to PAXgene tube"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","protocol type","direct to PAXgene tube"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","protocol type","lithium heparin tube to Tempus tube"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12710>","Transcription profiling of human peripheral blood samples collected into PAXgene or Tempus tubes vs. the same 5 healthy control samples drawn in Li Heparin Differential gene expression profiles are dependent upon method of peripheral blood RNA isolation (direct, heparin","protocol type","direct to Tempus tube"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","organism part","conjunctiva"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","cell type","conjunctival non-side population cells,epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","disease","lung cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","cell type","conjunctival side population cells,epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","disease","heart infarct"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12631>","Transcription profiling by array of human conjunctival epithelial side population cells","disease","brain embolism"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","disease","FAB: M2 acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","genotype","FLT3 ITD: negative; FLT3 D835: negative; NPM1 insertion: negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","ethnicity","White"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(8;21)(q22;q22); del(9)(q22q34)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","cell type","promyelocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","disease","FAB: M4 acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","genotype","FLT3 ITD: negative; FLT3 D835: negative; NPM1 insertion: positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","trisomy 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","disease","FAB: M1 acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(9;22)(q34;q11.2)-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","der(7)t(7;8)(p15;q13)t(8;21)(q22;q22)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","cell line","NB4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(11;19)(q23;p13.1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","genotype","FLT3 ITD: positive; FLT3 D835: negative; NPM1 insertion: negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","disease","FAB:M3 acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","del(7)(q22) trisomy 8 t(15;17)(q22;q21)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(15;17)(q22;q21)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","cell line","PR-9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","Compound treatment","zinc"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","ethnicity","African American"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","greater than 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","cell type","CD34 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","trisomy 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","genotype","FLT3 ITD: negative; FLT3 D835: positive; NPM1 insertion: positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","81 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","Compound treatment","negative control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(8;21)(q22;q22)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","cell type","neutrophil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","disease","FAB: M0 acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","genotype","FLT3 ITD: negative; FLT3 D835: positive; NPM1 insertion: negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","del(5)(q22q33)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","76 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(15;17)(q22;q21); trisomy 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","time","16 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","ethnicity","Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","genotype","FLT3 ITD: positive; FLT3 D835: negative; NPM1 insertion: positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","inv(16)(p13q22); t(2;4)(q34;q21)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","+ 21(q22); del(7)(p11.2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","add(7)(p22)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","ethnicity","Asian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","inv(16)(p13q22)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","ND"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","del(9)(q21q33); del(20)(q12)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","del(11)(p12)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","trisomy 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(8;21)(q22;q22); del(9)(q12q22)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","del(7)(q21q36)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(12;22)(p13;q12)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","ethnicity","H"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","t(11;19)(q23;p13.1); inv(12)(p12p13)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","iso(11)(q10)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","trisomy 21 trisomy 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","del(5)(q22q33); t(10;11)(p13~p15;q22~q23) i(17)(q10)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","trisomy Y"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","karyotype","-Xt(5;21)(q31;q22); t(1;6)(q21;p23)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12662>","Transcription profiling of human normal bone marrow CD34+ cells, promyelocytes, and neutrophils and PR9 cell line PML-RARA induction time series","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","disease","atopy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","growth condition","co-culture with airway epithelial cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","cell type","CD14 positive monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12773>","Transcription profiling of human airway epithelial cell-conditioned monocyte-derive dendritic cells","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318098_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","ethnicity","White"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","disease staging","primary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","Clinical info","smoking status: former"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","disease","lung adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318139_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","Clinical info","smoking status: current"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318136_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318082_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","Clinical info","smoking status: not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318104_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318083_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","Clinical info","smoking status: never"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318099_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318125_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318120_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","ethnicity","African American"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318107_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","disease","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318094_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318077_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318109_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318146_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318135_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318142_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318116_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318073_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318108_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318075_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","disease","large cell neuroendocrine carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318119_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318143_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318092_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318081_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318138_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318147_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318137_"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","ethnicity","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318131_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318140_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318100_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318141_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318144_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318111_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318127_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318124_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318095_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318132_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318086_N/A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318084_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318076_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318117_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318115_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318096_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318103_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318128_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318097_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318105_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","disease","squamous cell lung carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318093_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318091_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318110_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318130_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318126_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318088_AfAm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318114_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318085_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318122_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318074_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318106_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318078_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318121_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318134_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318133_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318101_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318080_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318102_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318145_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318079_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318112_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318118_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318123_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318089_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318129_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318113_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318090_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12667>","Transcription profiling of human lung adneocarcinomas - discovery of somatic mutations in lung adenocarcinomas","individual","GSM318087_Wh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","disease staging","Binet Stage:B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","Clinical info","low ZAP70 mRNA expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","disease","chronic lymphocytic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","cell type","CD19 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","Clinical info","high ZAP70 mRNA expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","disease staging","Binet Stage:A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","disease staging","Binet Stage:C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12734>","Transcription profiling of human chronic lymphocytic leukemia patients expressing high or low levels of ZAP70 mRNA","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","genotype","HRas over expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","genetic modification","transient transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","cell line","MCF10A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","genotype","MEK1 over expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12764>","Transcription profiling by array of human MCF10A cells reveal changes upon expression of activated versions of MEK1 and HRAS","genotype","empty vector control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","genotype","PKA RII-beta over expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","disease","ovarian carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","cell line","OVCAR-8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","genotype","PKA RI-alpha over expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","genetic modification","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12854>","Transcription profiling by array of human ovarian cancer cells overexpressing PKA regulatory subunits","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13142>","Transcription profiling by array of human HepG2/C3A cells cultured in complete or leucine-devoid medium","disease","hepatocellular carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13142>","Transcription profiling by array of human HepG2/C3A cells cultured in complete or leucine-devoid medium","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13142>","Transcription profiling by array of human HepG2/C3A cells cultured in complete or leucine-devoid medium","cell type","HepG2/C3A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13142>","Transcription profiling by array of human HepG2/C3A cells cultured in complete or leucine-devoid medium","growth condition","complete media"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13142>","Transcription profiling by array of human HepG2/C3A cells cultured in complete or leucine-devoid medium","growth condition","leucine free media"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","individual","G105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","organism part","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","disease","glioblastoma multiforme"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","Compound treatment","cilengitide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","xenograft","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","individual","G103"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-12949>","Transcription profiling by array of human glioblastoma multiforme tumor cells exposed to cilengitide in a mouse xenograft model","individual","G104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13002>","Transcription profiling by array of human multipotent stromal cells in single-cell-derived colonies to investigate commitment to differentiation","cell type","multipotent stromal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13002>","Transcription profiling by array of human multipotent stromal cells in single-cell-derived colonies to investigate commitment to differentiation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13002>","Transcription profiling by array of human multipotent stromal cells in single-cell-derived colonies to investigate commitment to differentiation","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13002>","Transcription profiling by array of human multipotent stromal cells in single-cell-derived colonies to investigate commitment to differentiation","growth condition","cells from inside colony"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13002>","Transcription profiling by array of human multipotent stromal cells in single-cell-derived colonies to investigate commitment to differentiation","growth condition","cells from outside colony"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13073>","Transcription profiling of human mesechymal stem cells exposed to keratinocyte conditioned medium","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13073>","Transcription profiling of human mesechymal stem cells exposed to keratinocyte conditioned medium","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13073>","Transcription profiling of human mesechymal stem cells exposed to keratinocyte conditioned medium","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13073>","Transcription profiling of human mesechymal stem cells exposed to keratinocyte conditioned medium","growth condition","keratinocyte cell conditioned medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13073>","Transcription profiling of human mesechymal stem cells exposed to keratinocyte conditioned medium","growth condition","keratinocyte growth medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","Infection","human rhinovirus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","disease","asthma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13396>","Transcription profiling of human bronchial epithelial cells from normal and asthmatic individuals to investigate rhinovirus-induced modulation of gene expression","individual","S13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","genetic modification","adenoviral transduction"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","genotype","Ad-HER2-ki (kinase inactive)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","passage","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","genotype","Ad-GFP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13274>","Transcription profiling by array of human mammary epithelial cells infected with a recombinant adenoviral vector expressing a mutated HER2 inactivated for kinase function or wild type HER2","genotype","Ad-HER2-wt (wild type)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3992_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","Clinical info","non lesional skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","disease","psoriasis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","Clinical info","lesional skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4162_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4934_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3983_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3059_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4216_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4284_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","953_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4607_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","Clinical info","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5414_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4362_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4339_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3937_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4163_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4356_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5008_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4616_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5177_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4981_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4089_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5849_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4368_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4344_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4505_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4688_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5023_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5325_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4368_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4908_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3171_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4990_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4505_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5258_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4160_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4208_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5293_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4136_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4609_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4598_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5292_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5414_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4079_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","511_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5147_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4697_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4213_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4968_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5815_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5305_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5243_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3059_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4778_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4935_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","999027_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5079_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4689_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3690_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4298_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4164_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4426_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4208_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5295_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5030_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5257_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3822_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3690_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5248_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4688_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","582_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4391_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5942_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4397_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5242_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5935_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4334_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4294_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4269_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5063_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5144_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3822_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4503_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4874_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5579_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4641_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4379_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5331_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4093_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4618_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4344_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3140_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","777_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5849_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5093_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4163_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3937_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3983_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4093_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","649_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5050_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4609_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3992_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3591_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","953_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4213_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4294_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4362_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5223_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4269_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5242_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4247_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","511_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4934_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4288_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4247_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4626_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4177_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4284_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4616_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4165_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4356_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5936_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4160_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4649_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4089_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4999_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4389_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4397_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4124_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5660_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4378_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5177_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4136_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4177_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5905_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4389_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4079_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4952_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3171_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4503_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4298_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4165_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5325_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5919_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4426_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5247_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","649_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4382_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","777_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4697_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4339_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5258_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5883_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3591_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4257_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4708_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5256_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4257_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","582_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5749_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4216_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5575_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5324_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4334_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5346_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5143_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5839_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3140_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4977_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5331_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3777_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3586_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5281_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4164_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4394_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5142_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3586_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4162_PN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","4992_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","5844_NN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13355>","Transcription profiling of human skin from psoriatic patients and normal controls","individual","3777_PP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13284>","RNAi profiling by array of human CD34-derived erythroid progenitors treated with BCL11A siRNAs","RNAi","BCL11A siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13284>","RNAi profiling by array of human CD34-derived erythroid progenitors treated with BCL11A siRNAs","cell type","erythroid progenitor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13284>","RNAi profiling by array of human CD34-derived erythroid progenitors treated with BCL11A siRNAs","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13284>","RNAi profiling by array of human CD34-derived erythroid progenitors treated with BCL11A siRNAs","RNAi","non-targeting siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","disease","lung cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","cell line","Calu-6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","growth condition","tobacco smoke condensate 3 microgram per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","growth condition","tobacco smoke condensate 0.6 microgram per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13309>","Transcription profiling of human A549 and Calu-6 lung cancer reveals tobacco smoke induces Polycomb-mediated repression of Dickkopf-1 in lung cancer cells","growth condition","tobacco smoke condensate 1 microgram per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","disease","pulmonary MALT lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","genotype","gene fusion: API2-MALT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13314>","Transcription profiling of human pulmonary MALT lymphoma","genotype","gene fusion: IgH-MALT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13319>","Transcription profiling of human and rat uterine leiomyoma: identification of a dysregulated mTOR pathway","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13319>","Transcription profiling of human and rat uterine leiomyoma: identification of a dysregulated mTOR pathway","disease","leiomyoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13319>","Transcription profiling of human and rat uterine leiomyoma: identification of a dysregulated mTOR pathway","organism part","myometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13319>","Transcription profiling of human and rat uterine leiomyoma: identification of a dysregulated mTOR pathway","organism part","leiomyoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13319>","Transcription profiling of human and rat uterine leiomyoma: identification of a dysregulated mTOR pathway","organism","Rattus norvegicus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13319>","Transcription profiling of human and rat uterine leiomyoma: identification of a dysregulated mTOR pathway","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","ethnicity","White"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","developmental stage","childhood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNH_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J40_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","disease","juvenile idiopathic arthritis subtype oligoarthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LSC_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","disease","juvenile idiopathic arthritis subtype enthesitis related arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LL3_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKE_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N1B_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMX_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNS_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNX_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","disease","juvenile idiopathic arthritis subtype rheumatoid factor polyarthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNS_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LPP_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MLT_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKN_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","061HZ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","disease","juvenile idiopathic arthritis subtype systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MKV_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQQ_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01L4M_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQT_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LM6_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","ethnicity","Black/African American"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N41_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LKM_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKL_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKJ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","ethnicity","UK"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N6Z_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLQ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N3C_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LS8_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKK_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N3X_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNK_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNY_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UPD_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNP_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LKZ_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N1J_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MJU_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01ML0_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J43_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N3M_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LN4_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LR3_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LN0_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQH_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LLC_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VCM_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N4C_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01L4N_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UMY_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N70_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LLX_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MLB_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N3H_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J48_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","ethnicity","Asian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP3_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNT_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LSM_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMJ_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UPE_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J47_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LL1_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLH_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UPB_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01JME_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J4C_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNL_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQD_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKR_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LN1_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMU_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N12_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LR8_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQK_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J46_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MLE_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNM_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLN_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LR6_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N1E_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N27_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MK9_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLE_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MJG_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNL_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMB_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01L4G_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN6_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LPG_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQX_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP9_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN8_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP6_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N71_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNW_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N72_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MHM_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LN8_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLF_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N0R_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N4E_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N0Z_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP4_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LM2_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01J45_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQG_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LZD_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","061J3_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LTR_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LRK_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01L4J_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N28_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLL_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UMZ_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKQ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MK6_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MJ2_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01JE9_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N2A_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","061J4_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N14_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N15_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LPC_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKP_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLD_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LPL_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","061J0_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","061J5_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKG_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLM_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01ML9_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQE_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNJ_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LS6_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LSH_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQJ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNE_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLJ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MCY_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MJD_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMV_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMY_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LMN_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKM_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N3E_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UMW_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MHW_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP0_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNJ_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N43_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN4_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNX_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN1_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LPE_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN5_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LKT_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N3S_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LNK_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN9_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LRH_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N4L_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N4H_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LPZ_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN2_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNR_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MJ9_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNV_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MKC_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LKY_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LLR_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LSD_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LP7_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LRF_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N0Y_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LKV_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LLB_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LN7_Systemic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLG_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP5_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VLK_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LQ2_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKH_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","061K3_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LP2_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UP8_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MLL_ERA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UMX_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N46_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNF_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01VKF_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UPC_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UN7_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UNG_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01MK1_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01UPA_CTRL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01LM3_Oligo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13501>","Transcription profiling of peripheral blood from juvenile idiopathic arthritis (JIA) patients and healthy children","individual","01N4B_PolyRF-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","disease","melanoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","Compound treatment","BAY-43-9006"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","cell line","A375"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","genotype","shGFP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","genotype","shB-Raf (doxycycline inducible)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","genotype","sh2B-raf (doxycycline inducible)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","Compound treatment","RAF inhibitor #1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","Compound treatment","doxycycline"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","Compound treatment","DMSO"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","genotype","negative control,wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13487>","shRNA profiling of melanoma A375 cells stably expressing a shRNA construct for doxycycline-inducible knockdown of B-Raf (2 mg/ml Dox, antitumor efficacy of RAF inhibitor GDC-0879 involving BRAFV600E mutational status and ERK/MAPK pathway suppression","Compound treatment","RAF inhibitor #2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","disease","rheumatoid arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","individual","EB87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","Compound treatment","transforming growth factor beta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","organism part","synovial membrane"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","disease","osteoarthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","individual","EB202"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","individual","EB220"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","Compound treatment","tumor necrosis factor-alpha"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","individual","EB221"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","individual","EB205"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13837>","Transcription profiling of human rheumatoid arthritis patients derived synovial fibroblasts - using  boolean network models for extracellular matrix formation","individual","EB190"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","Infection","FPV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","cell type","HUVEC,endothelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","organism part","umbilical vein"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","Infection","H5N1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","Infection","PR8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","genotype","pEGZ-transfected (empty vector)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13637>","Transcription profiling of HUVEC infected with Influenza virus","genotype","IKK2kd-transfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","disease","cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","metformin 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","time","18 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","growth condition","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","cell line","HT1080"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","organism part","bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","growth condition","5 grams per milliliter tunicamycin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","organism part","cervix"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","growth condition","5 millimolar 2-deoxyglucose"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","cell line","HeLa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","versipelostatin 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","growth condition","glucose free medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","pyrvinium pamoate 0.1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","organism part","stomach"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","cell line","MKN74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","cell line","HT-29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","time","15 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","versipelostatin 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","metformin 1500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","versipelostatin 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","growth condition","10 millimolar 2-deoxyglucose"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","buformin 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","phenformin 100 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","buformin 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","Compound treatment","phenformin 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13548>","Transcription profiling of human cancer cells treated with unfolded protein response modulators under endoplasmic reticulum stress conditions","growth condition","1 gram per milliliter tunicamycin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","cell type","immature dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","time","5 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","individual","donor #130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","cell type","differentiating dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","individual","donor #129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","cell type","CD14-positive monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","individual","donor #136"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13762>","Transcription profiling by array of human monocyte-derived dendritic cells treated with 1,25-dihydroxyvitamin D3","Compound treatment","1,25-dihydroxyvitamin D3 10 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","phenotype","senescent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","growth condition","static stress"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","passage","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","cell type","human umbilical vein endothelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","growth condition","shear stress"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","phenotype","young"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13712>","Transcription profiling by array of human young and senescent HUVECs under static and laminar shear stress conditions","passage","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","disease","ovarian cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","cell line","IGROV-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","RNAi","CXCR4 II shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","RNAi","CXCR4 I shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","RNAi","scrambled RNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13763>","RNAi profiling by array of human ovarian cancer cell line IGROV-1 knocked down for CXCR4","RNAi","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","cell line","HEK293"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","Compound treatment","epoxomicin 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14429>","Transcription profiling by array of human HEK293 cells treated with the proteasome inhibitor epoxomicin","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","disease","systemic lupus erythematosus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","stimulus","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","cell type","T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","stimulus","CD3/CD28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13887>","Transcription profiling of human CD3-positive T cells from SLE and controls reveals activation of mTOR controls the loss of TCRI? in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation","stimulus","nitric oxide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","phenotype","CD14 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13899>","Transcription profiling of human CD14+ monocytes were isolated from three healthy volunteers before and after a 2 wk supplementation period of 150mg quercetin per day","treatment","quercetin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","cell type","primary T lymphocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","growth condition","interleukin 2 deprivation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","disease","Nijmegen breakage syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","cell type","immortalised T lymphocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","age","11 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","organism part","spleen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13909>","Transcription profiling of human T lymphoblasts by IL-2 withdrawal  ro determione the molecular signature of induced cell cycle exit","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 60-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-063_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-083_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","non-smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 20-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-183_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-112_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 23-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 19-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-125_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-059_089AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-045_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-076_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-089_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","disease","chronic obstructive pulmonary disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-II, 75-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-087_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 30-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-230_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-057_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 24-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 119-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-136_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-035_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-114_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 22-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-033_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 15-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-059_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-147_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 34.5-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-122_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 3-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-066_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-129_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 11-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-130_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 12-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 44.3-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-164_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-003_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 5-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-161_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 33-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-119_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-060_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-059_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-II, 27-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-177_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 38-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 48-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-036_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-021_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 21-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-002_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-001_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-064_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-094_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 45-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-071_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-041_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-005_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-014_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-023_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-069_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 70-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-134_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-044_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 7.6-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-155_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 16-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-195_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 35-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-044_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-III, 87-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-047_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 23-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-103_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-068_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-II, 60-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-022_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-040_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 50 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-008_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-042_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-019_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-206_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 51-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-008_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-136_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 26-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-027_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-119_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 32.5-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-103_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-023_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-006_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-002_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-029_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-058_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 80-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-120_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","COPD-132_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","COPD; GOLD-I, 27-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-001_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","S-159_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","Clinical info","smoker; 3.8-pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13896>","Transcription profiling of human broncheolar lavage samples reveals smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of COPD","individual","NS-013_AM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","disease","gastric cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","organism part","stomach"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","genotype","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","genotype","microsatellite stable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","genotype","microsatellite instability"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13911>","Transcription profiling of human primary gastric tumors (MSI and MSS) and adjacent normal samples","organism part","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","organism part","ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","disease","ovarian serous carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","disease staging","high grade"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HOSE3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","disease staging","low grade"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","disease","normal,ovarian serous carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HOSE2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HOSE1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","HGOV8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14001>","Transcription profiling of human LMP ovarian tumors and low-grade ovarian carcinomas to identify genes which dffer from  high-grade ovarian carcinomas - PAX2: a potential biomarker for low malignant potential ovarian tumors and low-grade serous ovarian carcinomas","individual","LGOV9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14017>","Transcription profiling of human breast cancer metastases","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14017>","Transcription profiling of human breast cancer metastases","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14017>","Transcription profiling of human breast cancer metastases","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14017>","Transcription profiling of human breast cancer metastases","organism part","brain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14017>","Transcription profiling of human breast cancer metastases","organism part","bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","genotype","CEBPA expression silenced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","cell type","lymphoblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","genotype","CEBPA wildtype"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","disease","T acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","genotype","CEBPA mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14479>","Transcription profiling of human CEBPA mutant and CEBPA silenced AML and in T-ALL","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","time","11 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","passage","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","Compound treatment","microgel iron oxide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13975>","Transcription profiling by array of human fetal mesenchymal stem cell labelled with ferucarbotran or MGIO","Compound treatment","ferucarbutran"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","cell type","T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","cell line","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","disease","B cell chronic lymphocytic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","cell line","rolipram"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-13987>","Transcription profiling of human B lineage chronic lymphocytic leukemia, normal B, and normal T cells treated with rolipram, a PDE4 inhibitor","cell type","B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14390>","Transcription profiling by array of human alveolar macrophages infected by B. anthracis spores","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14390>","Transcription profiling by array of human alveolar macrophages infected by B. anthracis spores","Infection","mock infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14390>","Transcription profiling by array of human alveolar macrophages infected by B. anthracis spores","cell type","macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14390>","Transcription profiling by array of human alveolar macrophages infected by B. anthracis spores","organism part","aveoli"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14390>","Transcription profiling by array of human alveolar macrophages infected by B. anthracis spores","Infection","Bacillus anthracis spores"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","organism part","bronchiole"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","growth condition","cigarette smoke condensate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","time","1 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","cell line","BEAS-2B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","time","3 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","growth condition","DMSO"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","time","4 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","growth condition","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14383>","Transcription profiling of human bronchial epithelial cells to low doses of cigarette smoke condensate - chronic exposure","time","2 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","phenotype","HIV resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","cell type","CD4 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML466"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","ethnicity","African"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","clinical history","sex worker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","phenotype","HIV susceptible"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2200"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML767"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2040"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2043"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1928"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1700"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1747"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2034"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1260"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2243"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2140"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2236"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1938"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML2282"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1643"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14278>","Transcription profiling of human CD4+ T cell to identify differences between HIV-1 resistant and HIV-1 susceptible individuals","individual","ML1969"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","organism part","foreskin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell line","CRL-2097"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell type","fibroblast post hepatic differentiation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","organism part","embryo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell line","WAO9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell type","stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell type","induced pluripotent stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell type","stem cell post hepatic differentiation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14897>","Transcription profiling by array of human hepatic cells derived from foreskin fibroblast cell line and from embryonic stem cells.","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","organism part","tibia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","disease","osteosarcoma subtype osteoblastic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","Clinical info","Metastasis: Yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","clinical history","Chemotherapeutic response: poor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","cancer site","proximal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","disease","osteosarcoma subtype chondroblastic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","Clinical info","Metastasis: No"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","organism part","femur"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","clinical history","Chemotherapeutic response: good"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","cancer site","distal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","disease","osteosarcoma subtype telangiectatic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","disease","osteosarcoma subtype fibroblastic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","organism part","humerus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14827>","Gene expression profiles from osteosarcpma samples","age","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","NS1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","protocol type","cell isolation: negative selection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","cell type","CD4-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","PS10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","cell type","CD8-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","protocol type","cell isolation: positive selection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","PS6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","PS7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","NS2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","NS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","NS3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","NS5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","PS9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","PS8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14926>","Transcription profiling of human CD4 and CD8 T cells to identify effects of cell selection on gene expression","individual","PS11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","cell type","CD4-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M4Eo,prognosis Favourable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: Not applicable,prognosis Not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","cell type","CD8-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M2,prognosis Intermediate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M1,prognosis Intermediate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M4E0,prognosis Favourable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M4,prognosis Favourable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M4,prognosis Intermediate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14924>","Transcription profiling of human T cells from patients presenting with AML compared with healthy T cells","Clinical info","fab_type: M2E0,prognosis Favourable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14990>","MYC regulation of a ""poor prognosis"" metastatic cancer cell state","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14990>","MYC regulation of a ""poor prognosis"" metastatic cancer cell state","cell type","cancer cell culture"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14990>","MYC regulation of a ""poor prognosis"" metastatic cancer cell state","cell line","LNCAP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14990>","MYC regulation of a ""poor prognosis"" metastatic cancer cell state","cell line","MCF 10A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14990>","MYC regulation of a ""poor prognosis"" metastatic cancer cell state","cell type","immortalized cell culture"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","disease staging","Binet stage: C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","disease","chronic lymphocytic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","Compound treatment","valproic acid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","disease staging","Binet stage: B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","disease staging","Binet stage: A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","83 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-14973>","Transcription profiling of human chronic lymphocytic leukemia cells treated with valproic acid","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15205>","TGF or TNF Time series in ARPE19","Compound treatment","TNF"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15205>","TGF or TNF Time series in ARPE19","time","42 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15205>","TGF or TNF Time series in ARPE19","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15205>","TGF or TNF Time series in ARPE19","cell line","ARPE-19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15205>","TGF or TNF Time series in ARPE19","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15205>","TGF or TNF Time series in ARPE19","Compound treatment","TGF"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","disease staging","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","disease","polyarticular juvenile idiopathic arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","disease staging","clinical remission with medication"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","disease staging","active"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15645>","Transcription profiling of human polyarticular juvenile idipathic arthritis patients in different disease stages and with and without medication","disease staging","clinical remission without medication"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","individual","tonsil#8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","disease","inflamed tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","cell type","centroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","individual","tonsil#6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","cell type","centrocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","individual","tonsil#11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15271>","Expression data from CXCR4pos (centroblast) and CXCR4neg (centrocyte) Human Germinal Center B cells","individual","tonsil#7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","Compound treatment","R547"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","dose","IC90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","time","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","dose","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","dose","3xIC90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15389>","Transcription profiling of human peripheral blood mononuclear cells treated with a CDK inhibitor","Compound treatment","untreated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","developmental stage","gestation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","17.2 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","organism part","testis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","18.9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","16.1 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","12 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","14.4 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","organism part","ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","17.1 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","12.9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","13.6 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","9.1 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","16.9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","13.9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","16.4 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","12.6 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","11 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","9.9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","9.6 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","18.6 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","19.9 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","11.7 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15431>","Transcription profiling of human fetal testis and ovary","age","18.1 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","protocol type","expansion protocol: Whittier"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","cell type","islet beta cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","growth condition","redifferentiated cell culture"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","organism part","pancreas"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","protocol type","expansion protocol: NIH"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","growth condition","expanded cell culture"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","protocol type","expansion protocol: PPRF"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15543>","Transcription profiling of human islets after in vitro expansion.","growth condition","freshly isolated cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","organism part","umbilical cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","replicate","biological replicate 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","cell type","CD34+ cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","Compound treatment","BCR/FGFR1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","Compound treatment","MIG control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","replicate","biological replicate 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","Compound treatment","ZMYM2/FGFR1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","replicate","biological replicate 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15811>","ZMYM2/FGFR1, BCR/FGFR1 or BCR/ABL1 in human cord blood CD34+ cells reveals similar but distinct gene expression profiles","Compound treatment","BCR/ABL1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15799>","Expression data from NS398-treated and control HT29 colon adenocarcinoma cell line samples","cell line","HT-29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15799>","Expression data from NS398-treated and control HT29 colon adenocarcinoma cell line samples","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15799>","Expression data from NS398-treated and control HT29 colon adenocarcinoma cell line samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15799>","Expression data from NS398-treated and control HT29 colon adenocarcinoma cell line samples","treatment","NS398-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15893>","Gene expression pattern in CXCR4+ and CXCR4- subpopulation of breast cancer cells","cell line","MDAMB231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15893>","Gene expression pattern in CXCR4+ and CXCR4- subpopulation of breast cancer cells","cell type","CXCR4 negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15893>","Gene expression pattern in CXCR4+ and CXCR4- subpopulation of breast cancer cells","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15893>","Gene expression pattern in CXCR4+ and CXCR4- subpopulation of breast cancer cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15893>","Gene expression pattern in CXCR4+ and CXCR4- subpopulation of breast cancer cells","cell type","CXCR4 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15893>","Gene expression pattern in CXCR4+ and CXCR4- subpopulation of breast cancer cells","treatment","SDF1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","disease","periodontitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","organism part","gingival"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 121"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 85"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 119"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 76"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 107"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 131"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 98"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 123"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 126"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 125"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 88"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 108"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 78"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 86"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 95"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 82"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 115"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 84"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 91"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 94"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 92"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 102"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 101"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 89"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16134>","Transcription profiling of gingival tissue from patients with periodontitis: Bacterial Correlates of Gingival Gene Expression","individual","Patient 99"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","Compound treatment","1,25-dihydroxyvitamin D3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","cell line","RWPE1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15947>","Transcription profiling of human immortalized, non-tumorigenic prostate epithelial cell line -time course of 1,25(OH)2D treated RWPE1 cells.","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","cell type","polymorphonuclear leukocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","disease","autosomal dominant monocytopenia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16020>","Transcription profiling of polymorphonuclear leukocyte from patients affected with autosomal dominant monocytopenia and an increased susceptibility to mycobacterial infection.","individual","patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15960>","Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues","disease","colorectal cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15960>","Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15960>","Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues","isolation method","laser microdissected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15960>","Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues","cell type","colonic epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15960>","Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues","disease","adenoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-15960>","Expression data from human colonic epithelial cells normal (N), adenoma (AD) or colorectal cancer (CRC) tissues","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","Clinical info","survival"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","genotype","MYCN: single copy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","disease","neuroblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","6 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","disease staging","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 402"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 142"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","disease staging","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","9 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","8 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 365"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","disease staging","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","7 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 419"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 311"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","disease staging","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 287"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","46 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","Clinical info","death"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 423"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","3 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","16 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 401"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","72 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 384"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","36 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 426"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 424"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 434"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","23 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 364"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","genotype","MYCN: amplified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 280"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","53 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","disease staging","4S"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 410"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","64 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 379"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 296"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 400"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 151"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 418"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 194"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","117 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 189"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 452"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 259"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","106 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","15 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 351"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","1 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 338"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 314"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","12 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 346"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 342"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","38 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 360"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 413"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 428"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 429"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","19 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 373"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 147"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 430"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 313"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 288"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 320"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","13 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","age","2 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 160"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16237>","Transcription profiling of human neuroblastoma tissue samples","individual","case 163"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16193>","Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes","treatment","air"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16193>","Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes","cell type","THP-1 Cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16193>","Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16193>","Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes","treatment","LPS (1 ug/ml) and Carbon Monoxide (250 ppm)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16193>","Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes","treatment","LPS (1 ug/ml) and Air"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16193>","Interfering with Proximal TLR4 to NF-kappaB Signal Transduction in Human Monocytes","treatment","Carbon Monoxide Gas (250 ppm)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","clinical treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","disease","multiple sclerosis or clinically isolated syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","genotype","ICSBP1: allele 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","clinical treatment","glatiramer acetate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","genotype","ICSBP1: allele 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","clinical treatment","interferon beta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16214>","Transcription profiling of human peripheral blood from relapsing-remitting MS patients either untreated or treated with glatiramer acetate or interferon beta","genotype","ICSBP1: allele 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: undetectable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 326 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","ethnicity","Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1467"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1455"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 209 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 19400 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","ethnicity","African American"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","disease","acute HIV-1 infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 704 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","ethnicity","Hispanic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1476"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: greater than 100 000 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 410 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 683 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 3610 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1430"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","disease","asymptomatic HIV-1 infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1463"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 259 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 27200 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 202 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 122000 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 81 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","disease","AIDS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1462"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 35000 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 333 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1449"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 837 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1472"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 10684 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 188 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1406"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1442"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 485 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 147 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 4960 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1438"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 400 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1335"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 15284 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1389"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 32173 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 824 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1436"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 46400 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 248 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1431"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 71200 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1407"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 31922 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 372 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1459"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 286 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1408"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 685 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 20014 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 414 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1391"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 24718 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 742 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1452"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 14696 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1324"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 494 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 112 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 12046 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1327"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 370 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 484694 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1329"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 174000 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","clinical history","Peripheral Blood CD4 positive T cell level: 478 cells/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1456"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","age","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","Clinical info","plasma HIV-1 RNA level: 439000 copies/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16363>","Transcription profiling of human lymphatic tissue from HIV-1 infected individuals reveals stage-specific, gene-expression signatures in HIV-1 infection","individual","1458"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","organism part","lower lobe lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","ethnicity","Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","age","20-29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","environmental stress","non-smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","environmental stress","smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","organism part","upper lobe lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","age","40-49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","ethnicity","African American"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","age","50-59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","age","60-69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","environmental stress","former smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","age",">70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","age","30-39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-1643>","Transcription profiling of normal lung from 18 multi-organ donors to analyse variance of gene expression in lung","ethnicity","Hispanic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","cMCL (conventional mantle cell lymphoma)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","iMCL (indolent mantle cell lymphoma)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","HCL (Hairy Cell Leukemia)-variant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","HCL (Hairy Cell Leukemia)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","SMLZ (Splenic Marginal Zone Lymphoma)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","CLL (Chronic Lymphocytic Leukemia)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16455>","Transcription profiling by array of human indolent mantle cell lymphoma","disease","LF (follicular lymphoma)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","sample preparation","total RNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","disease","sickle cell anaemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","sample preparation","RNA extracted from PBMC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16728>","Transcription profiling of whole blood from sickle-cell disease patients using globin mRNA reduction","sample preparation","Globin-depleted RNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","organism part","pancreas"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","disease","pancreatic cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","76 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","84 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","81 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16515>","Transcription profiling of human pancreatic tumor and normal samples from the Mayo clinic","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","disease","Kawasaki disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","clinical treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","phenotype","intravenous immunoglobulin resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","phenotype","intravenous immunoglobulin responsive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","clinical treatment","intravenous immunoglobulin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16797>","Transcription profiling of Kawasaki disease patients who may benefit from methylprednisolone","clinical treatment","intravenous immunoglobulin and methylprednisolone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16836>","Transcription profiling of human CD16+ and CD16- peripheral blood monocytes from healthy individuals","cell type","CD16 positive,CD16 positive mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16836>","Transcription profiling of human CD16+ and CD16- peripheral blood monocytes from healthy individuals","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16836>","Transcription profiling of human CD16+ and CD16- peripheral blood monocytes from healthy individuals","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16836>","Transcription profiling of human CD16+ and CD16- peripheral blood monocytes from healthy individuals","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16836>","Transcription profiling of human CD16+ and CD16- peripheral blood monocytes from healthy individuals","cell type","CD16 negative,CD16 negative mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","cell type","polymorphonuclear leukocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","latex beads"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","Staphylococcus aureus strain 9897"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","Staphylococcus aureus strain 252"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","Staphylococcus aureus strain 10254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","Staphylococcus aureus strain Col"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","treatment","Staphylococcus aureus strain 11490"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-16837>","Transcription profiling of neutrophils exposed to  S. aureus infection","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","cell line","A459"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","cell type","lung carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","genotype","hypotriploid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","genotype","p53 deficient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","cell type","squamous cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17347>","Expression data of two human cancer cell lines cultivated in 2-dimensional (2D) vs. 3-dimensional (3D) cell culture","cell line","UT-15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","histology","DLBCL (PC)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Infection","Epstein-Barr virus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","disease","AIDS related lymphoma,activated B-cell-like diffuse large B-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","histology","High Grade, UC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","pleural fluid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","disease","AIDS related lymphoma,germinal center B-cell-like diffuse large B-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","histology","DLBCL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","mediastinal/atrial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","disease","AIDS related lymphoma,Burkitts lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","small intestine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","disease","AIDS related lymphoma,diffuse large B-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","jejunum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","neck"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","spinal/epidural"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","hilum/lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","Clinical info","age at diagnosis: 46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17189>","Molecular Classification of AIDS-Related Lymphomas","organism part","hilum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","individual","Donor 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","cell type","hepatocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","individual","Donor 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","individual","Donor 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","individual","Donor 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","Compound treatment","prinixic acid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","individual","Donor 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","individual","Donor 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17251>","Transcription profiling of human primary hepatocytes treated with transcription factor PPAR agonist Wy14643","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","cell line","2B4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","Infection","severe acute respiratory syndrome-associated coronavirus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17400>","Transcription profiling of the dynamic Innate Immune Responses in Human Bronchial Epithelial Cells against SARS-CoV and DOHV infection","Infection","Dhori virus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17385>","Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or beta-catenin knockdown.","cell line","MM.1S"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17385>","Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or beta-catenin knockdown.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17385>","Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or beta-catenin knockdown.","genetic modification","pKLO beta-catenin shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17385>","Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or beta-catenin knockdown.","disease","multiple myeloma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17385>","Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or beta-catenin knockdown.","genetic modification","pKLO GFP control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17482>","Gene expression profiles regulated by Stat5a/b vs. Stat3 in human prostate cancer cells.","cell type","prostrate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17482>","Gene expression profiles regulated by Stat5a/b vs. Stat3 in human prostate cancer cells.","cell line","CWR22Rv1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17482>","Gene expression profiles regulated by Stat5a/b vs. Stat3 in human prostate cancer cells.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17482>","Gene expression profiles regulated by Stat5a/b vs. Stat3 in human prostate cancer cells.","cell line","DU145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","Clinical info","kit expression: high"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","disease","gastrointestinal stromal tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","genotype","KIT mutation; PDGFRA wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","genotype","KIT wild type; PDGFRA mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","Clinical info","kit expression: low"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","genotype","KIT wild type; PDGFRA wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17743>","Transcription profiling of human gastrointestinal stromal tumours according to KIT mutations and expression","Clinical info","kit expression: MEDIUM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17763>","Trancription profiling of skin lesions from leprosy samples: Divergence of macrophage phagocytic and antimicrobial programs in leprosy","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17763>","Trancription profiling of skin lesions from leprosy samples: Divergence of macrophage phagocytic and antimicrobial programs in leprosy","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17763>","Trancription profiling of skin lesions from leprosy samples: Divergence of macrophage phagocytic and antimicrobial programs in leprosy","disease","reversal reaction leprosy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17763>","Trancription profiling of skin lesions from leprosy samples: Divergence of macrophage phagocytic and antimicrobial programs in leprosy","disease","lepromatous leprosy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17763>","Trancription profiling of skin lesions from leprosy samples: Divergence of macrophage phagocytic and antimicrobial programs in leprosy","disease","borderline tuberculoid leprosy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","metastasis","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","organism part","cancer, LCM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","metastasis","metastasis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","organism part","cancer, Homogenized"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","metastasis","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","metastasis","metastatic recurrence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18105>","Stage II and stage III colorectal cancer","organism part","normal. Homogenized"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","disease","choroideremia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","cell type","fibroblast,primary fibroblast culture"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17549>","Transcription profiling of  peripheral blood or primary finroblast cultures from choroideremia patients to determine if loss-of-function mutations in REP-1 affect intracellular vesicle transport in fibroblasts and monocytes of CHM patients","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","organism part","cultured skin substitute"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","time","3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","time","14 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","time","42 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","time","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","time","28 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17539>","Transcription profiling of human grafted engineered skin substitutes compared with intact human","time","56 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17636>","Expression data from breast cancer cells overexpressing NF1-C2","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17636>","Expression data from breast cancer cells overexpressing NF1-C2","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17636>","Expression data from breast cancer cells overexpressing NF1-C2","cell line","MDAMB436"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17636>","Expression data from breast cancer cells overexpressing NF1-C2","phenotype","overexpressing NF-C2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17636>","Expression data from breast cancer cells overexpressing NF1-C2","phenotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease","prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","tumor size","2.7 cubic centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease staging","Gleason stage: 4+4,tumor stage: T3b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","cell type","CD90 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease staging","Gleason stage: 4+5,tumor stage: T3aN1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","tumor size","less than 5 cubic centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","cell type","CD49a positive,stromal fibromuscular"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease staging","Gleason stage: 3+4,tumor stage: T2c"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","tumor size","2.5 cubic centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","tumor size","3.4 cubic centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","cell type","CD26 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","organism part","bladder"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","cell type","CD13 positive,stromal fibromuscular"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","cell type","CD13 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease","bladder cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease staging","Gleason stage: 3+3,tumor stage: T2cN0Mx"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","tumor size","4.7 cubic centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","disease staging","Gleason stage: 4+5,tumor stage: T3a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-17906>","Transcription profiling of human CD90+ stromal fibromuscular cells from tumor specimens reveals down-regulation in prostate tumor-associated stromal cells involves organ-specific genes","tumor size","3 cubic centimeters"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","genotype","FLT3-wild type; NPM1-mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","disease","without MLD"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","genotype","FLT3-wild type; NPM1-wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","disease","with MLD"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18018>","Multilineage dysplasia and AML with mutated nucleophosmin","genotype","FLT3-mutated; NPM1-mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18271>","Analysis of TALE homeobox genes in neuroblastic tumors: ganglioneuroblastoma and ganglioneuroma","organism part","ganglioneuroma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18271>","Analysis of TALE homeobox genes in neuroblastic tumors: ganglioneuroblastoma and ganglioneuroma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18271>","Analysis of TALE homeobox genes in neuroblastic tumors: ganglioneuroblastoma and ganglioneuroma","organism part","ganglioneuroblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism","Bos taurus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","morula"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism part","morula"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism part","embryo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","embryo at two cell stage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","embryo at four cell stage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","blastocyst"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism part","blastocyst"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","embryo at one cell stage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","embryo at eight cell stage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","embryo at sixteen cells stage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","developmental stage","oocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18290>","Transcription profiling of human, mouse, Bos taurus embryo","organism part","oocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18370>","21T series cell lines show distinct stage-specific gene expression alterations","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18370>","21T series cell lines show distinct stage-specific gene expression alterations","cell line","NTci"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18370>","21T series cell lines show distinct stage-specific gene expression alterations","cell line","PTci"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18370>","21T series cell lines show distinct stage-specific gene expression alterations","cell line","MT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","fetal RPE"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","age","gestational age 18 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","adult native RPE from 78 y.o. donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","age","gestational age not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","age","gestational age 16 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","adult native RPE from 89 y.o. donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","native fetal RPE"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell line","ARPE-19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","age","gestational age 17 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","adult native RPE from 76 y.o. donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18811>","Transcriptome Analysis and Molecular Signature of Human Retinal Pigment Epithelium","cell type","adult choroid from 76 y.o. donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","Infection","Newcastle disease virus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","10 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","cell type","dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","18 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","16 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18791>","Transcription profiling of dendritic cells infected with Newcastle Disease Virus reveals that antiviral response is dictated by a choreographed cascade of transcription factors","time","14 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","cell type","endothelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","organism part","umbilical vein"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","Compound treatment","vascular endothelial growth factor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","genotype","Egr-3 siRNA #2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18913>","Transcription profiling of human HUVEC cells for Egr-3 knockdown in VEGF-treated cells.","genotype","Egr-3 siRNA #1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18842>","Transcription profiling of human lung cancer and control samples","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18842>","Transcription profiling of human lung cancer and control samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18842>","Transcription profiling of human lung cancer and control samples","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18842>","Transcription profiling of human lung cancer and control samples","disease","non-small cell lung cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","disease","peripheral T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell type","CD8-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","not available years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","disease","T-cell acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell line","MOLT3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell type","CD4-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","87 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell line","HuT78"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","18.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","76 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","18.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","17 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell line","PEER"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell line","JURKAT_B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","14 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","82 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","12 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","80 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","97 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","86 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19069>","Transcription profiling of biopsy samples from peripheral T-cell lymphoma (PTCL)","cell type","lymphoblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","sampling time point","post-transplant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","Clinical info","cardiac death donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","donor","cardiac death donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","sampling time point","pre-transplant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","Clinical info","brain death donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","donor","brain death donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-18995>","Transcription profiling of lung tissue from cardiac death and brain death donors, both pre and post transplant","individual","No_4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19018>","Changes in gene expression of Imr90 cells with age and senescence under 3% and 20% oxygen growth conditions","cell line","IMR-90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19018>","Changes in gene expression of Imr90 cells with age and senescence under 3% and 20% oxygen growth conditions","developmental stage","young"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19018>","Changes in gene expression of Imr90 cells with age and senescence under 3% and 20% oxygen growth conditions","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19018>","Changes in gene expression of Imr90 cells with age and senescence under 3% and 20% oxygen growth conditions","growth condition","20% oxygen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19018>","Changes in gene expression of Imr90 cells with age and senescence under 3% and 20% oxygen growth conditions","developmental stage","old"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19018>","Changes in gene expression of Imr90 cells with age and senescence under 3% and 20% oxygen growth conditions","growth condition","3% oxygen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","organism part","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","disease","extranodal NK/T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell type","natural killer cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","NK92"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","disease","peripheral T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","SNT15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell type","gamma-delta T-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","NKYS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","disease","blastic NK-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","YT-N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","SNK10B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","cell line","SNT13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19067>","Transcription profiling of natural-killer (NK) cell lymphoma to determine the disease molecular signature.","age","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","treatment","FFPET"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","disease","B-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","disease staging","germinal center B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","protocol type","Eberwine biotin method"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","Clinical info","germinal center B-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","treatment","fresh/frozen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","disease staging","Unclassified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","Clinical info","Unclassified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","protocol type","Ribo-SPIA biotin method"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","disease staging","activated B-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19246>","A novel method of amplification of FFPET derived-RNA enables accurate disease classification with microarrays","Clinical info","activated B-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","individual","patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","treatment","paclitaxel-eluting stent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","individual","patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","treatment","bare metal cardiovascular stent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","individual","patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19136>","Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries","individual","patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","disease","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","56.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","organism status","deceased"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","cell type","LCC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","disease","healthy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","cell type","healthy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","organism status","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","103.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","organism status","alive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","cell type","ADC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","2.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","87.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","67.87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","4.87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","98.93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","9.47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","29.27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","17.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","16.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","24.17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","26.43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","cell type","SCC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","15.07"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","86.27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","12.57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","10.03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","27.97"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","7.13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","20.37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","2.43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","51.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","51.23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","47.23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","89.03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","66.47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","55.07"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","22.57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","12.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","11.43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","110.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","97.73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","19.17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","98.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","124.83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","80.03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","94.57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","3.97"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","31.47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","35.73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","5.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","23.13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","27.17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","10.33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","21.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","0.07"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","0.67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","63.87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","2.53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","17.67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","79.27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","9.23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","89.73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","79.87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","13.73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","78.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","1.13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","37.63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","5.53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","20.93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","20.53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","108.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","6.77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","32.07"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","2.67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","78.63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","127.17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","116.83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","3.17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","60.73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","32.77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","124.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","8.27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","46.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","63.03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","50.53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","67.63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19188>","Expression data for early stage NSCLC","survival time","0.87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","growth condition","long term estrogen deprived"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","cell line","MDA-361"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","estrogen receptor status","positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","cell line","ZR75-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","cell line","HCC-1428"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19639>","Transcription profiling of estrogen receptor positive breast cancer cell lines after long term estrogen deprivation","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","disease staging","IIIC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","disease","melanoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","Clinical info","Chemotherapy response: stable disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","genotype","BRAF mutation: negative;NRAS mutation: positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","genotype","BRAF mutation: not available;NRAS mutation: not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","Clinical info","Chemotherapy response: complete response"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","genotype","BRAF mutation: positive;NRAS mutation: negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","disease staging","IIIB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","Clinical info","Chemotherapy response: partial response"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","genotype","BRAF mutation: negative;NRAS mutation: negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","Clinical info","Chemotherapy response: progressive disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19293>","Trancription profling of In-transit extremity melanoma II lesions","disease staging","IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell type","lymphoblastoid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","Compound treatment","thapsigargin 500 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","family relationship","Twin number 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14406"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14406"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14506"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","family relationship","Twin number 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14506"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14417"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14417"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","The Human Biological Data Interchange (http://www.ndriresource.org/NDRI_Initiatives/HBDI/36/)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","individual","HB02069"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14584"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14584"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14478"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14478"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","Compound treatment","tunicamycin 4 micrograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07357"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM07357"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14582"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14582"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12751"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12751"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12043"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12043"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07034"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM07034"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14568"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14568"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14468"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14468"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12003"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12003"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14433"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14433"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14409"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14409"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12875"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12875"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12156"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12156"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14509"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14509"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12264"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12264"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14414"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14414"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM11994"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11994"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14408"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14408"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM06994"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM06994"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12716"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12716"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14504"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14504"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14476"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14476"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12248"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12248"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14533"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14533"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14447"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14447"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11829"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11829"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12005"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12005"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12249"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12249"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12155"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12155"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12234"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12234"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM06985"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM06985"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14382"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14382"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14481"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14481"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11881"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM11881"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM07055"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07055"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12813"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12813"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14440"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14440"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12814"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12814"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11995"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11995"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM06993"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM06993"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14532"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14532"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14536"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14536"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11832"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11832"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12763"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12763"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14535"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14535"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12750"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12750"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14439"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14439"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12762"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12762"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14455"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14455"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14454"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14454"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12057"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12057"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12891"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12891"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","individual","HB02070"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12892"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12892"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14503"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14503"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14507"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14507"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12004"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12004"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11830"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM11830"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12815"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12815"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14477"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14477"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14381"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14381"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11993"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11993"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14448"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14448"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12236"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12236"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12874"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12874"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12761"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12761"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11840"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11840"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12146"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12146"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14475"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14475"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12760"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12760"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14405"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14405"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14581"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14581"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14467"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14467"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14432"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14432"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12044"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12044"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12717"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12717"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11992"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11992"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM07022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12812"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12812"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14569"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14569"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12873"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM12873"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM11882"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11882"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14452"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14452"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14521"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14521"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14465"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14465"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14520"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14520"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12006"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12006"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12872"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12872"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM12239"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM12239"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14508"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14508"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14474"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14474"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11831"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM11831"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07000"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM07000"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14583"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14583"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM14479"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14479"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM14501"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM14501"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM07056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","Coriell: GM07345"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM07345"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","cell line","GM11839"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19519>","Transcription profiling of immortalized B cells from unrelated individuals and twins undergoing ER stress","biosource provider","http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM11839"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease staging","moderately differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","Clinical info","liver cancer tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease","hepatocellular carcinoma; HBV+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","189T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","376T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease staging","moderately-poorly differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease staging","poorly differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease","hepatocellular carcinoma HBV+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","363T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","363N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease","HCV+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease staging","chronic hepatitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","Clinical info","surrounding noncancerous liver tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease","hepatocellular carcinoma; HCV+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","364T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease","HBV+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","376N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","189N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","365T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","360T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","364N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","disease staging","liver cirrhosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","365N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","367T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","360N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","359T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","358T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","359N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","375T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","358N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","375N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19665>","Aberrant DNA methylation in hepatitis B and C virus-related hepatocellular carcinoma","individual","367N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","disease staging","international staging system: II"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","disease","multiple myeloma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","cell type","CD138-positive plasma cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","disease staging","international staging system: III"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","disease staging","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19784>","Transcription profiling of bone marrow plasma cells from 320 newly diagnosed multiple myeloma patients","disease staging","international staging system: I"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease","gastric cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease staging","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","organism part","intestine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease staging","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease staging","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease staging","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19826>","Transcription profiling of human chinese gastric cancer samples vs. adjacent samples","disease staging","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","Clinical info","survival"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","survival","survival"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 57 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","injury","burn"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","544.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease","inhalation injury"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","InhalationInjury","inhalation injury"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","43% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","developmental stage","child"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 28 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","74% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","injury","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","88"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 62 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","63% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 13 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","35.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease","no inhalation injury"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","InhalationInjury","no inhalation injury"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","58% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 25 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","77% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","599.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","Clinical info","Did not survive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","survival","Did not survive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 127 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","36.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","90% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","46% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 47 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","485.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","15.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","76% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","536.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 60 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","60% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","469.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 49 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","295.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","84% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","72% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 54 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","309.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","43.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 58 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","82% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 56 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","450"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","52% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 19 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","92% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","383.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","516"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","54% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","18.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","70% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 43 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 33 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","5.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","62% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 87 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","40% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","585.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","266.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","78% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","499.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","760.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","18.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","87% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 70 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","61% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 37 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 93 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","93% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","95.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 17 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","91% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 72 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","68% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","512.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","69% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","329.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 45 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","85"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 85 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","550.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","50% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 143 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","51% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","285.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","705.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","56% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","465.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","80% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 36 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","85.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","78.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 38 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","48% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","225.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","363.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 44 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","306.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 209 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","37.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","67% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","57.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 99 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","426.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","99"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","30.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 8 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","61.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","292.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","42% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","418.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","28.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 30 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","390.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","441"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","47% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","325.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 16 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","71.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","86% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","242"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","655.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 242 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","680.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 26 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","514.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","95.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 73 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","310.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","65% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","39.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","64% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 21 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 63 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","19.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","230"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 230 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","378"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","141.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","375.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","452.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 67 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","282.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 89 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","66% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","89"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","431"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","4.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","712"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 27 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","655"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","79% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","49.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","375.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","482"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","565.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","505.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","86.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","445.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","311.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","39.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","7.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","327.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","77.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","22.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","12.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","40.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","114.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","513"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","81.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","61.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","59.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","498"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","disease staging","41% total burn surface area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 145 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","11.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","14.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","9.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","301"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 42 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","74.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","24.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","clinical history","length of hospital stay: 18 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","LengthOfHospitalStay","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","165.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","32.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","280"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","41.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","360.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","349.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","357.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","6.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","473.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","18.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","543.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","317.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","120.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","43.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","443.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","18.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19743>","A large-scale clinical study of gene expression response to severe burn injury","sampling time point","141.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease","lung tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","139T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","Clinical info","non smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","ethnicity","Taiwanese"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","1B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","189T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","1A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease","lung cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","119N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","76 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","127N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","130N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","2A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","125T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","43N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","3B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","165T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","159T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","106N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","3A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","32T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","135N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","144T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","152N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","157T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","179T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","102N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","109T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","116N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","118N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","97N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","131N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","179N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","124T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","disease staging","2B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","167T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","142N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","137N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","122T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","156T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","130T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","148T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","133T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","109N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","136N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","91N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","146T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","115T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","80 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","103T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","126T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","159N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","123T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","156N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","142T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","17T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","114N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","149T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","123N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","145N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","121N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","37N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","165N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","2N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","167N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","189N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","92T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","79T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","103N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","177N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","127T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","177T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","152T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","97T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","2T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","144N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","119T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","37T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","120T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","131T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","102T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","129T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","106T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","79N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","114T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","117T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","129N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","134T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","137T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","91T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","124N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","120N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","40T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","154T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","122N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","94N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","126N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","132N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","154N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","143N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","121T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","139N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","134N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","94T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","117N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","17N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","6T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","146N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","125N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","32N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","135T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","92N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","3T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","118T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","33T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","132T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","33N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","157N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","3N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","116T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","158N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","133N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","148N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","40N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","158T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","115N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","149N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","43T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","6N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","143T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","145T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19804>","Transcription profiling of lung cancer tumors from a female, non-smoking taiwanese population: Genome-wide screening of transcriptional modulation in non-smoking female lung cancer in Taiwan","individual","136T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","growth condition","ras-induced senescence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","cell line","IMR-90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","genotype","empty vector control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","genotype","p130 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","growth condition","low serum quiescence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","growth condition","normal growth"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","genotype","p107 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","growth condition","confluent quiescence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19864>","Transcription profiling of human IMR90 cells after RNAi suppression of RB, p107 or p130 using in growing, quiescent or ras-induced senescent IMR90 cells","genotype","RB shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","genotype","c-myc wild_type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","cell line","Rat-1 fibroblast cell line TGR"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","organism","Rattus norvegicus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","protocol type","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","genotype","c-myc null"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","protocol type","siRNA-mediated cdr2 knockdown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","cell line","Rat-1 fibroblast cell line 15.19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","genotype","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20037>","cdr2 siRNA knockdown during passage through mitosis: HeLa cells, Rat1 wild type and c-myc null cells","cell line","HeLa cell-cervical carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19982>","Transcription profiling of chromophobe renal cell carcinoma and oncocytoma samples","disease","renal oncocytoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19982>","Transcription profiling of chromophobe renal cell carcinoma and oncocytoma samples","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19982>","Transcription profiling of chromophobe renal cell carcinoma and oncocytoma samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-19982>","Transcription profiling of chromophobe renal cell carcinoma and oncocytoma samples","disease","chromophobe renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","developmental stage","undifferentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","iPSC derived from hASC using minicircle reprogramming vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","iPS cells from episomal vectors (Defined Factor)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","adipose stem cells derived from adult human donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","iPSC derived from hASC using lentiviral reprogramming vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","iPS cells from episomal vectors (Defined Factor sub-clone)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","human embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20033>","Minicircle-derived iPS cells - Affymetrix Data","cell type","parental foreskin cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20086>","Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast","organism part","normal breast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20086>","Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast","cell type","normal fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20086>","Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20086>","Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast","cell type","carcinoma-associated fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20086>","Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast","organism part","breast carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","cell line","MDA231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","cell line","HT1080"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","cell line","U87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","cell line","U251"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","cell line","MDA435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20089>","Pseudopod Experiment","cell line","DU145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","disease","hypertriglyceridemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","clinical treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","clinical treatment","docosahexaenoic acid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20114>","Transcription profiling of blood cells from hypertriglyceridemic men treated with docosahexaenoic acid shows suppression of LDLR and OLR1 gene expression.","Compound treatment","lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND04158"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","biosource provider","NINDS Coriell Cell Repository"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","disease","Parkinson's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","sample type","B lymphocytes from peripheral blood were transformed with EBV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND00022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND01737"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND00268"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND02852"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND00151"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND04424"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND01173"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND02579"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND00397"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND06449"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND06229"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND00259"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND03367"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND00051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20153>","Expression analysis of lymphoblast cells lines in Parkinson's disease","cell line","ND03432"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20124>","Transcriptome analysis of human Whartons jelly stem cells: in-house analysis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20124>","Transcriptome analysis of human Whartons jelly stem cells: in-house analysis","cell type","Wharton's jelly stem cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20124>","Transcriptome analysis of human Whartons jelly stem cells: in-house analysis","cell type","embryonic carcinoma cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20124>","Transcriptome analysis of human Whartons jelly stem cells: in-house analysis","cell type","embryonic stem cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20124>","Transcriptome analysis of human Whartons jelly stem cells: in-house analysis","cell type","fetal fibroblast cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20266>","Salivary Transcriptomic and Proteomic Biomarkers for Breast Cancer Detection","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20266>","Salivary Transcriptomic and Proteomic Biomarkers for Breast Cancer Detection","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20266>","Salivary Transcriptomic and Proteomic Biomarkers for Breast Cancer Detection","biosource type","saliva"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20266>","Salivary Transcriptomic and Proteomic Biomarkers for Breast Cancer Detection","disease","healthy control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20272>","Expression data from human ovarian cancer cells induced by IL-6 and CNTO328","cell line","SKOV3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20272>","Expression data from human ovarian cancer cells induced by IL-6 and CNTO328","cell type","Ovarian cancer cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20272>","Expression data from human ovarian cancer cells induced by IL-6 and CNTO328","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20272>","Expression data from human ovarian cancer cells induced by IL-6 and CNTO328","cell line","CaOv3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20193>","Altered levels of MOF and decreased levels of H4K16ac correlate with a defective DNA damage response (DDR).","cell type","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20193>","Altered levels of MOF and decreased levels of H4K16ac correlate with a defective DNA damage response (DDR).","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20193>","Altered levels of MOF and decreased levels of H4K16ac correlate with a defective DNA damage response (DDR).","cell line","HEK293"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20193>","Altered levels of MOF and decreased levels of H4K16ac correlate with a defective DNA damage response (DDR).","cell type","hMOF over-expressed"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20193>","Altered levels of MOF and decreased levels of H4K16ac correlate with a defective DNA damage response (DDR).","cell type","hMOF knock-down"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","Clinical info","cycling endometrium secretory phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","cycle phase/ gestational age","cycling endometrium secretory phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","cell type","eNK cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","Clinical info","first trimester"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","cycle phase/ gestational age","first trimester"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","cell type","dNK cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","Clinical info","cycling endometrium proliferative phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20499>","Expression data of human decidual NK cells from gravid uteri and NK cells from cycling endometrium","cycle phase/ gestational age","cycling endometrium proliferative phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20504>","Human umbilical cord blood-derived endothelial colony forming cells under serum-free conditions","cell type","endothelial colony forming cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20504>","Human umbilical cord blood-derived endothelial colony forming cells under serum-free conditions","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20504>","Human umbilical cord blood-derived endothelial colony forming cells under serum-free conditions","growth condition","SF1 culture medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20504>","Human umbilical cord blood-derived endothelial colony forming cells under serum-free conditions","growth condition","EGM2 culture medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","disease","multiple myeloma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","genetic modification","green fluorescent protein expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","cell line","INA-6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","growth condition","co-culture with human bone marrow stromal cell line HS-5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","cell line","MM.1R"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","growth condition","cultured alone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20540>","Transcription profiling of human multiple myeloma cells co-cultured with bone marrow stromal cells in vitro","cell line","MM.1S"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","growth condition","S2 stimulation (British trial conditions)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","time","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","individual","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","cell type","bone marrow-derived CD34+ cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","time","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","individual","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","growth condition","S1 stimulation (French trial conditions)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","individual","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","time","96"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20505>","Expression data from CD34+ hematopoietic progenitor cells","growth condition","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","histology","well-differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","biosource provider","Cooperative Human Tissue Network"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","disease","liposarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","histology","well-differentiated spindle cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","biosource provider","Fox Chase Cancer Center Biorepository"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","histology","myxoid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","biosource provider","Anderson Cancer Institute"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","histology","dedifferentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","histology","pleomorphic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","histology","myxoid round cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20559>","Gene expression signature reflects differentiation differences rather than telomere maintenance mechanism","biosource provider","Cooperative Human Tissue Network (CHTN)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21164>","Expression data from total knee arthroplasty patients","sampling time point","T0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21164>","Expression data from total knee arthroplasty patients","organism part","Quadriceps muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21164>","Expression data from total knee arthroplasty patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21164>","Expression data from total knee arthroplasty patients","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21164>","Expression data from total knee arthroplasty patients","treatment","total knee arthroplasty treatment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21164>","Expression data from total knee arthroplasty patients","sampling time point","T1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20719>","Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20719>","Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941","cell line","T47D"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20719>","Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20719>","Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941","Compound treatment","1mM GDC-0941"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411001"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","disease","Liposarcoma - dedifferentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","organism part","extremity"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","disease","undifferentiated sarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411024"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","disease","other"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411030"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","disease","leiomyosarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411009"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","organism part","Trunk wall"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","organism part","Internal trunk"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411075"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411004"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411080"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410996"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410990"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410981"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411078"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411033"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","organism part","Head and neck"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411014"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410974"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411084"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411027"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411055"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411035"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410964"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410979"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410962"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410951"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410954"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411011"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411103"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410972"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411115"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411008"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411074"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411066"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411054"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411057"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410960"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410977"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411073"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411114"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410984"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411006"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411088"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410956"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411021"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410988"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410959"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411077"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411102"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410967"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411095"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410989"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410961"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411098"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411079"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411119"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411023"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411028"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411026"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411058"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411007"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410963"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411097"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410953"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410978"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410985"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410986"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411061"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411070"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410969"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411042"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411099"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411052"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411122"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410965"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411034"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410987"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411060"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411018"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411071"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411092"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411062"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411094"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411049"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411076"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411016"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411015"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410980"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410999"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410993"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411040"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411029"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411020"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411107"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411010"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411067"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411038"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411031"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410976"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410957"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410955"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411064"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411068"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410992"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411086"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410991"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410970"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411053"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410966"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411059"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411090"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411069"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411126"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411019"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411072"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411043"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411065"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410949"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411005"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411087"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411032"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411125"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411101"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411017"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410971"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410950"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411044"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411041"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411047"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411121"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411083"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410998"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410973"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410975"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410958"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411025"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411039"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411082"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411012"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411089"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411013"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411045"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411123"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411091"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410982"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411050"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411093"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411046"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411085"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410995"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411036"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410968"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411063"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411108"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410983"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410994"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411081"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411000"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411096"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411128"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410952"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411037"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410997"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411048"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM410948"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21050>","Transcription profiling of soft tissue sarcoma: Expression data from Complex genetics sarcomas (cohort 1 and 2)","individual","GSM411003"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","Infection","hepatitis C virus JFH-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","cell line","Huh7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","cell type","hepatoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","time","18 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20948>","Trancription profiling of the hepatoma cell line Huh7 infected with the Hepatitis C Virus","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","treatment","lbh589 only"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","individual","5269"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","individual","5278"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","treatment","lbh589 and imatinib"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","treatment","imatinib only"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20876>","Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate","individual","5258"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","Clinical info","insulin sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","disease","obese"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","organism part","subcutaneous adipose"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","organism part","omental adipose"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-20950>","Transcription profiling of human adipose tissue using an expanded patient cohort","Clinical info","insulin resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","disease staging","intermediate duration of illness - schizophrenia (DOI=7-18yrs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","organism part","Brodmann area46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","disease staging","long duration of illness - control (DOI=>28 yrs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","disease staging","short duration of illness control (DOI=<5 yrs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","disease staging","intermediate duration of illness - control (DOI=7-18yrs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","disease staging","short duration of illness-schizophrenia (DOI=<5 yrs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21138>","Gene Expression Profiles in BA46 of Subjects with Schizophrenia and Matched Controls","disease staging","long duration of illness - schizophrenia (DOI=>28 yrs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","disease","engineered invasive esophageal squamous cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","egfr overexpression","yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","htert over expression","yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","genotype","p53_mutation R175H"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","genotype","p53_mutation R273H"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","genotype","p53_mutation R248W"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","genotype","p53_mutation V143A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","egfr overexpression","no"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","disease","engineered non-invasive esophageal squamous cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","genotype","p53_mutation none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21293>","Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor invasive signature in esophageal cancer","genotype","p53_mutation 2R73H"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21261>","Transcription profiling of Multilineage Dysplasia (MLD) in AML correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21261>","Transcription profiling of Multilineage Dysplasia (MLD) in AML correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance","Clinical info","multilineage dysplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21261>","Transcription profiling of Multilineage Dysplasia (MLD) in AML correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21261>","Transcription profiling of Multilineage Dysplasia (MLD) in AML correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21261>","Transcription profiling of Multilineage Dysplasia (MLD) in AML correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21261>","Transcription profiling of Multilineage Dysplasia (MLD) in AML correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance","Clinical info","multilineage dysplasia related changes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","clinical history","rejection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","Rejection/Non-Rejection","rejection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","Clinical info","no"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","Failed: yes/no","no"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","341"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","341"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3499"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","669"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","669"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","clinical history","non-rejection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","Rejection/Non-Rejection","non-rejection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","639"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","639"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","12831"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","773"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","773"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","Clinical info","yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","Failed: yes/no","yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","273"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3099"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","259"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","259"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","476"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","476"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","11453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","310"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","965"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","965"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","577"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","577"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1562"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1167"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1167"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","543"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","543"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1244"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1244"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","524"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","524"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","772"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3233"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","225"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","225"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","928"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","928"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","281"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2752"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","237"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","237"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1093"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1093"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","664"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","664"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","995"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","844"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","844"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1093"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1591"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1491"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1491"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3683"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","762"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","762"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","463"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","463"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","306"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","493"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","712"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","712"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","402"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","135"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","659"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","659"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2676"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","811"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","811"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","345"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","777"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","777"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","175"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","175"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","6547"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","566"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","566"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1259"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1322"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1322"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","91"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","523"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","523"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3614"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1590"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1590"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2052"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","494"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","494"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","658"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","658"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","685"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","454"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","454"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","588"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","78"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1251"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1251"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3760"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","469"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","469"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","979"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","979"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2526"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1875"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","819"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","819"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5547"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","298"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","298"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","751"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4349"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","421"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","421"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","702"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","702"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1662"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","743"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1076"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1076"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","539"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","539"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","534"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","353"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","353"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","947"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","507"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","507"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","553"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","963"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","652"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","652"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1430"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1430"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2358"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1036"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1036"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","613"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","613"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1560"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1560"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","267"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1185"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1185"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2094"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","996"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","544"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","581"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","581"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1156"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1156"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2224"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1411"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1411"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1288"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1288"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1331"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1331"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2822"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","427"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","427"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1583"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1045"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1045"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1835"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","740"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","740"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","603"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","643"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","643"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","508"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","508"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","725"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1393"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1393"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","408"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","330"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1503"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1503"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","854"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","854"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","226"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","226"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","372"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","437"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","437"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","176"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4811"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","873"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","873"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1389"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1389"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","606"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","411"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","411"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","898"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","571"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","599"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","599"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","456"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","456"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","742"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1588"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1588"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","762"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","443"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1097"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1097"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1410"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1410"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","745"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","884"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","884"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1302"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1302"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","476"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","264"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","264"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1441"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1441"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","867"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","901"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","901"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5985"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4445"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1213"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","511"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","546"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","546"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","547"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","547"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","361"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","361"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4076"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","249"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1068"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1068"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","605"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","605"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","833"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","833"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","513"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","766"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","766"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","741"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","741"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","606"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","606"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","115"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","516"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","516"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","793"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","461"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","746"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","746"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","945"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","945"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1550"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1550"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","309"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1985"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","592"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","592"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1176"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1176"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","7387"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1153"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1153"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","642"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","642"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2914"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1327"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1327"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1258"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1258"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1703"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","587"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","587"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2559"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","902"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","902"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","656"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","656"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1317"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","392"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","392"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","474"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","364"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","364"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3775"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2404"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","585"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","585"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","795"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1696"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1696"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","169"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","802"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","802"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","360"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","238"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","238"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","770"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","551"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","551"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","905"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","905"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","85"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","241"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1165"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1165"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","183"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1650"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1650"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1440"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1440"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","10436"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1123"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","622"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","477"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","477"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","121"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","398"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","8973"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","575"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","575"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3717"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1360"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1360"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2043"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","698"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","698"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","6468"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","197"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","197"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","708"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","708"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","126"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","321"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","321"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","715"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1355"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1355"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","185"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","670"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","670"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","175"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","427"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4974"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","362"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","362"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1309"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1462"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","511"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","511"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3204"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3584"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1035"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1035"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2806"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","307"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","307"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","590"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","590"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","161"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","168"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","168"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1249"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","693"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","693"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","650"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","650"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5414"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","146"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","146"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5383"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1700"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","141"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","141"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1359"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1359"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","596"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","596"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","514"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","273"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","273"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","908"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1581"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1581"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","246"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","162"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4409"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","595"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","595"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3082"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","967"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","967"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1574"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1574"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","242"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1414"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1414"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5301"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1242"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1182"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1182"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","229"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","229"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","452"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1559"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1559"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1475"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1475"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","413"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","413"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","541"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","697"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","697"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","134"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1030"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1030"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","8419"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","379"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","379"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1283"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1283"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1374"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1374"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","687"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2384"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","731"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","731"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","881"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","881"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","969"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1170"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4434"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","192"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","192"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","174"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","797"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","797"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4174"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","466"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","466"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3617"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1078"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1078"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4995"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","442"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","442"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","637"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","387"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","727"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","727"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1170"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1170"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","492"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","492"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2533"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1206"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1206"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1531"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1531"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","611"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1234"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1234"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1497"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","155"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","155"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1612"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1612"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","954"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","954"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1926"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","583"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","583"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","7649"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","217"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","846"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","820"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","820"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3911"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1367"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1367"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","76"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","633"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","142"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","142"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","768"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","768"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","817"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","817"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1524"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","673"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","673"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","630"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","630"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","245"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","556"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1439"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1439"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","615"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","655"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","655"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","881"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1276"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1276"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1497"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1497"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","775"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","775"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","240"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1181"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1181"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","579"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","579"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","654"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1732"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1602"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1602"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2350"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1435"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3361"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","951"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","951"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","278"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","680"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","680"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","310"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","310"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","601"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3442"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1240"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1240"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1152"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1152"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","694"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","694"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2847"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2086"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","719"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","719"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","633"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","633"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1020"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","322"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","322"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","465"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1402"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","907"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","907"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1323"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1323"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1041"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","545"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","545"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","9056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","704"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","704"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","227"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1179"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1179"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2650"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","837"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","837"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1138"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1138"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","246"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","246"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","678"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","630"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2045"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","636"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","636"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","6034"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","2108"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1665"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","7730"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","375"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","375"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","323"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","323"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5065"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","887"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","887"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4726"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","700"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","700"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","302"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","827"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","827"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","287"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4135"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","981"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","981"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1461"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1277"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1277"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","718"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1505"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1505"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3878"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1082"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1011"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1011"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5181"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","282"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","282"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","390"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","357"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","357"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","638"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","638"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","498"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","277"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1084"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1084"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","936"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","936"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","5744"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","776"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","776"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","4203"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","557"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","557"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","230"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1603"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1603"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","922"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","882"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","882"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","701"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","701"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","527"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","527"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","464"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","182"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","623"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","623"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1029"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3984"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1454"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1454"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","6938"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","779"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","779"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","1667"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","1243"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","1243"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","163"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","time","399"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","TimeFromBiopsyToFailure/Censoring","399"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21374>","Expression data from human renal allograft biopsies","sampling time point","3240"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","disease","dilated cardiomyopathy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical history","after VAD support"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","organism part","myocardial tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: Novacor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: Heartmate I"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","disease","ischemic cardiomyopathy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical history","before VAD support"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: CorAide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","disease","dilated cardiomyopathy (VD)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: DuraHeart"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: Thoratec (biVAD)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical history","no VAD support"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","disease","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: Thoratec"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: Incor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","clinical treatment","ventricular assist device: Thoratec (iVAD)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","individual","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21610>","Gene expression analysis in non-failing and failing myocardium pre and post pulsatile and non-pulsatile VAD support","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","cell line","NCI-H1299"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","cell type","cultured spheroid,spheroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","media","stem-cell medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","growth condition","cultured"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","growth condition","xenografted"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","cell type","spheroid,xenografted spheroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","cell type","cultured parental,parental"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","media","serum-containing medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21612>","Expression data for cultured NCI-H1299 parental and spheroid cells as well as their derived xenograft models","cell type","parental,xenografted parental"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21887>","Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model","organism part","Human prostate cancer xenograft"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21887>","Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21887>","Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model","disease staging","castration-induced regression nadir"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21887>","Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model","disease staging","androgen-dependent growth"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21887>","Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model","disease staging","castration-resistant regrowth"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21668>","Expression data from undifferentiated human embryonic stem cells (hESC) and Day 3.5 mesodermal progenitor (CD326neg CD56+) population","cell type","undifferentiated cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21668>","Expression data from undifferentiated human embryonic stem cells (hESC) and Day 3.5 mesodermal progenitor (CD326neg CD56+) population","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21668>","Expression data from undifferentiated human embryonic stem cells (hESC) and Day 3.5 mesodermal progenitor (CD326neg CD56+) population","cell line","hESC H9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21668>","Expression data from undifferentiated human embryonic stem cells (hESC) and Day 3.5 mesodermal progenitor (CD326neg CD56+) population","cell type","CD326negCD56+ cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21774>","CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells: Groups 1-3","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21774>","CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells: Groups 1-3","cell type","CD3- CD56dim CD62L+ NK cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21774>","CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells: Groups 1-3","biosource provider","Leukocyte concentrates obtained from healthy donors (DRK, Berlin, Germany)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21774>","CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells: Groups 1-3","cell type","CD3- CD56bright CD62L+ NK cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21774>","CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells: Groups 1-3","cell type","CD3- CD56dim CD62L- NK cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","time","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","treatment","doxycycline"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","cell line","RPMI-8226 multiple myeloma cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","replicate","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","disease","Bmi1-shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","treatment","no dox"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","replicate","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","replicate","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","time","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-21912>","The Polycomb Group Protein Bmi-1 is essential for the growth of Multiple Myeloma cells","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","disease","Severe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","disease staging","stage III"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","gold stage","stage III"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","disease staging","Stage IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","gold stage","Stage IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","disease","Moderate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","disease staging","stage II"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","gold stage","stage II"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22148>","Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers","age","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22229>","Identification of a B cell signature associated with renal transplant Tolerance in humans","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22229>","Identification of a B cell signature associated with renal transplant Tolerance in humans","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22229>","Identification of a B cell signature associated with renal transplant Tolerance in humans","phenotype","healthy control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22229>","Identification of a B cell signature associated with renal transplant Tolerance in humans","phenotype","Tolerant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22229>","Identification of a B cell signature associated with renal transplant Tolerance in humans","phenotype","Standard Immunotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","disease","acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","phenotype","glucocorticoid resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-R10E7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","treatment","dexamethasone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","phenotype","glucocorticoid sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S27(ZR)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-R19E7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-R19F2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-S12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-R9C10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-R3B5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22152>","Transcription profiling of glucocorticoid resistant and sensitive acute lymphoblastic leukemia cell lines","cell line","C7H2-R19E5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22533>","Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program","cell line","MCF-7/LTED"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22533>","Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22533>","Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program","cell type","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22533>","Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program","treatment","fulvestrant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22533>","Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program","treatment","ethanol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22533>","Breast cancer cells resistant to hormone deprivation maintain an estrogen receptor alpha-dependent, E2F-directed transcriptional program","cell line","HCC-1428/LTED"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22501>","Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22501>","Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells","cell type","regulatory T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22501>","Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22501>","Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells","organism part","cord blood,umbilical cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22459>","Fibrosis with Inflammation at One Year Predicts Transplant Functional Decline","histology","1yr protocol bx - Banff: i/cg/ci=0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22459>","Fibrosis with Inflammation at One Year Predicts Transplant Functional Decline","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22459>","Fibrosis with Inflammation at One Year Predicts Transplant Functional Decline","histology","1yr protocol bx - Banff: i/cg=0; ci>0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22459>","Fibrosis with Inflammation at One Year Predicts Transplant Functional Decline","histology","1yr protocol bx - Banff: cg=0; i/ci>0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22513>","Trancription profiling of breast  tumor biopsies to identify markers of Taxane Sensitivity in Breast Cancer","organism part","breast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22513>","Trancription profiling of breast  tumor biopsies to identify markers of Taxane Sensitivity in Breast Cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22513>","Trancription profiling of breast  tumor biopsies to identify markers of Taxane Sensitivity in Breast Cancer","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22513>","Trancription profiling of breast  tumor biopsies to identify markers of Taxane Sensitivity in Breast Cancer","Clinical info","no response to therapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22513>","Trancription profiling of breast  tumor biopsies to identify markers of Taxane Sensitivity in Breast Cancer","Clinical info","response to therapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22522>","Comparison of the transcriptome of K-LEC spheroids to control LEC spheroids","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22522>","Comparison of the transcriptome of K-LEC spheroids to control LEC spheroids","cell type","LEC spheroids"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22522>","Comparison of the transcriptome of K-LEC spheroids to control LEC spheroids","Compound treatment","KSHV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22522>","Comparison of the transcriptome of K-LEC spheroids to control LEC spheroids","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 0 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","tumor grading","G2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","organism part","primary clear-cell renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","date of sample preparation and hybridisation","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","lymph node status","N0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease staging","pT2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","initial distant metastases","M1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","organism part","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease staging","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","tumor grading","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","lymph node status","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","initial distant metastases","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases",">80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 90 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","organism part","pulmonary metastasis of clear-cell renal cell carcinoma (laser resection)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","date of sample preparation and hybridisation","Apr 2007"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 31 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","114"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases",">80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 8 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","tumor grading","G3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 130 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease staging","pT1b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","initial distant metastases","M0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung, adrenal gland, renal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 6 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 148 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease staging","pT1a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung, bone, adrenal gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 45 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 112 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 155 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 38 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","156"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 11 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 114 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung, liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 12 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 2 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung, soft tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 83 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 127 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","95"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 1 month"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease staging","pT3a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","lymph node status","N1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lymph node, lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 96 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lymph node, bone, adrenal gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 106 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 9 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung, mediastinal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease staging","pT3b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 15 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","date of sample preparation and hybridisation","Oct 2008"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 60 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 36 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","lymph node status","N2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 156 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of metastases","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","adrenal gland, renal, pancreas, parotis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 95 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","localisation of metastases","lung, skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 82 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 99 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 140 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 63 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","disease free interval  dfi  in  months","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","DFS = 10 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","no  of pulmonary metastases","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22541>","Expression data from pulmonary metastases and primary tumors of clear-cell renal cell carcinoma (ccRCC) with different disease-free survivals","dfs follow up","Follow-up = 143 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","disease","breast cancer,infiltrating ductal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","disease","breast cancer,node metastasis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22544>","Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast: expression analysis","individual","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell type","renal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","disease","renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","SKRC39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","786-O"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","KTCL 140"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","Compound treatment","5-aza-2'-deoxycytidine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","SKRC45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","Caki1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","SKRC54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","KTCL26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","SKRC47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","RCC4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","UMRC2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22563>","Transcription profiling of  Renal Cell carcinoma cell lines following global de-methylation.","cell line","UMRC3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","clinical treatment","dexamethosone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","individual","E5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","disease","epilepsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","clinical treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","individual","E3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-22779>","Transcription profiling of non-leukemic individuals before and during in-vivo glucocorticoid treatment","individual","E4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","Clinical info","after methotrexate treatment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","disease","juvenile idiopathic arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L003"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L027"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L010"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","Clinical info","before methotrexate treatment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L221"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L016"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_287"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L015"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L009"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L014"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23687>","Transcription profiling of peripheral blood samples from juvenile idiopathic arthritis (JIA) patients pre and post methotrexate therapy. Expression data from SPARKS CHARMS JIA cohort","individual","A235_L017"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23031>","Ribavirin Treated Huh7.5.1 Cells","Compound treatment","PBS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23031>","Ribavirin Treated Huh7.5.1 Cells","cell line","Huh7.5.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23031>","Ribavirin Treated Huh7.5.1 Cells","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23031>","Ribavirin Treated Huh7.5.1 Cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23031>","Ribavirin Treated Huh7.5.1 Cells","Compound treatment","Ribavirin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell type","embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","WIBR2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell type","induced pluripotent stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB1lox_17puro_5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","BG01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","WIBR7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB1lox_21puro_26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB1lox_17puro_10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","biosource provider","Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=GM01660"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","GM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","H9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","C1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB2lox_21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB2lox_22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB2lox_5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","WIBR3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB1lox_21puro_28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","BG03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","A1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB2lox_17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","A6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","WIBR1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","PDB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","biosource provider","Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&amp;q=AG20442"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB1lox_21puro_20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23402>","Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells (Affymetrix)","cell line","hiPS_PDB1lox_17puro_33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell type","glioblastoma stem-like"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","disease","glioblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-7 clone 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell type","glioblastoma (neurosphere)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell type","glioblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","disease staging","tumor grade: WHO IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-7 clone 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","ML-5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell type","glioma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","M059J"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G121"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G140"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","LN229"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-3 clone 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-3 clone 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G28T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G84"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","M059K"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","SW1783"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-3 clone 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-7 clone 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G142"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G96"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-3 clone 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","DBTRG05MG"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G122"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","HS683"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","LN18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","U87MG"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","U118MG"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","ML-9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","ML-8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","SF268"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","A172"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","G141"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","SF539"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","T98G"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","GS-2."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","age","passage: 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23806>","Transcription profling of glioblastoma stem-like (GS) cell lines, conventional glioma cell lines and primary tumors","cell line","ML-4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","organism part","colorectal tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","organism part","colon tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23878>","Transcription profling of colorectal carcinoma in order to identify potential key gene expression","disease","colorectal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23984>","Transcription profiling  of  human activated T lymphocytes toi determine the effects of TX527, a hypocalcemic vitamin D analog.","stimulus","control (ethanol vehicle)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23984>","Transcription profiling  of  human activated T lymphocytes toi determine the effects of TX527, a hypocalcemic vitamin D analog.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23984>","Transcription profiling  of  human activated T lymphocytes toi determine the effects of TX527, a hypocalcemic vitamin D analog.","cell type","CD3 positive T lymphocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23984>","Transcription profiling  of  human activated T lymphocytes toi determine the effects of TX527, a hypocalcemic vitamin D analog.","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-23984>","Transcription profiling  of  human activated T lymphocytes toi determine the effects of TX527, a hypocalcemic vitamin D analog.","stimulus","TX527"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","Compound treatment","none 0 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","disease","colorectal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","cell line","RKO"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","Compound treatment","4-hydroxy-2-nonenal 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","Compound treatment","4-hydroxy-2-nonenal 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2397>","Transcription profiling time series of human RKO cell line responses to 2-hydroxy-2-nonenal","Compound treatment","4-hydroxy-2-nonenal 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","treatment","health control sera"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","IM9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","KG1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","treatment","recent-onset type I diabetes sera"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","THP-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","CCRFCEM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","HL-60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","K562"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24147>","Transcription profiling of human leukemia cell lines treated with sera from TypeI Diabetes patients to investigate sera-induced transcriptional signatures.","cell line","U937"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","age","young"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","organism part","biceps brachii"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24235>","Transcription profiling of skeletal muscle in response to resistance exercise: sex specific regulation","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","biosource provider","ATCC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","bj-fib_1: BJ (CRL-2522) fibroblasts were purchased from ATCC."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","bj-ipsc_1: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","biosource provider","Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=AG01972,Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=AG05247,Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=AG06297,Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=AG09602,Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=AG11498,Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=GM00038"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","hgps-ipsc_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","hgps-fib_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","bj-fib_2: BJ (CRL-2522) fibroblasts were purchased from ATCC."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","biosource provider","WiCell Research"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","h9-esc_1: H9 hESCs (WiCell Research)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","bj-ipsc_2: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","h9-esc_2: H9 hESCs (WiCell Research)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","hgps-ipsc_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24487>","Recapitulation of human premature aging by using iPSCs from Hutchinson-Gilford progeria syndrome","cell line","hgps-fib_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24868>","Suppression of major attributes of tumor-initiating cells through epithelial-mesenchymal transition","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24868>","Suppression of major attributes of tumor-initiating cells through epithelial-mesenchymal transition","cell line","PC-3/S"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24868>","Suppression of major attributes of tumor-initiating cells through epithelial-mesenchymal transition","cell line","PC-3/Mc"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24849>","Human CD34+-derived erythoblast (polychromatophilic and orthochromatic) response to co-culture with Plasmodium falciparum 3D7","cell type","growth factor-mobilized CD34+ hematopoietic stem cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24849>","Human CD34+-derived erythoblast (polychromatophilic and orthochromatic) response to co-culture with Plasmodium falciparum 3D7","developmental stage","differentiated to day 14 (orthochromatic stage)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24849>","Human CD34+-derived erythoblast (polychromatophilic and orthochromatic) response to co-culture with Plasmodium falciparum 3D7","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-24849>","Human CD34+-derived erythoblast (polychromatophilic and orthochromatic) response to co-culture with Plasmodium falciparum 3D7","developmental stage","differentiated to day 10 (polychromatophilic stage)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","chromosomal aberration","translocation(11;18)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","organism part","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","biosource provider","Department of Pathology, University Hospitals K.U.Leuven"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","disease","mucosa-associated lymphoid tissue lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL96"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","chromosomal aberration","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","S4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","organism part","spleen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","S1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","S2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","S5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","S3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LLX1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","MIX"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25550>","Transcription profiling of  t(11;18)-positive and t(11;18)-negative MALT lymphoma","individual","LL39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25518>","Transcription profiling of testis biopsies to investigate testis developmental gene expression in cryptorchid boys at risk of azoospermia","disease","cryptorchidism"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25518>","Transcription profiling of testis biopsies to investigate testis developmental gene expression in cryptorchid boys at risk of azoospermia","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25518>","Transcription profiling of testis biopsies to investigate testis developmental gene expression in cryptorchid boys at risk of azoospermia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25518>","Transcription profiling of testis biopsies to investigate testis developmental gene expression in cryptorchid boys at risk of azoospermia","organism part","testis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-25518>","Transcription profiling of testis biopsies to investigate testis developmental gene expression in cryptorchid boys at risk of azoospermia","disease","testicular agenesis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","phenotype","low PD-1 expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","cell type","CD8 positive; CD3 positive,T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","phenotype","high PD-1 expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26495>","Transcription profiling by array of CD8 T cells from healthy individuals that express high levals of Programmed Death-1 protein","phenotype","naive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","organism","Macaca fascicularis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","organism","Chlorocebus aethiops"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","organism","Macaca mulatta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2634>","Transcription profiling of blood from humans, rhesus macaque, cynomolgus macaque and the African green monkey to compare human and non-human primates' gene expression profiles using a human genechip","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","strain","129/Sv"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","cell type","murine bone-marrow derived macrophages"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","genotype","NFAT5 KO,NFAT5 knock-out"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","organism","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26343>","Gene expression from bone-marrow derived macrophages.","Compound treatment","lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","disease","endemic Burkitt lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","developmental stage","child"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","ethnicity","African"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","disease","sporadic Burkitt lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","ethnicity","european"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26673>","Transcription profiling of Burkitt lymphoma cases","disease","immunodeficiency associated Burkitt lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","histology","type 2A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","disease","papillary renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","test result","molecular class type 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","histology","type 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","test result","molecular class type 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","histology","type 1 and 2A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2748>","Transcription profiling of human papillary renal cell carcinoma to identify molecular PRCC subclasses with morphologic correlation","histology","type 2B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","organism part","pituitary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","Clinical info","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","clinical history","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","classifier","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","disease","pituitary cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","Clinical info","gonadotrope tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","classifier","non invasive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","clinical history","non recurrent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","clinical history","recurrent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","classifier","invasive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-26966>","Transcription profiling of gonadotrope pituitary tumors identifies Growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors","Clinical info","null cell tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27034>","Transcription profiling by array of human peripheral blood momonuclear cells from patients with peripheral arterial disease","cell type","peripheral blood mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27034>","Transcription profiling by array of human peripheral blood momonuclear cells from patients with peripheral arterial disease","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27034>","Transcription profiling by array of human peripheral blood momonuclear cells from patients with peripheral arterial disease","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27034>","Transcription profiling by array of human peripheral blood momonuclear cells from patients with peripheral arterial disease","disease","peripheral arterial disease (PAD)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","cell type","dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","Compound treatment","lipopolysaccharide and R848"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","Compound treatment","R848"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-2706>","Transcription profiling of human dendritic cells to identify a combinatorial code by which DCs discriminate pathogens and provide (suggest) a rationale to design adjuvants for TH1 responses.","Compound treatment","lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","genotype","DNMT3a R882 mutant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","SQM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","disease","acute myeloid leukemia (AML M5)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","genotype","DNMT3a R882 wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","DAX"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","WJH"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","GXL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","HLG"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","SXXL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","LJX"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","QYY"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","WBL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-27187>","Transcription profiling  of acute monocytic leukemia (AML-M5) patients with DNMT3A mutations","individual","YJF"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","cell line","HUES9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","organism part","blastocyst"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","organism part","Foreskin Fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","cell line","FTC1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","cell line","H1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","cell line","IMR-90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-28815>","Expression comparison between SMC4 and conventional cultures","organism part","Lung Fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-29908>","Expression data from peripheral blood mononuclear cell in patients with type 1 diabetes before and after peripheral stem cell transplantation","organism part","peripheral blood mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-29908>","Expression data from peripheral blood mononuclear cell in patients with type 1 diabetes before and after peripheral stem cell transplantation","time","at six months posttreat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-29908>","Expression data from peripheral blood mononuclear cell in patients with type 1 diabetes before and after peripheral stem cell transplantation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-29908>","Expression data from peripheral blood mononuclear cell in patients with type 1 diabetes before and after peripheral stem cell transplantation","time","before treatment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","Compound treatment","IFN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","time","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","time","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-31193>","A Robust Induction of  Type III Interferons and Chemokines Defines a Unique Pattern of Hepatic Innate Immunity in Response to Hepatitis C Virus Infection","Compound treatment","IL28B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","cell type","hematopoietic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","developmental stage","middle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","developmental stage","young"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","developmental stage","old"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","84 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","76 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","83 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32719>","Transcription profiling by array of human bone marrow hematopoietic stem cells from healthy young and elderly individuals","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32893>","Human bronchial epithelial cells exposed to A. alternata spores","cell line","BEAS-2B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32893>","Human bronchial epithelial cells exposed to A. alternata spores","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32893>","Human bronchial epithelial cells exposed to A. alternata spores","treatment","negative control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32893>","Human bronchial epithelial cells exposed to A. alternata spores","treatment","5 x 10^5 A. alternata spores"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3325>","Transcription profiling by array of human benign prostate, primary and metastatic prostate cancer prostate cancer samples to reveal signatures of metastatic progression","disease","primary prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3325>","Transcription profiling by array of human benign prostate, primary and metastatic prostate cancer prostate cancer samples to reveal signatures of metastatic progression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3325>","Transcription profiling by array of human benign prostate, primary and metastatic prostate cancer prostate cancer samples to reveal signatures of metastatic progression","disease","benign prostate tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3325>","Transcription profiling by array of human benign prostate, primary and metastatic prostate cancer prostate cancer samples to reveal signatures of metastatic progression","disease","metastatic prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33006>","Gene expression profiles from the hepatocellular carcinoma (HCC) tissues","organism part","Ajacent normal liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33006>","Gene expression profiles from the hepatocellular carcinoma (HCC) tissues","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33006>","Gene expression profiles from the hepatocellular carcinoma (HCC) tissues","organism part","hepatocellular carcinoma (HCC)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","treatment","10uM phevalin in growth media"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","cell type","Human Foreskin Keratinocytes were isolated at the University of Washington."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","treatment","1uM phevalin in growth media"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","treatment","Conditioned medium from planktonic S. aureus cultures spiked with phevalin during exponential phase growth."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","treatment","Conditioned medium from planktonic S. aureus cultures spiked with DMSO during exponential phase growth."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","treatment","vehicle control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-32920>","Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression","treatment","Conditioned medium from biofilm S. aureus cultures."
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3292>","Transcription profiling of human head and neck squamous cell carcinomas that are positive or negative for Human Papilloma Virus","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3292>","Transcription profiling of human head and neck squamous cell carcinomas that are positive or negative for Human Papilloma Virus","disease","HPV negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3292>","Transcription profiling of human head and neck squamous cell carcinomas that are positive or negative for Human Papilloma Virus","biosource type","biopsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3292>","Transcription profiling of human head and neck squamous cell carcinomas that are positive or negative for Human Papilloma Virus","disease","HPV positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33455>","Expression data from docetaxel-resistant prostate cancer cell lines","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33455>","Expression data from docetaxel-resistant prostate cancer cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33455>","Expression data from docetaxel-resistant prostate cancer cell lines","disease","metastatic prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33455>","Expression data from docetaxel-resistant prostate cancer cell lines","cell line","DU145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33455>","Expression data from docetaxel-resistant prostate cancer cell lines","treatment","converted to docetaxel-resistant cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33455>","Expression data from docetaxel-resistant prostate cancer cell lines","cell line","PC3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","cell line","THP-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","treatment","Infliximab"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","time","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-33585>","Expression data from monocytic cell lines (THP)","treatment","CDP870"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3397>","Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours","cell line","BEAS-2B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3397>","Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours","Infection","respiratory syncytial virus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3397>","Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3397>","Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3397>","Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3397>","Transcription profiling of human bronchial epithelial cells treated with respiratory syncytial virus (RSV) for 4 and 24 hours","Infection","uninfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34055>","A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","cell line","human mammary epithelial cells (HMECs)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34055>","A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","treatment","shRNA SAE2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34055>","A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34055>","A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","treatment","Tamoxifen induced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34055>","A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34055>","A sumoylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis","treatment","Tamoxifen+shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","5x10-9M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","cell line","BEAS-2B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","10-7 M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","10-9M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","5x10-10M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","10-8 M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","DMSO control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","5x10-7 M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","10-6 M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","10-10M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34635>","Defining a No Observable Transcriptional Effect Level (NOTEL) for low dose N-OH-PhIP exposures in human BEAS-2B bronchioepithelial cells","treatment","5x10-8 M N-OH-PhIP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34308>","Gene expression profiles of fibroblasts from childhood cerebral adrenoleukodystrophy patients and healthy controls","genotype","CCALD patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34308>","Gene expression profiles of fibroblasts from childhood cerebral adrenoleukodystrophy patients and healthy controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34308>","Gene expression profiles of fibroblasts from childhood cerebral adrenoleukodystrophy patients and healthy controls","cell type","dermal fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34308>","Gene expression profiles of fibroblasts from childhood cerebral adrenoleukodystrophy patients and healthy controls","genotype","healthy control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","organism part","thyroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 86"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","disease","papillary thyroid carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3467>","Transcription profiling of micro-RNA genes in human papillary thyroid carcinoma","individual","patient 77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","age","pediatric"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","age","fetal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","organism part","cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","organism part","cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","age","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34670>","Gene expression in pediatric cALL","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","clinical history","negative crossmatch kidney transplants, biopsy 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","Clinical info","<=1 year biopsy - Banff: cg=0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","clinical history","positive crossmatch, no transplant glomerulopathy, biopsy 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","Clinical info",">=2 year biopsy - Banff: cg=0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt3_repeat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","Clinical info",">=1 year biopsy - Banff: cg>0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","clinical history","negative crossmatch kidney transplants, biopsy 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","Clinical info",">=1 year biopsy - Banff: cg=0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","clinical history","positive crossmatch, transplant glomerulopathy, biopsy 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt6_repeat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","clinical history","positive crossmatch, transplant glomerulopathy, biopsy 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt5_repeat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt4_repeat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","Control_Pt7_repeat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/TG+_Pt8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34748>","Transcription profiling by array of human positive crossmatch kidney transplant recipients who develop transplant gloerulopathy","individual","+XM/NoTG_Pt5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3485>","RNAi knock down of LEDGF transcript from the PSIP1 gene in human 293T cells reveals a role for LEDFG/p75 in targeting HIV integration","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3485>","RNAi knock down of LEDGF transcript from the PSIP1 gene in human 293T cells reveals a role for LEDFG/p75 in targeting HIV integration","RNAi","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3485>","RNAi knock down of LEDGF transcript from the PSIP1 gene in human 293T cells reveals a role for LEDFG/p75 in targeting HIV integration","cell line","293TsiLL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3485>","RNAi knock down of LEDGF transcript from the PSIP1 gene in human 293T cells reveals a role for LEDFG/p75 in targeting HIV integration","RNAi","LEDGF knockdown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3485>","RNAi knock down of LEDGF transcript from the PSIP1 gene in human 293T cells reveals a role for LEDFG/p75 in targeting HIV integration","cell line","293T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","disease","B-precursor acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","treatment","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","cell line","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","cell line","Reh"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","treatment","2.5 uM vorinostat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","cell line","RS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","treatment","1 uM vorinostat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","cell line","MV4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-34880>","Epigenetic reprogramming in relapsed childhood ALL","treatment","0.5 uM vorinostat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","pharyngeal mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","cerebellum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","testes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","heart atrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","putamen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","temporal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","medulla"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","hippocampus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","midbrain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","dorsal root ganglion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","hypothalamus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","adipose tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","subthalamic nucleus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","tongue superior part w/ papillae"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","frontal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","colon cecum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","adipose tissue subcutaneous"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","nipple cross-section"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","corpus callosum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","spleen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","vestibular nuclei superior"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","cerebral cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","cervix"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","spinal cord"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","trigeminal ganglion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","accumbens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","oral mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","occipital lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","individual","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","substantia nigra"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","vagina"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","heart ventricle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","prostate gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","tongue main corpus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","pituitary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","ventral tegmental area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","parietal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","kidney medulla"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","adrenal gland cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","amygdala"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","stomach fundus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","thalamus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","thyroid gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","esophagus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","urethra"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","nodose nucleus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","kidney cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","stomach pyloric"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","trachea"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","saphenous vein"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","stomach cardiac"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","salivary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","myometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","coronary artery"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","vulva"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","skeletal muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3526>","Transcription profiling by array of human post mortem tissue samples","organism part","adipose tissue omental"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35972>","TOV112D cells treated with NSC319726","cell type","epithelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35972>","TOV112D cells treated with NSC319726","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35972>","TOV112D cells treated with NSC319726","Compound treatment","NSC319726 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35972>","TOV112D cells treated with NSC319726","disease","ovarian carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35972>","TOV112D cells treated with NSC319726","cell line","TOV-112D"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35972>","TOV112D cells treated with NSC319726","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35830>","Seminal plasma and transforming growth factor- regulate gene expression in human Ect1 ectocervical epithelial cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35830>","Seminal plasma and transforming growth factor- regulate gene expression in human Ect1 ectocervical epithelial cells","growth condition","recombinant human TGF-beta 3 (5 nanogram per milliliter)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35830>","Seminal plasma and transforming growth factor- regulate gene expression in human Ect1 ectocervical epithelial cells","cell line","Ect1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35830>","Seminal plasma and transforming growth factor- regulate gene expression in human Ect1 ectocervical epithelial cells","growth condition","10% seminal plasma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35830>","Seminal plasma and transforming growth factor- regulate gene expression in human Ect1 ectocervical epithelial cells","growth condition","medium alone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35603>","Network Biology of Tumor Stem-like Cells Identified a Regulatory Role of CBX5 in Lung Cancer","cell type","TSLC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35603>","Network Biology of Tumor Stem-like Cells Identified a Regulatory Role of CBX5 in Lung Cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35603>","Network Biology of Tumor Stem-like Cells Identified a Regulatory Role of CBX5 in Lung Cancer","cell type","ESC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35603>","Network Biology of Tumor Stem-like Cells Identified a Regulatory Role of CBX5 in Lung Cancer","cell type","parental tumor cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35603>","Network Biology of Tumor Stem-like Cells Identified a Regulatory Role of CBX5 in Lung Cancer","cell type","ESC (oocyte)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36149>","Gene expression data from obatoclax-treated SEM-K2 and RS4:11 cell lines","cell line","Acute Lymphoblastic Leukemia cell line SEM-K2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36149>","Gene expression data from obatoclax-treated SEM-K2 and RS4:11 cell lines","Compound treatment","vehicle control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36149>","Gene expression data from obatoclax-treated SEM-K2 and RS4:11 cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36149>","Gene expression data from obatoclax-treated SEM-K2 and RS4:11 cell lines","cell line","Acute Lymphoblastic Leukemia cell line RS4:11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36149>","Gene expression data from obatoclax-treated SEM-K2 and RS4:11 cell lines","Compound treatment","obatoclax 72h EC50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36149>","Gene expression data from obatoclax-treated SEM-K2 and RS4:11 cell lines","Compound treatment","obatoclax 3x 72h EC50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41855>","Expression data from quiescent cells and cycling cells isolated from Multicellular aggregates of lymphoma cells (MALC)","genotype","t(14,18)+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41855>","Expression data from quiescent cells and cycling cells isolated from Multicellular aggregates of lymphoma cells (MALC)","phenotype","Pyronin Y dull"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41855>","Expression data from quiescent cells and cycling cells isolated from Multicellular aggregates of lymphoma cells (MALC)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41855>","Expression data from quiescent cells and cycling cells isolated from Multicellular aggregates of lymphoma cells (MALC)","phenotype","Pyronin Y bright"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35685>","Lymphoid Priming in Human Bone Marrow Begins Prior to CD10 Expression with Up-Regulation of L-selectin","cell type","human bone marrow CD62Lhi"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35685>","Lymphoid Priming in Human Bone Marrow Begins Prior to CD10 Expression with Up-Regulation of L-selectin","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35685>","Lymphoid Priming in Human Bone Marrow Begins Prior to CD10 Expression with Up-Regulation of L-selectin","cell type","human bone marrow CD38-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-35685>","Lymphoid Priming in Human Bone Marrow Begins Prior to CD10 Expression with Up-Regulation of L-selectin","cell type","human bone marrow CD10+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","cell line","H460a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","treatment","gamma secretase inhibitor RO4929097"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36176>","Gene expression arrays on lung cancer cells exposed to  Notch inhibitor","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","organism part","primary keratinocytes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","untreated control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","IL17A-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","IFNg-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","IFNa-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","IL13-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","TNF-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36287>","Expression data from primary human keratinocytes exposed to cytokines in vitro (IL-4, IL-13, IL-17A, IFN-alpha, IFN-gamma, TNF)","treatment","IL4-treated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","treatment","2 hour ex vivo incubation at 37 deg C with Vehicle (DMSO)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","organism part","umbilical cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","cell type","CD34+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","treatment","1 hour ex vivo incubation at 4 deg C with Vehicle (DMSO)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","treatment","2 hour ex vivo incubation at 37 deg C with Prostaglandin (16,16-dmPGE2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36547>","Assessment of Ex Vivo Prostaglandin pathway activation in HSCs","treatment","1 hour ex vivo incubation at 4 deg C with FT-1050 (16,16-dmPGE2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","treatment","DFNB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","cell line","Shef3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","time","Day 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","time","Day 0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","cell line","H14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","cell line","Shef1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36754>","Gene expression of differentiating hESCs into otic progenitors","treatment","FGF3+10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","166.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","organism part","white blood cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","31.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","51.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","8.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","38.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","512.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","150.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","347.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","162.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","17.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","40.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","1.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","509"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","18.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","339"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","207.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","503.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","515.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","171.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","153.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","35.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","38.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","116.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","175.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","108.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","34.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","35.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","344.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","319.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","75.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","162.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","105.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","108.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","687.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","682.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","137.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","7.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","226"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","329"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","85.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","514.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","507.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","96.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","31.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","160.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","370.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","168.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","4.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","332.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","119.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","317.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","111.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","88.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","640.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","103.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","28.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","666.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","179.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","505.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","180.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","529.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","508.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","184.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","39.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","369.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","341.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","106.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","33.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","83.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","182.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","31.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","26.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","137.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","323.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","303.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","32.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","351.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","171.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","89.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","374.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","10.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","95"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","113.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","94.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","185.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","31.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","91.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","80.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","500.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","366.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","654.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","27.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","103.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","688"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","225"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","540"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","496.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","679"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","199"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","166.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","167.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","517.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","334.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","195.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","131.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","32.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","26.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","209.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","181.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","41.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","113.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","105.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","7.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","2.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","701.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","663.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","99"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","1.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","315.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","351.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","33.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","160.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","25.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","188.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","331.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","104.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","16.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","511.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","82.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","37.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","87.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","179"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","683.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","176.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","149.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","98.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","161.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","137.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","168.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","4.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","518"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","126"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","4.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","36.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","675"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","178.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","180.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","7.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","15.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","88.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","132"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","109.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","2.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","107.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","362.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","330.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","37.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","163.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","165.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","123.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","63.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","520.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","17.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","63.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","age","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","8.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","496.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","141.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","20.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","29.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","84.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","199.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","369.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","193"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","8.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","500.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","178.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","362.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","38.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","31.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","352.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","163.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","97"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","21.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","505"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","37.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","134.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","178.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","163.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","100.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","358.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","94.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","73.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","107.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","116.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","16.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","340.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","182.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","91.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","168.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","175.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","29.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","93.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","502.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","170.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","190.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","20.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","170.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","372"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","16.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","102.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","225.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","185.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","113.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","533.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","3.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","39.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","4.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","111.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","380.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","136.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","41.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","185.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","115.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","96.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","482.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","154.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","166.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","88"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","503"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","659.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","134.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","689.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","103.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","105.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","322.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","44.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","33.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","655"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","135.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","491.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","156.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","2.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","508"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","144.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","162.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","538.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","338.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","350.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","98.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","95.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","555.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","102.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","8.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","159.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","4.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","45.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","369.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","513.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","660"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","14.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","535.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","19.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","34.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","89"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","393.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","65.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","59.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","161.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","312.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","112.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","346.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","272.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","36.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","7.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","29.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","173.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","88.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","177.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","154.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","181.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","171.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","485.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","181.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","192.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","343"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","26.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","86.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","301.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","102.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","40.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","104.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","112.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","161.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","35.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","86.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","347.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","139.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","103.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","487.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","4.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","158.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","102.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","7.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","77.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","25.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","490.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","169.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","91.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","1.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","95.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","370.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","19.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","516.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","361.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","109.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","157.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","34.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","106.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","179.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","365.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","564"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","312.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","504.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","234.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","74.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","344.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","164.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","310.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","228.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","92.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","78.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","507.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","487.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","106.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","131.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","43.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","10.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","181.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","23.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","110.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","169.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","183.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","339.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","100.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","646"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","345.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","139.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","641"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","327.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","16.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","107.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","8.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","349.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","187.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","683.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","351.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","515.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","198.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","25.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","353.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","24.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","38.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","677.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","110.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","22.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","518.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","31.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","687.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","180.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","206.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","27.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","91.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","178.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","79.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","99.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","32.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","366.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","160.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","347.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","7.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","704.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","174.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","42.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","187.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","332.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","201.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","538.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","351.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","353.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","175.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","1.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","26.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","10.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","396.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","531.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","93.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","202"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","477.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","124.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","18.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","182.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","335.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","498.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","99.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","12.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","106.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","82.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","363.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","181.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","17.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","30.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","337.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","10.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","83.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","495.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","72.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","183.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","520.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","200.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","38.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","99.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","41.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","113.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","168.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","501.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","346.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","43.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","95.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","30.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","710.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","105.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","199.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","42.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","536.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","345.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","117.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","543.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","22.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","129.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","332.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","64.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","22.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","102"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","188.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","528.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","332"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","86.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","196.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","18.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","15.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","28.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","92.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","176.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","32.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","35.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","163"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","328.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","111.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","41.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","148.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","29.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","344.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","694.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","23.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","693.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","700"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","87.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","696"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","203.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","21.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","318.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","353.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","10.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","172.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","183.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","88.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","11.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","169.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","329.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","36.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","161.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","181.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","339.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","194"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","707.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","106.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","101.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","96.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","674.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","39.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","23.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","709.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","37.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","521.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","669.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","112.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","122.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","363.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","558.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","30.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","48.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","27.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","24.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","333.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","488"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","14.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","53.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","144.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","335.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","175.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","333.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","33.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","5.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","15.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","112.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","373.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","330.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","32.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","125.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","6.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","175.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","700.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","129.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","24.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","697.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","344.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","22.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","91.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","174.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","28.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","343.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","347.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","104.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36809>","A genomic storm in critically injured humans","injury","19.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3678>","Transcription profiling of human papillary thyroid carcinoma and paired normal tissues","organism part","thyroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3678>","Transcription profiling of human papillary thyroid carcinoma and paired normal tissues","disease","papillary thyroid carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3678>","Transcription profiling of human papillary thyroid carcinoma and paired normal tissues","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3678>","Transcription profiling of human papillary thyroid carcinoma and paired normal tissues","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","ecotype","Columbia-0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","treatment","osmotic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","organism part","leaves"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","organism","Arabidopsis thaliana"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","time","11 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","treatment","mock"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","time","10day"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36789>","Transcriptome Profiling of Roots and leaves Under High Osmotic Stress in Arabidopsis","organism part","roots"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","population","main"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","cell line","H1975"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","population","side"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","cell line","H460"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","cell line","H1650"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-36821>","A novel five-gene signature predicts overall and recurrence-free survival in NSCLC","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","karyotype","46, XY"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","cell type","iPSC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","disease","Klinefelter syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","karyotype","47, XXY"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37258>","Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient","cell type","hESC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T115"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","disease","non-basal-like breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","disease","sporadic basal-like breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T123"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T140"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T134"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T183"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T92"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T149"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T147"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T146"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T137"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T141"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T161"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB87"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","disease","BRCA1-associated breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T151"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T84"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T152"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T133"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T162"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T119"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","NB83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3744>","Transcription profiling of 47 human breast tumor cases","individual","T175"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","treatment","100 nM dexamethasone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-37474>","Dexamethasone induced gene expression changes in the human trabecular meshwork","age","90 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","cell type","leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","time","10 h"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","cell line","CCRF-CEM-C7-14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","treatment","dexamethasone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","time","2 h"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39338>","Expression data from glucocorticoid-treated ALL (CCRF-CEM-C7-14 cells)","time","0 h"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","treatment","DMNQ"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","genotype","Cystic Fibrosis deltaF508 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","cell line","CuFi"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","genotype","no-Cystic Fibrosis deltaF508 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39843>","Expression data of cystic fibrosis and non-cystic fibrosis airway cell lines under oxidative stress","cell line","NuLi"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","cell line","MCF10-T1k (MII)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","transfected with Control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","stably transfected with empty vector, transfected with Control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","cell line","SW480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","transfected with APC siRNA and TAZ siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","stably transfected with empty vector, transfected with TAZ siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","transfected with APC siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","transfected with beta-catenin siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","stably transfected with empty vector, transfected with beta-catenin siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","transfected with wild-type APC-expressing vector, transfected with Control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39907>","Role of TAZ as mediator of Wnt signaling","treatment","transfected with beta-catenin siRNA and TAZ siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39904>","Role of TAZ as mediator of Wnt signaling (SW480)","treatment","stably transfected with empty vector, transfected with beta-catenin siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39904>","Role of TAZ as mediator of Wnt signaling (SW480)","cell line","SW480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39904>","Role of TAZ as mediator of Wnt signaling (SW480)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39904>","Role of TAZ as mediator of Wnt signaling (SW480)","treatment","transfected with wild-type APC-expressing vector, transfected with Control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39904>","Role of TAZ as mediator of Wnt signaling (SW480)","treatment","stably transfected with empty vector, transfected with Control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39904>","Role of TAZ as mediator of Wnt signaling (SW480)","treatment","stably transfected with empty vector, transfected with TAZ siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","treatment","transfected with beta-catenin siRNA and TAZ siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","cell line","MCF10-T1k (MII)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","treatment","transfected with APC siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","treatment","transfected with APC siRNA and TAZ siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","treatment","transfected with beta-catenin siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-39902>","Role of TAZ as mediator of Wnt signaling (MII)","treatment","transfected with Control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3998>","Transcription profiling of four human prostate cell types","cell type","stromal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3998>","Transcription profiling of four human prostate cell types","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3998>","Transcription profiling of four human prostate cell types","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3998>","Transcription profiling of four human prostate cell types","cell type","basal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3998>","Transcription profiling of four human prostate cell types","cell type","secretory cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-3998>","Transcription profiling of four human prostate cell types","cell type","endothelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40231>","The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40231>","The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40231>","The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients","organism part","skeletal muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40231>","The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients","organism part","Visceral Fat"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40231>","The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients","organism part","Atherosclerotic aortic wall"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40231>","The Stockholm Atherosclerosis Gene Expression (STAGE) study: Global Gene Expression data from coronary and carotid artery disease patients","organism part","Internal mammary artery"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","treatment","DMSO"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","cell line","Caki1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","cell line","ACHN"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","treatment","A939572"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","cell line","Caki2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41485>","Expression data of A939572 SCD1 inhibitor treated ccRCC cells","cell line","A498"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40514>","The Requirement for Cyclin D Function in Tumor Maintenance","cell line","KOPTK1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40514>","The Requirement for Cyclin D Function in Tumor Maintenance","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40514>","The Requirement for Cyclin D Function in Tumor Maintenance","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40514>","The Requirement for Cyclin D Function in Tumor Maintenance","organism","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40514>","The Requirement for Cyclin D Function in Tumor Maintenance","organism part","Mammary epithelium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40514>","The Requirement for Cyclin D Function in Tumor Maintenance","Compound treatment","CDK4/6 inhibitor PD 0332991"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40512>","Gene expression profile of human T-ALL cell line KOPTK1 treated with vehicle or PD 0332991","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40512>","Gene expression profile of human T-ALL cell line KOPTK1 treated with vehicle or PD 0332991","cell line","KOPTK1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40512>","Gene expression profile of human T-ALL cell line KOPTK1 treated with vehicle or PD 0332991","Compound treatment","vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40512>","Gene expression profile of human T-ALL cell line KOPTK1 treated with vehicle or PD 0332991","Compound treatment","CDK4/6 inhibitor PD 0332991"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40613>","Effects of co-culture of  Endothelial Cells with Mesenchymal Stem Cells on Gene Expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40613>","Effects of co-culture of  Endothelial Cells with Mesenchymal Stem Cells on Gene Expression","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40613>","Effects of co-culture of  Endothelial Cells with Mesenchymal Stem Cells on Gene Expression","cell type","pulmonary endothelial cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","block","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","disease","primary Sjogren syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","organism part","parotid gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","disease","non primary Sjogren syndrome sicca"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","block","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","block","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","non-pSS sicca patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","control 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40611>","Gene expression data of parotid tissue from Primary Sjgrens Syndrome and controls","individual","pSS patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","cell type","alveolar macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","treatment","saline"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","treatment","LPS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-40885>","Data expression in alveolar macrophages induced by lipopolysaccharide in humans","individual","Subject 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41326>","Expression data from HepG2 cells before and after RNF43 knockdown","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41326>","Expression data from HepG2 cells before and after RNF43 knockdown","cell line","HepG2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41326>","Expression data from HepG2 cells before and after RNF43 knockdown","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41326>","Expression data from HepG2 cells before and after RNF43 knockdown","treatment","siRNF43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4182>","Transcription profiling of human fetuses using oligonucleotide microarray analysis of fetal mRNA isolated from amniocytes to investigate the genetic background of the polygenic neural tube defect spina bifida","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4182>","Transcription profiling of human fetuses using oligonucleotide microarray analysis of fetal mRNA isolated from amniocytes to investigate the genetic background of the polygenic neural tube defect spina bifida","cell type","amniocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4182>","Transcription profiling of human fetuses using oligonucleotide microarray analysis of fetal mRNA isolated from amniocytes to investigate the genetic background of the polygenic neural tube defect spina bifida","disease","spina bifida"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4182>","Transcription profiling of human fetuses using oligonucleotide microarray analysis of fetal mRNA isolated from amniocytes to investigate the genetic background of the polygenic neural tube defect spina bifida","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","cell line","cervical cancer (HeLa) cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","Compound treatment","Cas II-gly"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","cell line","cervical cancer (HeLa) cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","Compound treatment","Cas II-gly"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41827>","Expression data from HeLa cells treated with Casiopeina Cas-II-gly","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41386>","Role of REST in the pathogenesis of uterine fibroids","age","Ages 21 - 50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41386>","Role of REST in the pathogenesis of uterine fibroids","treatment","treated with siREST for 48h"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41386>","Role of REST in the pathogenesis of uterine fibroids","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41386>","Role of REST in the pathogenesis of uterine fibroids","organism part","Uterus, normal myometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41386>","Role of REST in the pathogenesis of uterine fibroids","organism part","Uterus, Leiomyoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41386>","Role of REST in the pathogenesis of uterine fibroids","treatment","treated with scrambled siRNA for 48h"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41459>","Effect of PRR15 knockdown on human trophoblast cell gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41459>","Effect of PRR15 knockdown on human trophoblast cell gene expression","cell line","ACH-3P cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41459>","Effect of PRR15 knockdown on human trophoblast cell gene expression","treatment","shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41459>","Effect of PRR15 knockdown on human trophoblast cell gene expression","treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","cell type","monolayer recovery"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","cell line","T98G glioma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","cell type","spheroid recovery"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","cell line","human foreskin fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","cell type","spheroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4219>","Transcription profiling of human T98G glioma and human foreskin fibroblast cell lines comparing spheroid vs. monolayer growth","cell type","monolayer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","time","Pre-dose"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","tissue type","Non-lesional skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","time","Week1_etanercept"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","tissue type","Lesional skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","time","Week2_etanercept"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","time","Week4_etanercept"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41663>","Re-analysis by microarray using cDNA target of samples from psoriasis patients enrolled in an etanercept trial","time","Week12_etanercept"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41856>","Cell growth in aggregates determines gene expression, proliferation, survival and chemoresistance of Follicular Lymphoma","genotype","t(14,18)+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41856>","Cell growth in aggregates determines gene expression, proliferation, survival and chemoresistance of Follicular Lymphoma","phenotype","Pyronin Y bright"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41856>","Cell growth in aggregates determines gene expression, proliferation, survival and chemoresistance of Follicular Lymphoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41856>","Cell growth in aggregates determines gene expression, proliferation, survival and chemoresistance of Follicular Lymphoma","phenotype","not specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-41856>","Cell growth in aggregates determines gene expression, proliferation, survival and chemoresistance of Follicular Lymphoma","phenotype","Pyronin Y dull"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","cell line","VAL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","treatment","LITAF-specific siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","cell type","diffuse large B-cell lymphoma (DLBCL) cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","cell line","RL"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","treatment","doxycycline"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","cell type","diffuse large B-cell lymphoma (DLBCL) cells stably transfected with a tetracycline-inducible LITAF expression vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","cell line","KARPAS-231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","treatment","non-targeting siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-42174>","Global expression analysis of DLBCL cell lines with LITAF over-expression or silencing","cell line","SC-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","disease","epilepsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","organism part","brain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","tumor grading","grade IV"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","disease","glioblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","disease","astrocytoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","tumor grading","grade III"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","disease","oligodendroglioma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4290>","Transcription profiling of human glioma tumor samples","tumor grading","grade II"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","organism part","atrial tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","Compound treatment","sevoflurane"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","Clinical info","coronary artery bypass surgery patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","Compound treatment","baseline propofol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","Compound treatment","propofol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","Compound treatment","baseline sevoflurane"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4386>","Transcription profiling of human atrial tissue from patients undergoing coronary artery bypass graft surgery to determine the effect of anesthesia on gene expression","individual","H17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","cell line","HeLa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","disease","cervical adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","growth condition","normoxia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","growth condition","hypoxia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4483>","Transcription profiling of HeLa cell line and primary human astrocytes under normoxic and hypoxic conditions to identify hypoxia-responsive genes in primary human astrocytes","cell type","astrocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","Clinical info","refractory anemia with ringed sideroblasts"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","disease","myelodysplastic syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","Clinical info","refractory anemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","Clinical info","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","Clinical info","refractory anemia with excess blasts"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","N1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4619>","Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.","individual","MDS33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","cell type","CD34+ erythroid progenitor cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","time","11 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","time","3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","time","5 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","time","9 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","time","1 day"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4655>","Transcription profiling of developing human erythroid progenitor cells sampled at multiple time points reveals patterns of coregulation and potential transcriptional regulators.","time","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4567>","Transcription profiling of human pulmonary artery endothelial cell culture treated with Chapel Hill Ultrafine particle","cell type","endothelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4567>","Transcription profiling of human pulmonary artery endothelial cell culture treated with Chapel Hill Ultrafine particle","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4567>","Transcription profiling of human pulmonary artery endothelial cell culture treated with Chapel Hill Ultrafine particle","organism part","pulmonary artery"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4567>","Transcription profiling of human pulmonary artery endothelial cell culture treated with Chapel Hill Ultrafine particle","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4567>","Transcription profiling of human pulmonary artery endothelial cell culture treated with Chapel Hill Ultrafine particle","Compound treatment","ultrafine particles"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","phenotype","differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","genotype","MeCP2 decoy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","cell line","SH-SY5Y neuroblastoma cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","Compound treatment","phorbol 12-myristate 13-acetate 16 nanomoles"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","genotype","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","genotype","control decoy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","phenotype","undifferentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4600>","Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected MeCP2 a transcriptional repressor elevated in mature neurons to investigate the neurodevelopmental disorder Rett syndrome","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","cell type","dendritic monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","Compound treatment","CyP + lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-057"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","Compound treatment","CyP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-058"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-050"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-055"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-052"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-049"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-054"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-053"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","Compound treatment","lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4748>","Transcription profiling of human dendritic monocytes treated with LPS (lipopolysaccharide) or CyP (Cyanobacterial Product) reveals cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression","individual","IOSI 05-056"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","time","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","cell type","monocyte derived macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","stimulus","simvastatin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4883>","Transcription profiling of human peripheral blood monocytes treated with simvastatin reveals it has an anti-inflammatory effect on macrophages via upregulation of Kruppel-like factor-2","stimulus","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","organism part","uterus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","Clinical info","menstrual cycle phase: unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","Clinical info","menstrual cycle phase: proliferative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","Clinical info","menstrual cycle phase: mid secretory"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","organism part","endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","Clinical info","menstrual cycle phase: early secretory"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4888>","Transcription profiling of human endrometrium samples obtained across the menstrual cycle of normo-ovulatory women to determine molecular signatures for different phases","Clinical info","menstrual cycle phase: late secretory"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","cell type","monocyte derived dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","individual","DONOR 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","Compound treatment","control - vehicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","individual","DONOR 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","Compound treatment","galectin-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","cell type","mature monocyte derived dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","Compound treatment","control - untreated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","cell type","immature monocyte derived dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","Compound treatment","lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-4984>","Transcription profiling of human monocyte derived dendritric cells matured with Galectin-1 or LPS vs controls","individual","DONOR 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","cell type","lymphoblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","individual","GM15851"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","Compound treatment","pyrrole-imidazole polyamide: FA1 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","individual","GM15850"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","disease","Freidriech's ataxia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","Compound treatment","pyrrole-imidazole polyamide: FA1 2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5040>","Transcription profiling of human lymphoblast cells from a Freidriechs Ataxia patient incubated with pyrrole-imidazole polyamides targeted to the GAA triplet repeat in the intron 1 reveals polyamides alleviate transcription inhibition associated with long repeat srepeats in Friedreicha??s ataxia","Compound treatment","pyrrole-imidazole polyamide: FA2 2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","organism part","vastus lateralis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","individual","subject 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","environmental stress","pre-immobilization"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","age","20.4 + 0.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","biosource type","biopsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","environmental stress","post-immobilization"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","individual","subject 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","individual","subject 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","individual","subject 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5110>","Transcription profiling of human vastus lateralis skeletal muscle (knee) after 48 h of immobilization","individual","subject 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","disease","hepatocellular carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","dose","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","cell line","HepG2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","time","24 hours / 4 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","dose","2.5 uM/500 nM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","Compound treatment","5-aza-2'-deoxycytidine + trichostatin A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","dose","2.5 uM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","time","4 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","Compound treatment","5-aza-2'-deoxycytidine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","dose","500 nM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5230>","Transcription profiling human hepatoma cells treated with 5-aza-dC, Trichostatin A, both, or control to elucidate the response to inhibition of DNA methylation and histone deacetylation","Compound treatment","trichostatin A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","individual","donor 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","cell type","primary epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","14 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","4 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","10 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","individual","donor 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","17 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","8 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","1 day"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","individual","donor 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","28 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","2 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","21 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5264>","Transcription profiling of human airway epithelial cells sampled at multiple time points to examine mucociliary differentiation","time","12 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","injury","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","ethnicity","White"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","sampling time point","0 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","NS2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","clinical history","smoking history: 0 pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","Clinical info","non-smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","ethnicity","black"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","S4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","Clinical info","smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","clinical history","smoking history: 20 pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","S1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","sampling time point","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","clinical history","smoking history: 25 pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","injury","mechanical injury"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","clinical history","smoking history: 23 pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","S5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","clinical history","smoking history: 21 pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","S2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","S3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","clinical history","smoking history: 30 pack years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","NS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","sampling time point","14 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","NS3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5372>","Transcription profiling of human airway epithelium, large airways, pre and post-mechanical injury","individual","NS1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","organism part","vulva"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B131"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","disease","vulvar intraepithelial neoplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B077"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B043"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B017"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B040"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B027"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B135"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B060"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B084"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B090"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B132"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B149"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B004"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","con_B130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5563>","Transcription profiling of human vulvar epithelial neoplasia vs normal controls","individual","VIN_B105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","Compound treatment","AM580"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","cell type","dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","Compound treatment","rosiglitazone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5679>","Transcription profiling of human freshly isolated PPARg and RARa ligand treated dendritic cells","Compound treatment","rosiglitazone and AGN193109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","disease","invasive lobular carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","developmental stage","postmenopausal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","8ILC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","Clinical info","normal tissue from invasive lobular carcinoma patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","9ILC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","disease","invasive ductal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","Clinical info","normal tissue from invasive ductal carcinoma patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","3IDC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","Clinical info","invasive lobular carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","5IDC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","10ILC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","7ILC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","1IDC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","2IDC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","Clinical info","invasive ductal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","6ILC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5764>","Transcription profilimg of human lobular and ductal invasive carcinomas vs normal breast tissue from the same patient to identify gene expression profiles of ductal and lobular carcinomas in relation to normal ductal and lobular cells","individual","4IDC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5741>","Transcription profiling of human ARPE-19 cells treated with LDL or ox-LDL induces a physiological and pathological transcriptional response","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5741>","Transcription profiling of human ARPE-19 cells treated with LDL or ox-LDL induces a physiological and pathological transcriptional response","Compound treatment","low-density lipoprotein 200 micrograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5741>","Transcription profiling of human ARPE-19 cells treated with LDL or ox-LDL induces a physiological and pathological transcriptional response","cell line","APRE-19 cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5741>","Transcription profiling of human ARPE-19 cells treated with LDL or ox-LDL induces a physiological and pathological transcriptional response","Compound treatment","oxidized low-density lipoprotein 200 micrograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5741>","Transcription profiling of human ARPE-19 cells treated with LDL or ox-LDL induces a physiological and pathological transcriptional response","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","cell type","stromal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","organism part","endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","growth condition","control conditioned medium from non-decidualized stromal cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","growth condition","trophoblast conditioned medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5809>","Transcription profiling of human endometrial stromal cells treated with human trophoblasts vs. control, sampled at multiple time points to investigate stromal cell response to paracrine signals from the trophoblast","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","cell line","HeLa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","disease","cervical cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","RNAi","c-MYC knockdown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","RNAi","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","cell line","BT-474"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-5823>","RNAi profiling of human cancer cell lines depleted for  c-MYC depletion","cell line","MDA-MB-231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","histology","invasive tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","organism part","thyroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","disease","papillary thyroid cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","histology","central tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","histology","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6004>","Transcription profiling of human intratumoral samples from central and invasive regions of seven widely invasive PTCs and normal thyroid tissue","individual","T21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","cell line","MT-4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","disease","adult T-cell leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","cell type","T-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","Compound treatment","bortezomib 15 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","cell line","TaY"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","cell line","MT-2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","Compound treatment","bortezomib 5 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6034>","Transcription profiling of human Adult T-cell leukemia (ATL) treated with proteasome inhibitor, bortezomib","cell line","TaT"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","cell type","CD14 positive,monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","genotype","heterozygous LDLR mutant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","disease","familial hypercholesterolemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6054>","Transcription profiling of human circulating monocytes from patients with familial hypercholesterolemia","genotype","homozygous LDLR mutant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","age","16 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","developmental stage","gestation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","karyotype","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","cell type","amniocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","cell type","chorion villus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","age","14 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","karyotype","trisomy 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","karyotype","trisomy 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","age","13 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","age","12 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","age","15 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6283>","Transcription profiling of human fetus with autosomal trisomies","karyotype","trisomy 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","Compound treatment","serum amyloid A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","organism part","umbilical vein"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","cell type","endothelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6241>","Transcription profiling of human umbilical vein endothelial cells to investigate the effects of Serum Amyloid A, time series","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","organism part","mid secretory phase endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","time","mid secretory phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","time","proliferative phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","organism part","proliferative phase endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","disease","endometriosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","organism part","early secretory phase endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6364>","Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","time","early secretory phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","disease","peripheral T-cell lymphoma unspecified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","disease staging","diagnosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","cell type","CD4-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","organism part","peripheral blood or tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","disease","anaplastic large cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","disease","angioimmunoblastic T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","cell type","HLA-DR positive T-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","cell type","CD8-positive T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6338>","Transcription profiling of human peripheral T-cell Lymphoma/Unspecified T cells and normal T cells","cell type","HLA-DR negative T-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","disease","lung carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","dose","5 ug/ml"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","actinomycin D"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","dose","5%"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","mannitol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","dose","1.25 uM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","sapphyrin PCI-2050"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","dose","2.5 uM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","sapphyrin PCI-2055"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","sapphyrin PCI-2052"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","sapphyrin PCI-2051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","sapphyrin PCI-2054"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6400>","Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.","Compound treatment","sapphyrin PCI-2053"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6495>","Transcription profiling of human MOLT4 cell lines before and after inhibition of gamma secretase to investigate NOTCH signaling in T-cell acute lymphoblastic leukemia cell lines","cell line","MOLT-4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6495>","Transcription profiling of human MOLT4 cell lines before and after inhibition of gamma secretase to investigate NOTCH signaling in T-cell acute lymphoblastic leukemia cell lines","disease","T cell acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6495>","Transcription profiling of human MOLT4 cell lines before and after inhibition of gamma secretase to investigate NOTCH signaling in T-cell acute lymphoblastic leukemia cell lines","genotype","NOTCH 1 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6495>","Transcription profiling of human MOLT4 cell lines before and after inhibition of gamma secretase to investigate NOTCH signaling in T-cell acute lymphoblastic leukemia cell lines","Compound treatment","N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6495>","Transcription profiling of human MOLT4 cell lines before and after inhibition of gamma secretase to investigate NOTCH signaling in T-cell acute lymphoblastic leukemia cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6495>","Transcription profiling of human MOLT4 cell lines before and after inhibition of gamma secretase to investigate NOTCH signaling in T-cell acute lymphoblastic leukemia cell lines","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease","hepatitis C virus, hepatocellular carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","pre neoplastic lesion: cirrhoses"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","very early"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease","no infection, normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","pre neoplastic lesion: low-grade liver dysplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","early"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","very advanced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","advanced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease staging","pre neoplastic lesion: high-grade liver dysplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6764>","Transcription profiling of human liver samples from HCV-induced dysplasia and hepatocellular carcinoma patients, progression study","disease","no infection, cirrhoses"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6872>","Transcription profiling of human sperm from normospermic (normally fertile) and teratozoospermic individuals","disease","teratozoospermia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6872>","Transcription profiling of human sperm from normospermic (normally fertile) and teratozoospermic individuals","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6872>","Transcription profiling of human sperm from normospermic (normally fertile) and teratozoospermic individuals","cell type","sperm"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6872>","Transcription profiling of human sperm from normospermic (normally fertile) and teratozoospermic individuals","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-6872>","Transcription profiling of human sperm from normospermic (normally fertile) and teratozoospermic individuals","disease","normospermic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","growth condition","serum free"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","organism part","umbilical cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","genotype","MLL-AF9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","cell type","CD34 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","growth condition","with serum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","genotype","AML1-ETO"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7011>","Transcription profiling of human cord blood cells transduced with Leukemia fusion-gene","genotype","CBFbeta-MYH11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","nipple"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","kidney cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","ventral tegmental area"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","thalamus subthalamic nucleus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","myometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","temporal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell type","T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","none;anti-CD3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","time","30 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","cerebellar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","vestibular nuclei"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","endometriosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","endometrium/ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","substantia nigra pars compacta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","gloubus pallidum internal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","sex","mixed sex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","brain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","thalamus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","rheumatoid arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","synovial membrane"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","Parkinson's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","accumbens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","dorsal root ganglion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","substantia nigra"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","trachea"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell line","MDAMB231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","Cxcl12 10 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","cerebellum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","medulla"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","putamen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","endometrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","Cxcl12 75 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","caudate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","testis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell line","HUVEC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","oral mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","jejunum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell type","CD8+ cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","hippocampus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","adenomyosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","heart"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","subthalamic nucleus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","aorta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","gloubus pallidum external"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","corpus callosum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","deltoid muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell type","peripheral blood mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","amygdala"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","uterine fibroid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","subcutaneous adipose tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","duodenum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","esophagus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","heart atrium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","fallopian tube"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","salivary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","occipital lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","parietal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","frontal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","cerebral cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","vagina"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell line","HepG2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","SDF;none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","spleen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","urethra"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","none;Cxcr4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","neuromuscular pain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","paravertebral muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","anti-CD28;anti-CD3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","pituitary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","spinal cord"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","trigeminal ganglion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","tongue superior with papillae"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","benign prostatic hyperplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","penis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","stomach fundus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","stomach pyloric"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","saphenous vein"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","melanoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","retrocervical infiltrate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","adrenal gland cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","colon cecum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","IL-4;anti-CD40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell type","B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","hypothalamus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","thalamus lateral nucleus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","skeletal muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","tongue main corpus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","kidney medulla"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","SDF;Cxcr4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","small intestine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","interferon gamma + lipopolysaccharide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","cell type","CD4+ cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","vulva"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","uterus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","globus pallidus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","adipose tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","stomach"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","tongue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","cervix"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","pharyngeal mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","nodose nucleus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","thyroid gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","midbrain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","joint synovium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","stomach cardiac"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","bronchus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","pericardium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","substantia nigra reticulata"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","vena cava"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","pancreas"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","frontal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","coronary artery"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","heart ventricle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","peritoneum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","Compound treatment","ionomycin;none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","thymus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","placenta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","pons"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","cerebellar vermis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","prefrontal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7307>","Transcription profiling of panel of 677 samples of normal and diseased human tissues","disease","prostate cancer - adjacent tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","disease","sleep apnea"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","organism part","gingival"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7224>","Transcription profiling of human tonsil and oral epithelia","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7179>","Comparison of gene expression data between wild-type and DM1-affected undifferentiated hES cells.","karyotype","X,Y"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7179>","Comparison of gene expression data between wild-type and DM1-affected undifferentiated hES cells.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7179>","Comparison of gene expression data between wild-type and DM1-affected undifferentiated hES cells.","karyotype","X,X"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","organism part","epidermis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","cell type","keratinocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interleukin 24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interleukin 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interferon gamma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interleukin 1b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interleukin 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","keratinocyte growth factor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interleukin 22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7216>","Transcription profiling of human epidermal keratinocytes (NHEK) from neonatal foreskin treated with IL20 subfamily cytokines vs. controls suggests potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","Compound treatment","interleukin 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","disease","high risk B-precurser acute lymphoblastic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","rapid early responder ; relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","slow early responder; continuous complete remission"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","177"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","rapid early responder"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","134"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","slow early responder"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","208"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","128"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","158"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","rapid early responder ; continuous complete remission"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","176"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","continuous complete remission"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","170"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","125"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","146"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","187"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","Clinical info","slow early responder; relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","169"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","185"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","214"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","189"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","152"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","126"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","183"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","179"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","191"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","141"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","199"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","198"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","153"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","202"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","136"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","188"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","161"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","213"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","173"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","139"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","193"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","138"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","225"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","167"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","135"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","101"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","132"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","133"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7440>","Transcription profiling of human diagnostic samples from children with NCI high risk B-precursor ALL treated on the protocol COG 1961 to investigate early response and outcome in high-risk childhood acute lymphoblastic leukemia","age","150"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","growth condition","anti-FcgRIIB antibody"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","cell type","immature dendritic,mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","cell type","dendritic cell,mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","growth condition","control antibody"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","cell type","monocyte,mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","growth condition","isotype control antibody"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","growth condition","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","growth condition","inflammatory cytokines"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7509>","Transcription profiling of human dendritic cells and monocytes treated with anti-FcgRIIb","growth condition","interferon alpha"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","individual","subject E"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","Compound treatment","granulocyte-colony stimulating factor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","individual","subject B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","individual","subject D"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","individual","subject C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7400>","Transcription profiling of human G-CSF-mobilized peripheral blood stem cell allograft","individual","subject A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","Clinical info","kidney allograft recipient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","time","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","histology","subclinical interstitial fibrosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","histology","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7392>","Transcription profiling of human normal and fibrotic renal allografts one year post-transplant","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","stimulus","parthenolide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","cell type","CD34 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","disease","acute myelogenous leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","stimulus","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7538>","Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)","individual","Patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7515>","Transcription profiling of cancer mammospheres and bulk tumors","cell type","mammosphere cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7515>","Transcription profiling of cancer mammospheres and bulk tumors","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7515>","Transcription profiling of cancer mammospheres and bulk tumors","organism part","breast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7515>","Transcription profiling of cancer mammospheres and bulk tumors","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7515>","Transcription profiling of cancer mammospheres and bulk tumors","cell type","breast tumor cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","genotype","Alk shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","cell line","DAOY"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","disease","medulloblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","genotype","Bmi-1 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","genotype","Bmi-1 Mel-18 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","genotype","Mel-18 shRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7578>","shRNA-mediated knock down of Bmi-1 and Mel-18 in medulloblastoma cells","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","growth condition","dexamethasone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","cell type","macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","Compound treatment","TGF-beta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7568>","Transcription profiling of primary human macrophages treated with TGF-beta","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","clinical history","nulliparous"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","organism part","placenta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 0.7 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","histology","inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","638"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","disease","chronic malaria"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","disease","previous malaria infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","histology","no inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 0 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","409"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 10 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","586"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","543"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 4.6 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","540"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","545"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","disease","acute malaria"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 0.6 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","482"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","475"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 7 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","716"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","460"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 1.3 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","660"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","517"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 63 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","687"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 1.7 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","702"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","449"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","491"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","Clinical info","parasitemia: 1.1 %"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","735"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","649"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7586>","Transcription profiling of human placenta isolated from first time mothers with placental malaria","individual","606"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7621>","Transcription profiling of human substantia nigra from postmortem brain of Parkinsons disease patients (PD)","disease","Parkinson's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7621>","Transcription profiling of human substantia nigra from postmortem brain of Parkinsons disease patients (PD)","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7621>","Transcription profiling of human substantia nigra from postmortem brain of Parkinsons disease patients (PD)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7621>","Transcription profiling of human substantia nigra from postmortem brain of Parkinsons disease patients (PD)","organism part","substantia nigra"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7621>","Transcription profiling of human substantia nigra from postmortem brain of Parkinsons disease patients (PD)","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7621>","Transcription profiling of human substantia nigra from postmortem brain of Parkinsons disease patients (PD)","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","organism part","brain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","disease","glioblastoma multiforme"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","Clinical info","temozolomide and radiotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","26.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1317"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","49.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","Clinical info","radiotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 147"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","45.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1076"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","Clinical info","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","59.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 345"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: ge197"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","46.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","70.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","56.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 506"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","57.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 269"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 390"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","41.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","37.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","disease","recurrent glioblastoma multiforme"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1430"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 461"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","63.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 284"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","51.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 444"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","63.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 563"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","52.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","54.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 242"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: ge205"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","55.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1795"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","43.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","48.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1284"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","49.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","56.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 283"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","47.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 300"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 157"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","48.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 528"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","33.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","56.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 344"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","27.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1854"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","49.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 288"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","44.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 566"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","43.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 534"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","41.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","59.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 212"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 246"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","48.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1437"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","56.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 236"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1621"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","61.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 155"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","52.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 558"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","55.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","46.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 574"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 218"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 211"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","44.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 458"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1780"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","60.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 159"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","37.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","38.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1399"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1453"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","53.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1297"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","36.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","61.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 222"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","52.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","53.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 84"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 547"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","43.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","49.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 396"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","52.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 527"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","57.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 428"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1553"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1357"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","35.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","63.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 356"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","32.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1360"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 94"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","58.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","46.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 190"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","60.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","48.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","62.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 97"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 360"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","48.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 274"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","64.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 323"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","60.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","53.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","survival","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 161"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 1308"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","51.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 349"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","age","62.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7696>","Transcription profiling of human glioblastoma samples from a homogenous cohort of patients treated within clinical trial with eitehr radiotherapy or radiotherapy and temonzolomide","individual","patient: 328"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","Compound treatment","bicalutamide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","growth condition","dihydrotestosterone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","disease","prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","cell line","LNCAP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","Compound treatment","Polyamide 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","Compound treatment","polyamide 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7708>","Transcription profiling of human LNCaP cells to investigate androgen receptor mediated gene expression by a sequence-specific DNA binding polyamide","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","Compound treatment","polyamide 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","growth condition","deferoxamine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","cell type","glioblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","cell line","U251"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","Compound treatment","HIF-1a siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7835>","Transcription profiling of human U251 cells treated with hypoxia inducible factor HIF-1I siRNA or a polyamide targeted against the hypoxia response element (HRE) after induction of hypoxia","Compound treatment","echinomycin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","histology","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","disease","renal cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","histology","medium cyst"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","disease","autosomal dominant polycystic kidney disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","histology","small cyst"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","histology","large cyst"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7869>","Transcription profiling of human renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients","histology","non cystic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","sampling site","keloid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","sampling site","normal scar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-7890>","Transcription profiling of human keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways","Compound treatment","hydrocortisone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8023>","Transcription profiling of human AML1-ETO transduced cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected","organism part","umbilical cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8023>","Transcription profiling of human AML1-ETO transduced cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected","genetic modification","AML1-ETO fusion gene"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8023>","Transcription profiling of human AML1-ETO transduced cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8023>","Transcription profiling of human AML1-ETO transduced cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8023>","Transcription profiling of human AML1-ETO transduced cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected","cell type","CD34 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8023>","Transcription profiling of human AML1-ETO transduced cord blood cells, CD34 selected, compared to normal cord blood cells, CD34 selected","genetic modification","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","organism part","small intestine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","genotype","KIT mutation: Exon 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","disease","gastrointestinal stromal tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","genotype","KIT mutation: wildtype"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","organism part","stomach"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","genotype","KIT mutation: Exon 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","76"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","tumor size","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8167>","Transcription profiling of human gastrointestinal stromal tumor (GIST) reveals gene expression determined distinct classes.","age","82"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","estrogen supplementation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","genotype","HER2 overexpression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","estrogen deprivation plus gefinitinib"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","tamoxifen plus gefinitinib"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","estrogen plus gefinitinib"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","tamoxifen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","estrogen deprivation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","estrogen plus tamoxifen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8141>","Transcription profiling of human MCF7 wt and MCF7/HER2-18 xenografts","growth condition","estrogen plus fulvestrant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","cell type","lymphoblastoid cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8131.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","disease","asthma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8065.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8093.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8081.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8097.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8114.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8045.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8165.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8174.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8193.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8193.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8089.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8078.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8049.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8104.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8004.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8175.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8021.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8157.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8213.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8196.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8176.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8207.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8184.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8033.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8020.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8176.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8213.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8059.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8199.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8153.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8015.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8118.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8113.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8073.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8136.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8162.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8101.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8202.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8133.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8125.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8030.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8100.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8083.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8185.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8042.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8070.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8084.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8169.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8112.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8062.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8085.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8032.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8058.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8060.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8046.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8108.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8158.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8163.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8015.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8119.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8043.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8195.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8103.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8017.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8027.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8003.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8080.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8127.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8070.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8166.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8122.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8118.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8046.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8064.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8116.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8175.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8144.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8113.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8180.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8135.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8191.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8039.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8088.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8157.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8073.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8129.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8207.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8120.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8068.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8021.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8019.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8033.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8041.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8007.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8135.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8080.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8177.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8141.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8121.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8156.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8196.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8123.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8114.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8140.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8054.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8094.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8003.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8201.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8047.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8010.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8182.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8054.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8179.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8209.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8123.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8152.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8019.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8108.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8206.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8075.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8083.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8028.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8205.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8107.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8126.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8079.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8117.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8134.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8064.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8115.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8183.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8110.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8211.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8136.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8105.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8158.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8190.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8013.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8128.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8161.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8137.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8208.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8087.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8042.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8096.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8026.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8076.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8174.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8172.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8057.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8169.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8177.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8139.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8160.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8148.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8150.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8179.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8175.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8013.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8159.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8162.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8098.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8147.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8164.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8073.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8050.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8203.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8168.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8009.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8145.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8105.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8187.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8001.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8098.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8171.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8178.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8125.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8201.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8202.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8129.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8167.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8126.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8052.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8188.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8131.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8007.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8016.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8069.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8189.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8113.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8164.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8060.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8154.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8165.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8200.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8194.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8137.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8201.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8199.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8161.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8127.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8210.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8163.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8036.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8214.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8171.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8168.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8173.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8093.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8109.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8185.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8038.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8206.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8034.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8061.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8121.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8023.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8026.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8163.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8060.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8190.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8008.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8165.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8213.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8008.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8072.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8151.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8096.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8148.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8014.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8101.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8172.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8204.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8016.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8167.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8090.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8090.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8177.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8148.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8051.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8189.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8145.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8138.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8203.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8047.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8197.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8022.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8053.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8099.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8143.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8115.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8052.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8066.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8173.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8037.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8181.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8120.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8030.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8048.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8111.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8204.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8198.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8118.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8196.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8192.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8065.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8044.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8111.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8087.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8182.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8111.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8109.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8058.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8170.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8184.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8136.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8156.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8006.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8017.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8064.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8106.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8211.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8049.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8209.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8101.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8124.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8132.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8132.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8166.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8094.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8066.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8028.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8059.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8005.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8152.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8067.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8151.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8057.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8006.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8197.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8107.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8072.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8038.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8112.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8020.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8142.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8037.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8055.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8149.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8138.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8115.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8091.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8040.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8155.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8180.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8004.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8003.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8092.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8100.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8146.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8199.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8198.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8191.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8034.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8100.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8043.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8210.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8102.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8200.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8147.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8174.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8062.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8022.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8063.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8130.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8075.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8186.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8084.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8080.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8067.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8039.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8063.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8040.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8101.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8076.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8155.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8050.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8127.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8025.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8159.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8054.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8044.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8010.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8156.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8178.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8192.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8103.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8075.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8089.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8153.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8012.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8069.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8128.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8036.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8150.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8002.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8099.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8108.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8143.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8154.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8124.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8061.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8146.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8104.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8169.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8079.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8135.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8051.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8091.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8172.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8193.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8117.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8041.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8205.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8081.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8118.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8092.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8141.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8201.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8133.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8110.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8116.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8055.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8122.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8139.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8188.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8170.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8125.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8183.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8124.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8130.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8045.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8052>","Transcription profiling of lymphoblastoid cell lines from 404 human individuals to find determinants of susceptibility to childhood asthma","individual","8097.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","organism part","whole blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","developmental stage","child"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","disease","septic shock"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","time","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","06_0003_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","10_0004_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0029_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","06_0004_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0005_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","time","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","07_0002_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0017_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","09_0002_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","06_0001_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","01_0019_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","25_70603_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","01_0025_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0019_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0027_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0008_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0002_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","04_0004_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","01_0026_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0001_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","09_0001_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","01_0024_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","05_0006_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0004_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","02_0001_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0037_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","05_0008_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","06_0006_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","10_0020_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","05_0010_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","04_0003_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0020_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0007_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","05_0007_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","10_0017_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","10_0012_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0009_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0003_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0008_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0014_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","01_0030_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0012_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0013_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","27_70603_Patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0011_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","15_0001_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8121>","Transcription profiling of human whole blood from pediatric septic shock patients","individual","11_0018_Normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8514>","Expression data from normal adrenal gland and aldosterone-producing adenoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8514>","Expression data from normal adrenal gland and aldosterone-producing adenoma","disease","aldosterone-producing adenoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8514>","Expression data from normal adrenal gland and aldosterone-producing adenoma","organism part","adrenal gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8514>","Expression data from normal adrenal gland and aldosterone-producing adenoma","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","genotype","PPARg receptor: wildtype,wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","time","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","growth condition","human serum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","82"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","growth condition","fetal bovine serum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","89"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","time","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","Compound treatment","rosiglitazone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","92"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","95"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","genotype","PPARg receptor mutation: C131Y"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","mass","80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","age","47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8658>","Transcription profiling of human monocytes from patients with dominant negative mutations in PPARg and rosiglitazone treated cells to investigate PPARg regulated gene expression in human dendritic cells","genotype","PPARg receptor mutation: C114R"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","cell line","Detroit 562"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","cell type","epithelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","organism part","pharynx"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 2 strain D39 (wild type)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 19F strain G54delta-cps"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 4 strain TIGR4delta-cps"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 2 strain D39delta-cps"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 19F strain G54 (wild type)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 4 strain TIGR4 (wild type)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Infection","Streptococcus pneumoniae serotype 2 strain D39delta-cps (low dosage)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8527>","Transcription profiling of human pharyngeal epithelial cells response to adherent pneumococci","Compound treatment","Streptococcus pneumoniae type2 capsular polysaccharides 20 micrograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","growth condition","dimethyl sulfoxide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","Compound treatment","17beta-estradiol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","cell line","MCF7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","growth condition","cycloheximide"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8597>","Transcription profiling of human hormone treated MCF7 breast cancer cells in the presence or absence of cycloheximide","Compound treatment","ethanol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","cell type","cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","organism part","peripheral nerve sheath"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","cell line","T265"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","disease","malignant peripheral nerve sheath tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","Infection","herpes simplex virus G207"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","cell line","S462"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","cell line","8814"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","cell line","90-8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8717>","Transcription profiling of human MPNST cancer cells infected with G207 an oncolytic HSV","cell line","26T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","clinical history","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 114 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","acute rejection plus chronic allograft nephropathy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","clinical history","allograft,donor: deceased"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 356 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","chronic allograft nephropathy grade II"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 298 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","chronic allograft nephropathy grade III"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 495 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 204 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","clinical history","allograft,donor: living"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","no rejection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 219 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 161 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","acute rejection IB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 107 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","acute rejection IA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 187 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","chronic allograft nephropathy grade I"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 110 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 158 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","clinical history","allograft"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 572 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 427 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 267 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 130 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 200 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 250 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 167 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 88 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 171 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 121 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 182 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 104 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 93 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","borderline changes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 806 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 192 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 61 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 118 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 91 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 1000 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 120 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","76 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 210 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","acute rejection IIB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 328 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 230 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 113 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","82 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 240 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 122 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 186 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 65 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 640 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 201 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 75 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 199 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 900 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","histology","acute rejection IIA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 228 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 270 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 175 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 466 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","control,serum creatinine: 36 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9489>","Transcription profiling of human renal allograft biopsies reveal conserved rejection signatures and molecular pathways I","Clinical info","allograft,serum creatinine: 332 micromole per liter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","Clinical info","smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","23 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","organism part","alveolus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","cell type","macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","ethnicity","African"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","ethnicity","Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","Clinical info","non-smoker"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","45 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","15 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","70 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","20 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","21 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","80 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","38 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","24 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","60 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","ethnicity","Hispanic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","clinical history","30 pack-years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","individual","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8823>","Transcription profiling of human alveolar macropages reveales overexpression of apoptotic cell removal receptor, MERTK,","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","organism part","bronchiole"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","Infection","human metapneumovirus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","time","72 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8961>","Transcription profiling of human airway epithelial cells metapneumovirus-induced gene networks","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","cell type","stromal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","disease","invasive ductal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS817"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS820"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS816"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS718"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS795"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS768"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","Nstr122204"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS818"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","Nstr101904"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","TS838"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","Nstr112204"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-8977>","Transcription profiling of human stromal samples prepared from 15 normal/DCIS and 7 IDC tumor specimens reveals bone-marrow-derived mesenchymal stem cells promote breast cancer metastasis","individual","NS817"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9171>","Transcription profiling by array of human glioblastoma frozen tumors and cell lines","material type","organism_part"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9171>","Transcription profiling by array of human glioblastoma frozen tumors and cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9171>","Transcription profiling by array of human glioblastoma frozen tumors and cell lines","disease","glioblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9171>","Transcription profiling by array of human glioblastoma frozen tumors and cell lines","organism part","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9171>","Transcription profiling by array of human glioblastoma frozen tumors and cell lines","cell line","unspecified cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9171>","Transcription profiling by array of human glioblastoma frozen tumors and cell lines","material type","cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","organism part","vastus lateralis muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","environmental history","sedentary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","age","young"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","age","old"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","environmental history","trained"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OS7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","OT8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YT10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9103>","Transcription profiling of human skeletal muscle transcript from trained or sedentary young and old subjects","individual","YS11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","76"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","82"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","70"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","72"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","89"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9348>","Expression data from healthy controls and early stage CRC patient's tumor","age","86"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","organism part","descending colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","disease","ulcerative colitis pre-inflammation,ulcerative colitis without inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","disease","ulcerative colitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","organism part","sigmoideum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","disease","ulcerative colitis with inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9452>","Transcription profiling of human ulcerative colitis colonic mucosa to define an ulcerative colitis preinflammatory state","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","cell line","SH-SY5Y (HTB-11)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","cell type","neuroblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","growth condition","retinoic acid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","cell line","SH-SY5Y (CRL-2266)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","time","5 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","cell line","SH-SY5Y (EC94030304)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","Compound treatment","LY294002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","growth condition","brain-derived neurotrophic factor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","time","2 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","time","3 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","time","1 day"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9169>","Transcription profiling of neuronal differentiation in two subtypes of SH-SY5Y","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","survival","yes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","disease","septic shock"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","developmental stage","child"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","survival","no"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","group A streptococcus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","Staphylococcus aureus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","Neisseria"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","Streptococcus pneumoniae"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","group B streptococcus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9692>","Transcription profiling of human pediatric septic shock samples to validation of previous experiment","Infection","adenovirus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","growth condition","cysteine deprivation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","cell line","C3A/HepG2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","cell type","hepatoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","growth condition","cysteine abundance"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9517>","Transcription profiling of human liver cell line after cysteine deprivation","time","42 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","Clinical info","mouse xenograft"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","phenotype","EGFR inhibition resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","disease","pancreatic cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","organism part","pancreas"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","cell type","tumor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9599>","Transcription profiling of human pancreatic cancer samples: coordinated over-expression of genes in the EGFR pathway predicts sensitivity to EGFR inhibition","phenotype","EGFR inhibition sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","growth condition","normoxia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","cell line","Human Mammary Epithelial Cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","Compound treatment","sodium lactate 25 millimolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","Compound treatment","lactic acid 25 millimolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","growth condition","hypoxia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9649>","Transcription profiling of human HMEC exposed to lactic acidosis and hypoxia","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","genotype","overexpression of estrogen receptor beta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","cell line","MDAMB231"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","genotype","overexpression of estrogen receptor alpha 203/204/211E (3411E)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","genotype","overexpression of estrogen receptor beta mutant defective in binding to ERE"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","genotype","overexpression of estrogen receptor alpha"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9761>","Transcription profiling of human MDA-MB-231 cells response to adenovirus expressed estradiol-ERalpha, estradiol-Erbeta, and ERE Binding defective mutants","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9894>","Transcription profiling of human culture-amplified and native bone marrow mesenchymal stem cells to characterize specific plasma membrane protein phenotype","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9894>","Transcription profiling of human culture-amplified and native bone marrow mesenchymal stem cells to characterize specific plasma membrane protein phenotype","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9894>","Transcription profiling of human culture-amplified and native bone marrow mesenchymal stem cells to characterize specific plasma membrane protein phenotype","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9894>","Transcription profiling of human culture-amplified and native bone marrow mesenchymal stem cells to characterize specific plasma membrane protein phenotype","cell type","erythropoietic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9894>","Transcription profiling of human culture-amplified and native bone marrow mesenchymal stem cells to characterize specific plasma membrane protein phenotype","cell type","granulopoietic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9894>","Transcription profiling of human culture-amplified and native bone marrow mesenchymal stem cells to characterize specific plasma membrane protein phenotype","cell type","hematopoietic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","phenotype","mild cognitive impairment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism status","postmortem"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism part","superior frontal gyrus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","cell type","layer 3 neuron"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism part","middle temporal gyrus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism part","primary visual cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism part","posterior cingulate cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism part","hippocampus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","cell type","layer 2 stellate neuron"
"<http://rdf.ebi.ac.uk/resource/atlas/E-GEOD-9770>","Transcription profiling of human neurons from different brain regions derived from individuals with mild cognitive impairment","organism part","entorhinal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1072>","Transcription profiling of human A549 epithelial cells infected with polio virus or mock infected to compare Nanostring and Affymetrix technologies","disease","mock infected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1072>","Transcription profiling of human A549 epithelial cells infected with polio virus or mock infected to compare Nanostring and Affymetrix technologies","cell type","lung epithelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1072>","Transcription profiling of human A549 epithelial cells infected with polio virus or mock infected to compare Nanostring and Affymetrix technologies","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1072>","Transcription profiling of human A549 epithelial cells infected with polio virus or mock infected to compare Nanostring and Affymetrix technologies","biosource provider","Roger E. Bumgarner"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1072>","Transcription profiling of human A549 epithelial cells infected with polio virus or mock infected to compare Nanostring and Affymetrix technologies","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1072>","Transcription profiling of human A549 epithelial cells infected with polio virus or mock infected to compare Nanostring and Affymetrix technologies","disease","poliovirus-infected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","growth condition","10 ng/ml LPS in media"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","cell type","monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","growth condition","media only"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1103>","Transcription profiling of normal human monocytes in response to Aspergillus fumigatus","growth condition","A. fumigatus condia in media"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","cell type","embryonic stem cell,human embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","BMP2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","cell treatment","medium with BMP4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","cell line","H9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","developmental stage","embryonically derived stem cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","cell treatment","medium with BMP4 and inhibitors"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","INHIB2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","INHIB3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","BMP1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","INHIB1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","BMP3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","CDM1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","cell treatment","medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","CDM3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1192>","Transcription profiling of human embryonic stem cells treated with BMP4 in chemically-defined medium, with and without inhibitors of Activin and FGF signalling to investigate the induction of extra-embryonic tissue differentiation by BMP signalling","individual","CDM2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","disease","colorectal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","phenotype","SN38 sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","cell line","HCT116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1171>","Transcription profiling by array of human colorectal carcinoma cell line HCT116 treated with SN38 (7-ethyl-10-hydroxy-20(S)-camptothecin)and sampled at 3 timepoints","phenotype","SN38 resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","disease","type 1 diabetes longstanding"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","organism part","islet of Langerhans"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","organism part","pancreas"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","disease","type 1 diabetes clinical onset"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","disease","type 1 diabetes recent onset"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1140>","Transcription profiling of human pancreas from patients with type 1 diabetes (clinical onset and longstanding)","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1235>","Transcription profiling of human HepG2 cells expressing gain-of-function mutant D374Y-PCSK9","genotype","D374Y-PCSK9 gain of function"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1235>","Transcription profiling of human HepG2 cells expressing gain-of-function mutant D374Y-PCSK9","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1235>","Transcription profiling of human HepG2 cells expressing gain-of-function mutant D374Y-PCSK9","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1235>","Transcription profiling of human HepG2 cells expressing gain-of-function mutant D374Y-PCSK9","cell line","Hep2G"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1235>","Transcription profiling of human HepG2 cells expressing gain-of-function mutant D374Y-PCSK9","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","Clinical info","TRUS-guided biopsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","genotype","GSTM1 null"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease","high-grade prostatic intraepithelial neoplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","treatment","broccoli"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","time","12 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease","benign prostatic hyperplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","time","0 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","Clinical info","TURP biopsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","time","6 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","treatment","peas"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","genotype","GSTM1 positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease staging","Gleason 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","87 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease","prostate cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease staging","Gleason 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease staging","Gleason 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease staging","Gleason 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","disease staging","Gleason 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1243>","Transcription profiling by array of human prostate from patients with a previous diagnosis of Prostatic Intraepithelial Neoplasia and following consumption of high glucosinolate broccoli or peas to investigate interactions with the GSTM1 genotype","individual","Patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","cell type","adipose-derived stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","time","28 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","organism part","adipose tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat280505"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat160205A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","time","2 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat140105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat190105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat200204"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat240605"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","hFOBS"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","organism part","bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","cell type","osteoblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","cell line","hFOB"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","developmental stage","embryo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","cell type","kidney cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","cell line","HEK293"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","HEK"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat301104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat010205A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat240904"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat160404"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat190303"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat160205B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat220605"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat110104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat151004"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat150304"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat250804"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat290904"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat010404"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","cell type","dermal fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","HDF"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1216>","Transcription profiling of human adipose derived stem cells before induction and at two time points after induction of differentiation","individual","Pat110304"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1230>","Transcription profiling by array of human dendritic cells after Poly(I:C)-based or PGE2-based maturation","cell type","dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1230>","Transcription profiling by array of human dendritic cells after Poly(I:C)-based or PGE2-based maturation","growth condition","PGE2-DC maturation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1230>","Transcription profiling by array of human dendritic cells after Poly(I:C)-based or PGE2-based maturation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1230>","Transcription profiling by array of human dendritic cells after Poly(I:C)-based or PGE2-based maturation","growth condition","no treatment"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1230>","Transcription profiling by array of human dendritic cells after Poly(I:C)-based or PGE2-based maturation","growth condition","poly(I:C)-DC maturation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","Infection","uninfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","individual","Donor 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","cell type","macrophage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","age","26-66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","individual","Donor 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","cell type","macrophage; T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","Infection","Leishmania chagasi"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","individual","Donor 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1290>","Transcription profiling of human monocyte-derived macrophages infected in vitro with wild type Leishmania chagasi parasites and then cultured with naive, autologous T-cells","individual","Donor 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","disease","adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","Compound treatment","cooked broccoli"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","time","1 minutes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","cell line","Caco-2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","time","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","Compound treatment","water"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","time","5 minutes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","time","4 minutes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1372>","Transcription profiling of human colon Caco-2 cells treated with extracts from broccoli that had been cooked for different lengths of time","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1315>","RNAi knock down of the DNA-repair enzyme and transcriptional co-activator APE1 in human HeLa cells","cell line","HeLa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1315>","RNAi knock down of the DNA-repair enzyme and transcriptional co-activator APE1 in human HeLa cells","RNAi","scrambled control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1315>","RNAi knock down of the DNA-repair enzyme and transcriptional co-activator APE1 in human HeLa cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1315>","RNAi knock down of the DNA-repair enzyme and transcriptional co-activator APE1 in human HeLa cells","RNAi","APE1 RNAi"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","Compound treatment","indomethacin 125 milligrams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","cell type","intestinal mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","organism part","intestine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1337>","Transcription profiling by array of human duodenal mucosa from healthy subjects after treatment with the non-steroidal anti-inflammatory drug idomethacin or a placebo","Compound treatment","placebo 0 milligrams"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","cell type","promyelocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","cell line","HL-60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","Compound treatment","eicosapantaenoic acid 35 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1389>","Transcription profiling by array of human HL60 cells treated with eicosapantaenoic acid (EPA) to investigate the effect on the signalling pathways involved in growth arrest/apoptosis","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","cell type","pro-B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","organism part","cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","phenotype","CD34+CD38+CD19+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","genotype","control vector transduced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","cell type","CD34+CD38-/lowCD19+ cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","phenotype","CD34+CD38-/lowCD19+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","genotype","TEL-AML1 vector transduced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","genotype","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","phenotype","CD34+CD38-/lowCD19-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1403>","Transcription profiling of human hematopoietic stem cells, pro-B cells and TEL-AML1 tranduced cord blood cells to study TEL-AML1 associated childhood leukemia","cell type","hematopoietic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","genetic modification","miR15a/miR16-1 transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","miR-03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","cell line","MEG01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0368"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","disease","chronic lymphocytic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","IWF0009"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","JCB0010"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","Empty-02"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","genetic modification","empty vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","KRR0008"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","IWF0071"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0385"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0233"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","JGG0103"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0198"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0189"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","IWF0100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","miR-02"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","Empty-03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0303"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0262"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","Empty-01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0383"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","miR-01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0294"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1482>","Transcription profiling of human chronic lymphocytic leukemia samples and pRS-15/16 transfected MEG01 cell lines to identify MiR-15a and miR-16-1 cluster function in human leukemia","individual","TJK0309"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1412>","Transcription of human CD133+ G0 and G1 human ubmbilical vein cells reveals MLLT3 regulates erythroid and megakaryotic cell fate","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1412>","Transcription of human CD133+ G0 and G1 human ubmbilical vein cells reveals MLLT3 regulates erythroid and megakaryotic cell fate","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1412>","Transcription of human CD133+ G0 and G1 human ubmbilical vein cells reveals MLLT3 regulates erythroid and megakaryotic cell fate","developmental stage","neonate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1412>","Transcription of human CD133+ G0 and G1 human ubmbilical vein cells reveals MLLT3 regulates erythroid and megakaryotic cell fate","phenotype","CD133+ G0 phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1412>","Transcription of human CD133+ G0 and G1 human ubmbilical vein cells reveals MLLT3 regulates erythroid and megakaryotic cell fate","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1412>","Transcription of human CD133+ G0 and G1 human ubmbilical vein cells reveals MLLT3 regulates erythroid and megakaryotic cell fate","phenotype","CD133+ G1 phase"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","time unit","years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","age","26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","organism part","adipose tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 24.78"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","age","25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 25.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","disease","obesity"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","age","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 31.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","age","27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 29.15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 26.05"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 31.51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 28.45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 22.76"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","age","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 32.53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 28.11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 25.51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 28.06"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 27.35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 25.09"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 32.91"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 26.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 30.63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 29.73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 25.36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 24.54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 22.83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 32.48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 28.23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 25.63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","family relationship","monozygotic twin pair 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1425>","Transcription profiling of fat biopsies from monozygotic twins discordant for body mass index to elucidate the effects of acquired obesity","Clinical info","BMI: 30.15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1599>","Transcription profiling of human A549 lung epithelial cells exposed to acrolein shows activation of early growth response genes dominate transcriptional responses","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","individual","3F1020"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","time","5 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","organism part","bronchial epithelium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","Compound treatment","cigarette smoke"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","individual","3F1044"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","time","23 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","individual","2F0358"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1512>","Transcription profiling of human bronchial epithelial cells following exposure to whole cigarette smoke","Compound treatment","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","cell type","CD34+ hematopoietic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","organism part","umbilical cord"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","initial time point","beginning_of_stage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","cell type","CD41 negative portion"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","time","10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1546>","Transcription profiling of human differentiating cord blood derived megakaryocytes","cell type","CD41+ cord blood derived megakaryocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","cell type","gamma delta T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","Compound treatment","HMB-PP 1 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","Compound treatment","anti-CD3 antibody 1 microgram per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1601>","Transcription profiling by array of human peripheral blood gamma-delta T cells stimulated with HMB-PP or OKT-3","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","individual","SB3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","cell type","embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","cell line","H9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","growth condition","chemically defined medium supplemented with FGF2 and SB431542"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","individual","SB2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","individual","SB1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","growth condition","chemically defined medium supplemented with activin and FGF"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","individual","CDM1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","individual","CDM2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1741>","Transcription profiling of human embryonic stems cells grown in chemically defined medium supplemented with Activen and FGF or FGF2 and SB431542 to identify genes controlled by Activin/Nodal signalling","individual","CDM3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","Clinical info","biopsy taken after 2 years on gluten free diet"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","3.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","organism part","duodenum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","disease","celiac disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","4.4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","2.9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","Clinical info","biopsy taken at diagnosis of celiac disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","4.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","6.15 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","4.1 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","5.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","3.1 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","1.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","4.9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","6.4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","2.1 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","4.15 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","2.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","age","1.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1828>","Transcription profiling of duodenum biopsies from patients with celiac disease taken at time of diagnosis or after two years of a gluten free diet","individual","Patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","RNAi","H1015 ASCL1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","disease","small cell lung cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 1015, repeat 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","cell line","NCIH1618"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 938, repeat 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","RNAi","H938 ASCL1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 1033, repeat 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","RNAi","H1033 ASCL1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 1015, repeat 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 1033, repeat 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 1015, repeat 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","RNAi","Dharmacon control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","Control siRNA 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 1033, repeat 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","Control siRNA 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 938, repeat 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","Control siRNA 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1857>","RNAi knock down of ASCL1 in human NCI-H1618 small cell lung cancer cells","individual","ASCL1-targeting siRNA 938, repeat 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","genotype","ELMOD2 over-expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","individual","ELMOPDSRed B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","cell line","A549"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","disease","adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","individual","ELMOPDSRed A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","individual","ELMOPDSRed C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","genotype","vector"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","individual","PDSRed B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","individual","PDSRed C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1838>","Transcription profiling of human adenocarcinoma cell line A549 over-expressing ELMOD2","individual","PDSRed A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","time","0.5 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","disease","cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","cell line","SW620"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","Compound treatment","docosahexaenoic acid 70 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2010>","Transcription profiling of human colon cancer cell line SW620 treated with docosahexaenoic acid","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","RT3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","clinical treatment","pre-therapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","Clinical info","diagnostic biopsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","disease","rectal adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","organism part","rectum"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","CON1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","Clinical info","surgical resection biopsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","clinical treatment","no therapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","CON2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","CRT4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","clinical treatment","chemoradiotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","CRT3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","clinical treatment","radiotherapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","CRT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","RT4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","CRT2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","RT1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","individual","RT2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1901>","Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","organism part","connective tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","disease","leiomyosarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","organism part","abdomen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","disease","undifferentiated sarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","organism part","thorax"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","organism part","hindlimb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","82 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS148L"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","organism part","forelimb"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS78"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS82"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS86"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS80"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S92"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S137"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS79"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S73"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","88 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS76"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","LMS109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1922>","Transcription profiling of human well-differentiated leiomyosarcomas and undifferentiated sarcomas","individual","S71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","individual","patient F2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","genotype","mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","individual","patient F6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1956>","Transcription profiling of cultured fibroblastic cell lines from Rett syndrome patients","individual","patient F3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","Compound treatment","lipopolysaccharide 1 microgram per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","cell type","dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","growth condition","co-cultured with SK-MES-1 cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-1958>","Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide","growth condition","co-cultured with A549 cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","INHIB4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","cell line","IMR-90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","RNAi","siRNA-mediated CDC7 inhibition"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","cell type","fibroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","developmental stage","embryo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","CONTROL1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","RNAi","non-specific siRNA control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","CONTROL5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","CONTROL3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","INHIB3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","CONTROL2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","INHIB5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","INHIB1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","CONTROL4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2115>","RNAi knock down of CDC7 in human IMR90 primary diploid fibroblasts derived from embryonic lung tissue","individual","INHIB2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","cell type","stromal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","clinical history","primary prostate cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","iberin 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","disease","benign prostatic hyperplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","cell line","primary cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","dimethyl sulfoxide 0.1 volume percent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","sulforaphane 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","time","6 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","cell line","PC3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","clinical history","prostate cancer cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","iberin 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","disease","prostate carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","5-azacytidine 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","sulforaphane 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","genistein 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","epigallocatechin gallate 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2034>","Transcription profiling of human primary prostate epithelial and stromal cells exposed to 4-methylsulphinylbutyl and 3-methylsulphinypropyl isothiocyanates","treatment","5-azacytidine 20 micromolar and TSA 0.33 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","cell type","gamma delta T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","age","37-41 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","initial time point","birth"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","individual","CMVneg10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","Clinical info","CMV negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","clinical history","CMV negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","individual","CMVneg8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","Clinical info","CMV positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","clinical history","CMV positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","individual","CMVpos9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","individual","CMVpos8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","individual","CMVpos5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2055>","Transcription profiling of human fetal gammadelta T cells from that cytomegalovirus (CMV) positive or negative","individual","CMVneg3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","cell type","peripheral blood mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","disease","gulf war illness"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","time","30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","time","60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","GW9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","individual","Con8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2069>","Transcription profiling of blood from Gulf War Illness sufferers and control veterans before and during exercise","time","20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","initial time point","birth"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","cell type","intestinal epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","disease","active Crohn's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","disease","active ulcerative colitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","disease","non-active ulcerative colitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2083>","Transcription profiling of human intestinal epithilium from patients suffering from inflammatory bowel disease","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","Constantinidis type A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 4 years; Cause of death: complications secondary to a cerebro vasculair accident"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","organism part","medial temporal lobe"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","98-075"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease","Pick's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease","progressive supranuclear palsy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","96-119"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","stage unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 9 years; Cause of death: dehydration and respiratory insufficiency"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 8:55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-086"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 2 years; Cause of death: euthanasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 3:55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","96-094"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","Constantinidis type C1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 8 years; Cause of death: cachexia and dehydration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-142"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","Braak stage 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","82 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Cause of death: myocardial infarction"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 3 years; Cause of death: respiratory insufficience"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","03-049"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-099"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","Braak stage 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 7 years; Cause of death: unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease","Alzheimer's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 3:35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 11 years; Cause of death: pneumonia in a dehydrated and cachexic patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","98-119"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 3:45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","01-028"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 4:50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","96-012"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 7:55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 6 years; Cause of death: bleeding of the stomach"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-140"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 15 years; Cause of death: dehydration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 14 years; Cause of death: infection of lungs"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","98-029"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Cause of death: pancreatic cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 4:20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","99-116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","Braak stage 0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","96-098"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 7 years; Cause of death: pulmonary arrest"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 12 years; Cause of death: bronchopneumonia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","97-051"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Cause of death: heart attack"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","01-021"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 7:40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 15 years; Cause of death: aspiration pneumonia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","02-062"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","98-101"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Cause of death: heart failure"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 6:45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 16 years; Cause of death: acute cardiac arrest"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","83 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","98-159"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 6 years; Cause of death: pneumonia and cachexia by PSP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","97-072"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","98-163"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 8 years; Cause of death: lungdisorder with fever for 4 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 6:15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 5:00"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","01-091"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 10 years; Cause of death: cachexia following swallowing disturbances"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","80 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-044"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: more than 7 years; Cause of death: general deterioration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","95-099"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 8:10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 4 years; Cause of death: septic with a urinary infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 3 years; Cause of death: cachexia and dehydration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","93 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 4:15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","99-050"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","disease staging","Braak stage 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-096"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 3 years; Cause of death: pneumonia / cachexia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 12 years; Cause of death: sepsis, due to an urinary tract infection, and cachexia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","96-064"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 8 years; Cause of death: aspiration pneumonia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","95-069"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","89-073"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 3:25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 13 years; Cause of death: cachexia and dehydration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","95-086"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","Clinical info","post mortem delay 4:40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 6 years; Cause of death: myocardial infarction"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","individual","00-066"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2280>","Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways","clinical history","Disease duration: 7 years; Cause of death: dehydration and vascular insufficiency"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","individual","DONOR2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","cell type","hepatocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","Compound treatment","flucloxacillin 500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","individual","DONOR1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","individual","DONOR3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2128>","Transcription profiling of human liver in response to flucloxacilin-induced liver injury","time","72 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","Compound treatment","CNOT8 + non-targeting"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","dose","5 nM + 5 nM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","Compound treatment","CNOT7+CNOT8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","Compound treatment","non-targeting"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","dose","10 nM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2218>","Transcription profiling of human MCF7 cell line with siRNA mediated knockdown of CNOT7 and/or CNOT8 subunits of Ccr4-Not deadenylase compared to control","Compound treatment","CNOT7 + non-targeting"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2236>","Transcription profiling of human scalp fibroblasts in four craniosynostosis disease groups","disease","Muenke syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2236>","Transcription profiling of human scalp fibroblasts in four craniosynostosis disease groups","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2236>","Transcription profiling of human scalp fibroblasts in four craniosynostosis disease groups","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2236>","Transcription profiling of human scalp fibroblasts in four craniosynostosis disease groups","disease","Nonsyndromic Sagittal Synostosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2236>","Transcription profiling of human scalp fibroblasts in four craniosynostosis disease groups","disease","Apert syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2236>","Transcription profiling of human scalp fibroblasts in four craniosynostosis disease groups","disease","Soetre-Chotzen syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","genotype","miR-34a LNA inhibitor transfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","Compound treatment","ethanol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","cell line","TIG3 TERT/ deltaB-RAF:ER"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","genotype","scrambled control LNA transfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2241>","Transcription profiling of human cells transfected with a miR-34a LNA inhibitor to investigate its role in oncogene-induced senescence","Compound treatment","4-hydroxytamoxifen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2351>","Transcription profiling of human SEGA (subependymal giant cell astrocytoma) brain tumors as compared to control brain tissue","organism part","brain"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2351>","Transcription profiling of human SEGA (subependymal giant cell astrocytoma) brain tumors as compared to control brain tissue","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2351>","Transcription profiling of human SEGA (subependymal giant cell astrocytoma) brain tumors as compared to control brain tissue","disease","subependymal giant cell astrocytoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2351>","Transcription profiling of human SEGA (subependymal giant cell astrocytoma) brain tumors as compared to control brain tissue","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","cell type","plasma cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","time","10 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","cell type","activated B-cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","time","4 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","time","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","cell type","plasmablast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2360>","Transcription profiling of human memory B cells to plasma cells differentiation time course","cell type","memory B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","genetic modification","Tet21N MYCN,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","disease","neuroblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","strain","SHEP-Tet21N"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","cell line","SHEP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","developmental stage","child"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2340>","Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N MYC.","genetic modification","Tet21N minus MYCN,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","Compound treatment","SPC3649 1 milligram per kilogram"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","individual","4x0358"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","11 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","disease","hepatitis C infected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","organism","Pan troglodytes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","-4 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","Compound treatment","SPC3649 5 milligrams per kilogram"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","19.14286 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","individual","4x0514"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","15 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","25 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","individual","4x0513"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","19 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","individual","4x0267"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2375>","Transcription profiling of liver from Pan troglodytes with chronic hepatitis C virus infection following therapeutic silencing of microRNA-122 using SPC3649","time","0 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2488>","Transcription profiling of human nucleus pulposus vs articular cartilage cell types","cell type","nucleus pulposus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2488>","Transcription profiling of human nucleus pulposus vs articular cartilage cell types","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2488>","Transcription profiling of human nucleus pulposus vs articular cartilage cell types","cell type","articular cartilage"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","cell type","neuroepithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","developmental stage","embryo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","time","6 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","time","10 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","time","17 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","time","0 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2426>","Transcription profiling of human embryonic stem cells and neuroepithelial cells","cell type","embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2447>","Transcription profiling of human HeLa cells treated by various doses of cortisol","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2447>","Transcription profiling of human HeLa cells treated by various doses of cortisol","cell line","HeLa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2447>","Transcription profiling of human HeLa cells treated by various doses of cortisol","Compound treatment","cortisol 200 nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2447>","Transcription profiling of human HeLa cells treated by various doses of cortisol","Compound treatment","cortisol pulsatile nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2447>","Transcription profiling of human HeLa cells treated by various doses of cortisol","Compound treatment","cortisol 100 nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2447>","Transcription profiling of human HeLa cells treated by various doses of cortisol","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","ethnicity","Danish Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","disease","type 2 diabetes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","organism part","skeletal muscle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","disease","healthy first degree relative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2559>","Gene expression profiling in diabetic skeletal muscle","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","organism part","colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","disease","colon adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","cell line","SW620"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","Compound treatment","tetradecylthioacetic acid 75 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2590>","Transcription profiling of human colon cancer cell line SW620 treated wit tetradecylthioacetic acid (TTA) or control (NaOH).","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","biosource type","primary cell stroma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","growth condition","cultured with 3D BPH-1 epithelial acini"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","cell line","primary prostate stroma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","disease","benign prostatic hyperplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","developmental stage","derived from adult tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","cell type","stromal cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","growth condition","cultured without epithelial acini"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","75 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","83 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","individual","Exp 53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-2657>","Transcription profiling by array of human stromal cells cultured with or without 3D BPH-1 prostate epithelial cells","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","disease","EBV-infection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","organism part","umbilical cord"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB04"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T05"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","organism part","palatine tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T06"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB06"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB04"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB05"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T04"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T08"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T07"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB03"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB02"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB08"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","PB02"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","T02"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3582>","Impact of EBV infection on B cells from tonsils cord blood and peripheral blood","individual","CB01"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3628>","miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma","disease","osteosarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3628>","miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma","organism part","bone"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3628>","miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3628>","miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3628>","miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","Compound treatment","miR-146a 50 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","disease","gastric cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","cell line","SNU638"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3479>","miR-146a target identification in gastric cancer","Compound treatment","siGlo 50 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","cell line","MKN74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","time","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","cell type","gastric epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","disease","Enterococcus faecalis infected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3496>","MKN74 gastric epithelial cells infected with Enterococcus faecalis for 24hrs or 5day","time","5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","cell line","HUES-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","cell type","embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","Compound treatment","retinoic acid 2 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","specimen with known storage state","fresh specimen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","Compound treatment","no treatment 0 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","Compound treatment","DMSO 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","Compound treatment","retinoic acid 200 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3577>","Development of a  Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure","Compound treatment","retinoic acid 2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3641>","Comparing the transcriptome in cumulus and granulosa cells","biosource type","frozen sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3641>","Comparing the transcriptome in cumulus and granulosa cells","cell type","cumulus cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3641>","Comparing the transcriptome in cumulus and granulosa cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3641>","Comparing the transcriptome in cumulus and granulosa cells","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3641>","Comparing the transcriptome in cumulus and granulosa cells","organism part","ovarian follicle"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3641>","Comparing the transcriptome in cumulus and granulosa cells","cell type","granulosa cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","cell line","CD3- CD19+ CD27+ CD38 high"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","organism part","spleen"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","RTX 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","clinical history","RTX-treated patients"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","cell type","plasma cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","RTX 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","RTX 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","cell line","CD19+ CD20- CD27+ CD38 high HLA-DR low"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","ITP PB 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","clinical history","ITP patient"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","cell type","plasmablast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","RTX 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","ITP PB 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","clinical history","Healthy donor"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","HD PB 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","ITP PC 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","ITP PB 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","ITP PC 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","HD PC 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","HD PC 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","HD PB 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","HD PC 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3711>","MatthieuMAHEVAS","biosource provider","ITP PC 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","cell type","MoDC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","cell type","CD34-LC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","cell line","MUTZ-3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","cell type","HLA-DR and CD1a positive MUTZ-3 DCs"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3787>","in vitro DC models","cell type","CD34-DC"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","genotype","gamma-catenin knock in"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Catenin4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","cell type","CD34+ haemopoetic progenitor cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","organism part","cord blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","biosource provider","A Tonks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","genotype","GFP control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal Mono (3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","cell type","monoblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Gran (2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","cell type","myeloblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","NormalEry(4)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","cell type","erythroblast"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","CatGran (4)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normalgran (4)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Ery(3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal Mono (2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Mono (2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Catenin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Gran (3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Ery(4)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normalgran (1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","NormalEry(1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Mono (3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Mono (1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","NormalEry(3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Catenin2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Mono_4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Ery(1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Catenin3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Gran (1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Catenin1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal Mono (4)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normalgran (3)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal Mono (1)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Cat Ery(2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normalgran (2)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3810>","Gamma-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation","individual","Normal1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","time","12 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","cell line","HEK293T"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","genotype","STK3 overexpression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","genotype","XBP1 overexpression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","genotype","ACO1 overexpression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-421>","Transcription profiling of human embryonic kidney cells expressing apoptosis inducing proteins, time course","Compound treatment","staurosporine"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","disease","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","sampling time point","before colonoscopy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","sampling time point","after colonoscopy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","disease","colorectal cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","CRC_9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_AF_1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-3756>","Blood Gene Expression Profiling in Colorectal Cancer","individual","Control_BF_9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","Infection","uninfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","cell type","lymphatic endothelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","disease","Kaposi's sarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","Infection","Kaposi's sarcoma-associated herpesvirus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-561>","Transcription profiling of human lymphatic endothelial cells response to Kaposi-sarcoma herpesvirus","genetic modification","virus_integration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","genetic modification","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","genetic modification","hTERT/HPVE6 transfection,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","genetic modification","hTERT/HPVE6/HPVE7 transfection,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","genetic modification","hTERT transfection,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","genetic modification","hTERT/HPVE6/HPVE7/SV40t transfection,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-563>","Transcription profiling of human mesenchymal stem cells transformed with lentiviral vectors of TERT, E6, SV40 and RAS","genetic modification","hTERT/HPVE6/HPVE7/SV40t/hRas transfection,transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","Infection","Escherichia coli"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","Compound treatment","TAT-BH4 peptide 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","cell type","peripheral blood monocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","Compound treatment","TAT-BH4D2 peptide 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-555>","Transcription profiling of human lymphocyte response to E. coli to identify any transcriptional component to the protection in vitro bacterially induced PBMC apoptosis","Infection","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","cell type","mesenchymal stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","time","9 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","time","7 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-858>","Transcription profiling time series of human mesenchymal stem cells after induction of differentiation","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","genotype","over-expression of MycER"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","cell line","MCF10A MycER"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","time","48 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","cell type","mammary epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","media","3D Matrigel culture"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","media","2D monolayer with EGF and insulin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","Compound treatment","4-hydroxytamoxifen 100 nanomolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","media","2D monolayer without EGF and insulin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-765>","Transcription profiling of human mammary epithelial cells with MycER activation using 4-hydroxytamoxifen following growth in 2D monoloyers with or without EGF and insulin or in 3D Matrigel culture","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","ESC1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","cell line","H9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","growth condition","chemically defined feeder-free medium"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","cell type","embryonic stem cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","developmental stage","embryo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","cell type","mesendoderm/endoderm progenitor cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","LE2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","cell line","H9-derived"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","LE1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","ESC3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","LE4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","ESC2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-930>","Transcription profiling of human embryonic stem cells and their differentiated progeny grown in chemically defined conditions","individual","LE3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","disease","ovarian carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","organism part","ovary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-935>","Transcription profiling of human ovarian cancer tumor samples to investigate heterogeneity","individual","tumor 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","individual","Donor A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","cell type","peripheral blood mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","protocol type","Enzo labeling kit"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","protocol type","Invitrogen labeling kit"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","individual","Donor B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-884>","Transcription profiling of human peripheral blood mononuclear cells to compare one-cycle target labeling assays from Affymetrix, Enzo Life Sciences and Invitrogen Life Technologies","protocol type","Affymetrix labeling kit"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-964>","Transcription profiling of undifferentiated and differentiated human soft tissue sarcomas isolated from adipose tissue","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-964>","Transcription profiling of undifferentiated and differentiated human soft tissue sarcomas isolated from adipose tissue","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-964>","Transcription profiling of undifferentiated and differentiated human soft tissue sarcomas isolated from adipose tissue","cell type","soft tissue sarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-964>","Transcription profiling of undifferentiated and differentiated human soft tissue sarcomas isolated from adipose tissue","disease","undifferentiated sarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-964>","Transcription profiling of undifferentiated and differentiated human soft tissue sarcomas isolated from adipose tissue","organism part","adipose tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-964>","Transcription profiling of undifferentiated and differentiated human soft tissue sarcomas isolated from adipose tissue","disease","well-differentiated sarcoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","sex","not available"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","age","4 months"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","developmental stage","fetus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","cell type","epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","cell line","NT-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","disease","cystic fibrosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-980>","Transcription profiling of a human Cystic Fibrosis cell line and a control cell line","cell line","CFT-2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","disease","systemic juvenile idiopathic arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","Clinical info","inactive arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","cell type","mononuclear"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 013"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 020"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 025"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 006 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","Clinical info","active arthritis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 012"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 016"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 001"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 014"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 015"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 014 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 019"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 008"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 005"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 007"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-987>","Transcription profiling of peripheral blood monocytes from patients with systemic juvenile idiopathic arthritis during active and inactive disease","individual","A125 SYSM 006"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE687"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","tumor grading","Gleason 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","differentiation state","prostate epithelial transit amplifying cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","disease","prostate adenocarcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","organism part","prostate"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","cell type","CD133-/alpha2 integrin low prostate epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE667"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","tumor grading","Gleason 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","differentiation state","Prostate Epithalial transit amplifying cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","cell type","CD133+ prostate epithelial cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","differentiation state","Prostate Epithelial Stem Cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE003"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE690"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","disease","benign prostatic hyperplasia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","tumor grading","Gleason 7, patient was recieving hormone therapy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE704"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE627"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE563"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE693"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE561"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE662"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE569"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","tumor grading","Gleason 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE484"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE605"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE661"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE228"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE512"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","tumor grading","Gleason 8/9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE434"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","individual","PE665"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MEXP-993>","Transcription profiling by array of human prostate cancer stem cells","differentiation state","Prostate Epithalial Stem Cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","cell line","NHBE cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","Compound treatment","Recombinant Tumor Necrosis Factor-Alpha 0.1 nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","Compound treatment","Recombinant Tumor Necrosis Factor-Alpha 10 nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","Compound treatment","Recombinant Tumor Necrosis Factor-Alpha 100 nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","time","30 minutes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1027>","Network Perturbation Amplitude on NHBE cells","Compound treatment","Recombinant Tumor Necrosis Factor-Alpha 1 nanogram per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","phenotype","low miR-3151 expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_93"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_157"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","phenotype","high miR-3151 expression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_122"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_159"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_224"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_145"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_266"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_297"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_245"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_127"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_184"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_228"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_203"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_193"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_205"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_221"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_250"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_187"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_90"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_137"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_94"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_233"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_222"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_208"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_273"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_189"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_241"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_299"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_135"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_132"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_107"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_238"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_190"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_142"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_175"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_237"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_179"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_141"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_152"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_229"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_121"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_166"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_131"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_290"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_102"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_164"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_204"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_139"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_239"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_177"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_260"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_138"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_270"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_130"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_200"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_160"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_124"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_108"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_147"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_115"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_92"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_185"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_155"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_167"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_286"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_162"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_265"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_210"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_151"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_180"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_230"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_149"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_264"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_183"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_174"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_96"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_168"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_291"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_170"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_169"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_161"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_158"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_223"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_298"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_242"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_144"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_114"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_99"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_283"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_97"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_197"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_85"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_289"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_252"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_226"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_251"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_262"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_150"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_206"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_227"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_186"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_195"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_256"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_258"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_246"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_199"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_91"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_126"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_278"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_101"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_119"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_202"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_136"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_253"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_268"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_255"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_294"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_285"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_128"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_207"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_156"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_104"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_225"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_269"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_98"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_274"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_192"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_95"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_293"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_86"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_181"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_296"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_171"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_103"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_140"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_267"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_172"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_244"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_182"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1075>","miR-3151 interplays with its host gene BAALC and independently impacts on outcome of patients with cytogenetically normal acute myeloid leukemia - expression microarray data","individual","Patient AML_89"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","disease","chronic lymphocytic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","genotype","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","cell type","B cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","cell line","MEC2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","genotype","transfected with mir-125b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1131>","Transcription profiling by array of MEC2 cells overexpressing miR-125b","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","genetic modification","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","biosource provider","Our laboratory"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","cell line","LNCAP"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-108>","Transcription profiling of human LNCaP prostate cancer cell line to identify FOXP3 targets","genetic modification","FOXP3 transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","phenotype","Type A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_278"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_305"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_273"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_092"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_225"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_049"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_046"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_243"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_019"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_501"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_207"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_029"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_316"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_078"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_511"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_505"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","phenotype","Non-Type A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_506"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_503"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_291"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_064"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_011"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_179"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_353"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_517"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_234"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_062"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_152"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_105"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_137"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_071"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_254"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_508"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_018"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_189"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_510"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_330"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_509"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_301"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_002"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_341"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_223"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_080"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_013"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_515"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_031"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_507"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_216"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_108"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_275"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_159"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_184"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_198"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_187"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_209"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_178"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_182"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_512"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_280"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_151"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_129"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_321"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_096"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_516"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_287"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_168"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_363"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_022"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_513"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_352"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_253"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_264"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_196"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_500"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_023"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_518"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_107"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_148"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_193"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_519"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_220"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_125"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_024"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_154"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_122"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_269"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_247"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_224"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_311"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_298"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_164"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_504"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_032"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_514"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_256"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_005"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_073"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1356>","inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations","individual","Patient CBF_502"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","disease","asthma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","12 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","disease","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","15 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","17 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","13 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","7 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","11 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","10 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","14 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-1425>","MRCA expression","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-566>","celecoxib-treated vs control breast tumours","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-566>","celecoxib-treated vs control breast tumours","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-566>","celecoxib-treated vs control breast tumours","Compound treatment","celecoxib"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-566>","celecoxib-treated vs control breast tumours","Compound treatment","placebo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-317>","Transcription profiling by array of human CD138 purified bome marrow plasma cells from patients with mutliple myeloma or monoclonal gammopathy of unknown significance","cell type","CD138-purified plasma cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-317>","Transcription profiling by array of human CD138 purified bome marrow plasma cells from patients with mutliple myeloma or monoclonal gammopathy of unknown significance","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-317>","Transcription profiling by array of human CD138 purified bome marrow plasma cells from patients with mutliple myeloma or monoclonal gammopathy of unknown significance","disease","myeloma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-317>","Transcription profiling by array of human CD138 purified bome marrow plasma cells from patients with mutliple myeloma or monoclonal gammopathy of unknown significance","disease","monoclonal gammopathy of unknown significance (MGUS)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-372>","Gene Expression Profiling in Multiple Myeloma - Reporting of Entities, Risk and Targets in Clinical Routine","cell type","CD138-positive plasma cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-372>","Gene Expression Profiling in Multiple Myeloma - Reporting of Entities, Risk and Targets in Clinical Routine","disease","myeloma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-372>","Gene Expression Profiling in Multiple Myeloma - Reporting of Entities, Risk and Targets in Clinical Routine","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-372>","Gene Expression Profiling in Multiple Myeloma - Reporting of Entities, Risk and Targets in Clinical Routine","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-372>","Gene Expression Profiling in Multiple Myeloma - Reporting of Entities, Risk and Targets in Clinical Routine","disease","monoclonal gammopathy of uncertain significance"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-73>","Transcription profiling of human breast cancer cell line MCF7 with FOXP3-induced gene expression","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-73>","Transcription profiling of human breast cancer cell line MCF7 with FOXP3-induced gene expression","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-73>","Transcription profiling of human breast cancer cell line MCF7 with FOXP3-induced gene expression","cell line","MCF-7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-73>","Transcription profiling of human breast cancer cell line MCF7 with FOXP3-induced gene expression","genetic modification","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-73>","Transcription profiling of human breast cancer cell line MCF7 with FOXP3-induced gene expression","genetic modification","FOXP3 transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","sampling time point","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","cell type","hepatocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","iproniazid 240 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","sampling time point","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetaminophen 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","isoniazid 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","sampling time point","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","cimetidine 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","carbamazepine 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","indomethacin 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","amiodarone 7 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenylanthranilic acid 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diclofenac 16 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chloramphenicol 450 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrofurantoin 125 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","clomipramine 2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenobarbital 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","mexiletine 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlormadinone 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","carbon tetrachloride 7500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methyltestosterone 0.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlormezanone 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diltiazem 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrofurantoin 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenylbutazone 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","WY-14643 6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenytoin 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ranitidine 800 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tiopronin 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tiopronin 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","bromobenzene 8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","fluphenazine 0.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tolbutamide 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","haloperidol 0.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","perhexiline 0.6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ibuprofen 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","azathioprine 14.6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlormadinone 8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","cimetidine 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","glibenclamide 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulfasalazine 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","griseofulvin 0.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpromazine 0.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","aspirin 3000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","thioacetamide 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","metformin 1000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methyltestosterone 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","cyclophosphamide 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","lomustine 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methapyrilene 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","thioacetamide 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","naproxen 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","etoposide 330 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","fenofibrate 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","disopyramide 3500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","captopril 8000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","penicillamine 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrofurazone 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","benzbromarone 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","perhexiline 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nimesulide 66 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ketoconazole 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","naphthyl isothiocyanate 8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methapyrilene 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","clofibrate 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","erythromycin ethylsuccinate 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","allopurinol 140 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethinylestradiol 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tetracycline 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","omeprazole 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","adapin 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","enalapril 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","isoniazid 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","carbon tetrachloride 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","carbamazepine 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrosodiethylamine 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","valproic acid 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","hexachlorobenzene 1.2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","bromobenzene 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","moxisylyte 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetaminophen 5000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethionamide 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","hexachlorobenzene 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","azathioprine 72.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethionine 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","gemfibrozil 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","furosemide 500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","rifampicin 14 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ibuprofen 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenytoin 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","benzbromarone 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diazepam 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","theophylline 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ranitidine 4000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methyldopa 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","fluphenazine 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","imipramine 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tamoxifen 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tetracycline 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","lomustine 24 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methyltestosterone 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nicotinic acid 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenylbutazone 80 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diclofenac 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","glibenclamide 0.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","famotidine 700 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","adapin 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","furosemide 2500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethambutol 800 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","gemfibrozil 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","theophylline 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlormezanone 250 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","coumarin 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","allopurinol 28 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","meloxicam 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","caffeine 1500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","danazol 35 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","propylthiouracil 4000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenobarbital 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","carbon tetrachloride 1500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","valproic acid 1000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","allopurinol 5.6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","mexiletine 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","adapin 75 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulindac 3000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","allyl alcohol 14 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","disopyramide 700 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","coumarin 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methimazole 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenylbutazone 16 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","flutamide 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","hydroxyzine 8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nicotinic acid 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","benzbromarone 100 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","monocrotaline 90 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diazepam 250 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","naproxen 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpromazine 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","bucetin 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methapyrilene 24 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethionine 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","isoniazid 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","monocrotaline 18 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","clofibrate 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","hydroxyzine 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ketoconazole 0.6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ticlopidine 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","aspirin 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","disulfiram 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tetracycline 25 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","aspirin 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenacetin 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpropamide 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","promethazine 35 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","cyclophosphamide 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","meloxicam 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","coumarin 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","metformin 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tannic acid 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","griseofulvin 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","haloperidol 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","disulfiram 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","labetalol 5.6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","lomustine 4.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tacrine 16 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chloramphenicol 90 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","naphthyl isothiocyanate 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpropamide 750 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","cyclophosphamide 80 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","haloperidol 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","fenofibrate 6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ticlopidine 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetazolamide 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","allyl alcohol 70 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","flutamide 2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","omeprazole 24 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethambutol 4000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","imipramine 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","labetalol 28 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","pemoline 75 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","benziodarone 8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","propylthiouracil 800 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","azathioprine 2.9 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methyldopa 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","indomethacin 8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrofurazone 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","hexachlorobenzene 6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nifedipine 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","WY-14643 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","valproic acid 5000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","clofibrate 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","griseofulvin 4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tamoxifen 25 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","allyl alcohol 2.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","lornoxicam 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","rifampicin 70 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","thioacetamide 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","captopril 1600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetamidofluorene 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetaminophen 1000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diclofenac 80 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ketoconazole 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","terbinafine 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","simvastatin 6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","thioridazine 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","penicillamine 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ajmaline 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrofurantoin 25 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulpiride 5000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","fluphenazine 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","papaverine 12 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenobarbital 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","cimetidine 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","enalapril 400 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","glibenclamide 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nimesulide 330 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","iproniazid 1200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","promethazine 7 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","thioridazine 0.6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","danazol 7 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","moxisylyte 80 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetamidofluorene 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenylanthranilic acid 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethionine 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulfasalazine 6 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diltiazem 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","colchicine 800 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ajmaline 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","thioridazine 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethanol 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","diazepam 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tacrine 80 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","indomethacin 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","papaverine 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acarbose 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenytoin 2.4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acetazolamide 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","amitriptyline 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","benziodarone 40 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulfasalazine 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","WY-14643 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","etoposide 66 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tolbutamide 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","propylthiouracil 160 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","mefenamic acid 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nifedipine 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","colchicine 4000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethanol 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethionamide 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","famotidine 140 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","erythromycin ethylsuccinate 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","flutamide 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","amiodarone 0.28 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ethinylestradiol 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","quinidine 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","nitrosodiethylamine 2000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","quinidine 50 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","naphthyl isothiocyanate 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpromazine 20 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ciprofloxacin 25 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","bucetin 300 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","labetalol 140 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","omeprazole 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","methimazole 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","caffeine 7500 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","carbamazepine 60 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulindac 600 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","dantrolene 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","bromobenzene 200 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","gemfibrozil 100 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","amiodarone 1.4 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","clomipramine 10 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","pemoline 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","mefenamic acid 150 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","vitamin A 1.5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","vitamin A 7.5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","terbinafine 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","lornoxicam 15 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","amitriptyline 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","acarbose 10000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","simvastatin 30 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","sulpiride 1000 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","rifampicin 2.8 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","phenacetin 120 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","tannic acid 1 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","ciprofloxacin 5 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","perhexiline 3 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpheniramine 18 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","chlorpheniramine 90 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-798>","Open TG-GATEs (in vitro, human)","Compound treatment","dantrolene 2 micromolar"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","biosource type","RNAlater"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","organism status","in vivo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","disease","Decidualised"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","organism part","Decidual Tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","disease","Non-decidualised"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-680>","Tubal ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast","disease","Partially decidualised"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","Clinical info","platinum resistant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","disease","ovarian carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","individual","Patient 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","clinical history","relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","cell line","PEO23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","individual","Patient 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","cell line","PEO4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","clinical history","second relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","Clinical info","platinum sensitive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","cell line","PEO14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","clinical history","presentation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","cell line","PEO1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-691>","Transciptome profiling of ovarian cancer cell lines","clinical history","first relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","age","8 weeks"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","biosource provider","The Scripps Research Institute, La Jolla, California, USA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","organism","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","strain","C57BL/6J"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","organism part","vomeronasal organ"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","biosource type","fresh sample"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-698>","RNA-seq of vomeronasal tissue from adult male and female mice","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","disease","multiple sclerosis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","organism part","cerebrospinal fluid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","disease staging","relapse"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","organism part","peripheral blood lymphocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","disease staging","remission"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","disease staging","NA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","disease","neurological disease, non-inflammatory"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-69>","Transcription profiling by array of paired cerebrospinal fluid and peripheral blood lymphocyte samples from multiple sclerosis patients and controls with other non-inflammatory neurological disorders","individual","Individual 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","cell type","bronchial epithelial"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","dose","15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","growth condition","28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","organism part","lung"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","cell line","AIR-100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","time","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","Compound treatment","cigarette smoke"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","Compound treatment","synthetic air"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","growth condition","14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","dose","100"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","time","0.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","growth condition","7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","growth condition","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","time","2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","time","48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-874>","AIR100 SysBio Approach","time","24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-93>","RNAi knock down of TIA-proteins in human HeLa cells","RNAi","TIAR siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-93>","RNAi knock down of TIA-proteins in human HeLa cells","cell line","HeLa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-93>","RNAi knock down of TIA-proteins in human HeLa cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-93>","RNAi knock down of TIA-proteins in human HeLa cells","RNAi","TIA-1 and TIAR siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-93>","RNAi knock down of TIA-proteins in human HeLa cells","RNAi","TIA-1 siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-MTAB-93>","RNAi knock down of TIA-proteins in human HeLa cells","RNAi","control siRNA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","individual","donor2-3F1004"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","ethnicity","Caucasian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","growth condition","smoke"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","time","24 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","growth condition","air control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","individual","donor1-2F0358"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","growth condition","incubator control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","time","0 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","ethnicity","Asian"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-127>","Transcription profiling of human bronchial epithelial cells from cultures exposed to cigarette smoke or filtered air","individual","donor3-4F0507"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","chromosomal aberration","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","genotype","WT1 mutation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1020>","Oligonucleotide expression microarray data for analysis of Wilms tumor 1 gene (WT1) mutations in cytogenetically normal acute myeloid leukemia (AML) patient samples","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","chromosomal aberration","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","genotype","FLT3-ITD absent"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1029>","Oligonucleotide expression microarray data for analysis of FLT3 internal tandem duplications (FLT3-ITD) in samples from older patients with cytogenetically normal AML","genotype","FLT3-ITD present"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1138>","Baseline and Post-Bortezomib gene expression profiling of CD138 purified bone marrow plasma cells from multiple myeloma patients","disease","multiple myeloma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1138>","Baseline and Post-Bortezomib gene expression profiling of CD138 purified bone marrow plasma cells from multiple myeloma patients","treatment","Baseline (untreated)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1138>","Baseline and Post-Bortezomib gene expression profiling of CD138 purified bone marrow plasma cells from multiple myeloma patients","cell type","CD138-purified plasma cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1138>","Baseline and Post-Bortezomib gene expression profiling of CD138 purified bone marrow plasma cells from multiple myeloma patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1138>","Baseline and Post-Bortezomib gene expression profiling of CD138 purified bone marrow plasma cells from multiple myeloma patients","treatment","48hr after Bortezomib administration"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history age","age at diagnosis over 25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history extra intestinal","extra-intestinal manifestations"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","organism part","descending colon"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history fistula","no fistula"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","biopsy site","inflamed"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","disease","Crohn's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history fibrostenotic","not fibrostenotic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history fistula","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history fibrostenotic","fibrostenotic"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history age","age at diagnosis under 25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history extra intestinal","no extra-intestinal manifestations"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C99"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history fibrostenotic","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C114"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C113"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history fistula","fistula"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C120"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C96"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C98"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C112"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C84"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C102"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C107"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C121"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","biopsy site","non-inflamed"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history age","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","clinical history extra intestinal","unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C115"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C106"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C116"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C118"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C111"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C109"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C110"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C117"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-118>","Transcription profiling of biopsies from the descending colon of Crohns disease patients","individual","C56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","disease","acute myeloid leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","genotype","ASXL1 mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","chromosomalaberrationclassification","cytogenetically normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","genotype","ASXL1 wild_type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-1208>","Gene expression signature associated with ASXL1 mutations in cytogenetically normal acute myeloid leukemia (CN-AML)","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","organism part","sigmoid colon mucosa"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 44"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 29"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","Clinical info","constipation-predominant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","disease","irritable bowel syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 37"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 38"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 52"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 48"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 27"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","Clinical info","diarrhea-predominant"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 41"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 40"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 33"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 23"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 43"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 16"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 20"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 30"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 39"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 22"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 24"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 58"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 55"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 46"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 60"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 47"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 51"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 61"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 34"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 26"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 31"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 36"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 49"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 25"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-176>","Transcription profiling of sigmoid colon mucosal biopsies from irratable bowel syndrome patients and healthy control subjects","individual","patient 59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","organism part","testis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","disease location","testis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","clinical history","vasectomized"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","histology","Johnsen score count 10: full spermatogenesis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","disease","ejaculatory azoospermia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 541 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","initial time point","birth"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","organism status","premortem"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 649 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","histology","Johnsen score count 5: no spermatids, many spermatocytes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","clinical history","idiopathic infertility"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 612 re #2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 444 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","histology","Johnsen score count 8: hypospermatogenesis - many early and elongated, few late spermatids"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","histology","Johnsen score count 3.2: Sertoli cells and few spermatogonia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 553 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 583 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","clinical history","cryptorchidism"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","histology","Johnsen score count 2: Sertoli Cell Only-Syndrome"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 436 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 582 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 400 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 484 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 585 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 629 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","31 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 525 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 520 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 438 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 546 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 403 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 611 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 496 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","histology","Johnsen score count 7: many early spermatids, no late spermatids"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 435 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 469 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 506 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 462 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 434 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 384 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 595 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","29 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 480 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 458 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 543 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 612 re #1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 298 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 39 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 304 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 32 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 177 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 306 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 608 re"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 381 li"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-234>","Transcription profiling of human testis samples from men with highly defined and homogenous testicular pathologies reveals patterns that correlate with distinct stages of spermatogenesis","individual","Patient number 612 re #3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 negative; progesterone receptor negative; HER2/NEU negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","disease","breast carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","observation","1 cm away from the tumor boundary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","histology","invasive ductal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","developmental stage","adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","Clinical info","no evidence of disease reccurence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","tumor grading","3 (grading system not specified)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8513"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","tumor grading","2 (grading system not specified)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8642"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","observation","0 cm away from the tumor boundary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","Clinical info","evidence of disease reccurence"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 positive; progesterone receptor positive; HER2/NEU status unknown"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","tumor grading","4 (grading system not specified)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","histology","cystic change"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8672"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 negative; progesterone receptor negative; HER2/NEU positive"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","observation","2 cm away from the tumor boundary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","observation","3 cm away from the tumor boundary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 positive; progesterone receptor positive; HER2/NEU negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","11770"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8636"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","10143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","tumor grading","9 (grading system not specified)"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 positive; progesterone receptor positive; HER2/NEU borderline"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","9740"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","observation","4 cm away from the tumor boundary"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 positive; progesterone receptor negative; HER2/NEU negative"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","10781"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","69 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8936"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","histology","not applicable"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","436"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","histology","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8703"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","498"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","10473"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","460"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","test result","estrogen receptor 1 negative; progesterone receptor negative; HER2/NEU borderline"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","10180"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","74 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8542"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","86 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","11688"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","8862"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","480"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","544"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","10928"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","512"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","426"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","414"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","474"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-276>","Transcription profiling of breast tumors and surrounding tissue to detect pre-malignant histological and genetic changes","individual","422"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","52CA_05i11034"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","tumor grading","T2, N0, M0, grade 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","disease","clear cell renal carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","36MMl_04i18916"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","tumor grading","T3, N0, M0, grade 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","49CA_05i6348"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","51MI_05i10081"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","tumor grading","T1, N0, M0, grade 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","41SG_04i20655"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","46SA_05i6348"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","32GM_04i12879"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","tumor grading","T3, N0, M0, grade 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","27CG_03i16741"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","33BV_04i13776"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","44DE_ 05i3989"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","35PA _04i18143"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","40RR_04i20257"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","50PC_05i9837"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","37BA_04i19473"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","45DM_05i5902"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","31NR_04i12877"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","28RA_04i3579"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","tumor grading","grade 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-282>","Transcription profiling of clear cell renal carcinomas and normal kidney cortical tissues","individual","47CA_04i3579"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","histology","well-differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","Clinical info","lymph node stage 0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","organism part","oral cavity"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","disease staging","T3N0M0, T1-3N1M0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","disease","head and neck squamous cell carcinoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","histology","poorly differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","organism part","hypopharynx"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","organism part","tongue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","Clinical info","lymph node stage 2b"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","disease staging","T4N0-1M0, TN1-3M"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","disease staging","T2N0M0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","histology","moderately differentiated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","organism part","oropharynx"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","Clinical info","lymph node stage 2c"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","Clinical info","lymph node stage 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","71 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","66 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","Clinical info","lymph node stage 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","Clinical info","lymph node stage 2a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-302>","Transcription profiling of human head and neck squamous cell carcinomas to identify metastasis predictors and descriptors, and differentiation classifiers","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","organism part","whole blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","disease","ICA"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","ICA_2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","T1D_3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","disease","pre-diabetes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","ICA_1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","T1D_C2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","5.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","T1D_1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","2.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","6.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","2.7 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","5.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","T1D_C1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","disease","type 1 diabetes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","6.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","1.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","2.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","T1D_2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3.4 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3.1 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","5.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3.7 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","individual","T1D_C3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","3.8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.9 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","6.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","7.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","5.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","2.2 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.6 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","1.5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-666>","Transcription profiling human whole blood from children with pre-type1diabetes","age","4.1 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","15 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","disease","cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","organism part","adrenal gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","disease","adenoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","48 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","61 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","73 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","68 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","34 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","26 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","79 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","30 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","55 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","27 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","78 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","59 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","65 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","45 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","37 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","51 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","47 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","33 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","81 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-311>","Transcription profiling by array of human adrenocortical tumors and normal adreanal samples to identify molecular predictors of adrenocortical tumor diagnosis and prognosis","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","genotype","M molecular form"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","organism","Anopheles gambiae"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","strain","M-GA-CAM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","developmental stage","4th instar larva"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","sex","mixed sex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","developmental stage","virgin adult"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","strain","Mali-NIH"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","developmental stage","gravid"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","strain","Pimperena"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","genotype","S molecular form"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-344>","Transcription profiling by array of M and S molecular forms of Anopheles gambiae at each of three developmental stages","strain","KIST"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","cell type","BDCA1+ dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","organism part","tonsil"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","cell type","BDCA3+ dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","cell type","CD16+ dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-34>","Transcription profiling of dendritic cell subsets in human tonsils and blood","cell type","plasmacytoid dendritic cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","cell type","CD8+ naive CD8 T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","individual","buffy coat 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","individual","buffy coat 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","cell type","CD8+ effector memory RA T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","cell type","CD8+ effector memory T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","individual","buffy coat 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","cell type","CD8+ central memory T cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-40>","Transcription profiling of human CD8 naive (TN), central memory (TCM), effector memory (TEM), and effector memory RA (TEMRA) T cells","individual","buffy coat 1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","cell type","hematopoietic progenitor cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","phenotype","LSK, Flk2+ Ncad+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","individual","Population A"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","organism part","bone marrow"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","strain","N-cadherin LacZ gene trap mice"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","organism","Mus musculus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","phenotype","LSK, Flk2+ Ncad-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","individual","Population B"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","individual","Population C"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","phenotype","LSK, Flk2- Ncad+"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","individual","Population D"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-404>","Transcription profiling of mouse hematopoetic progenitor cells with Flk12+ Ncad-, Flk12- Ncad+, Flk12+ Ncad+ or Flk12- Ncad- phenotypes","phenotype","LSK, Flk2- Ncad-"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","cell type","keratinocyte"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","age","38 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","growth condition","FGF stimulation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","3 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","growth condition","SDF stimulation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","2 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","6 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","growth condition","HGF stimulation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","4 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","growth condition","GM-CSF stimulation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","0"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","growth condition","uninduced"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","1 hour"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-440>","Transcription profiling of human keratinocytes after stimulation with recombinant human cytokines to study the events controlling cell migration)","time","8 hours"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","disease","villitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","disease staging","mild inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","organism part","placenta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","disease staging","moderate inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","disease staging","no inflamation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-577>","Transcription profiling of human placenta from women presenting at term with villitis of unknown etiology","disease staging","severe inflammation"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","disease","breast cancer"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","genotype","miR221 transfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","organism part","mammary gland"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","cell line","MCF7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","genotype","miR206 transfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","genotype","miR222 transfected"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-601>","Transcription profiling by array of human breast cancer cell line MCF7 transfected with miR221, miR222 and miR206 to identify the different functions of these microRNAs","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","disease","nodal peripheral T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","63 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","sex","unknown sex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","disease","normal"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","67 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","organism part","hypophysis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","disease","extranodal NK/T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","organism part","nasopharyngeal region"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","62 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","77 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","64 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","organism part","skin"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","32 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","70 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","disease","extranodal NK/T-cell lymphoma derived cell line"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","72 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-702>","Transcription profiling by array of human non anaplastic T-cell lymphoma biopsies and cell lines","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-733>","Transcription profiling of human macrophages from Crohns disease patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli;","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-733>","Transcription profiling of human macrophages from Crohns disease patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli;","growth condition","heat-killed Escherichia coli"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-733>","Transcription profiling of human macrophages from Crohns disease patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli;","disease","healthy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-733>","Transcription profiling of human macrophages from Crohns disease patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli;","disease","colonic Crohn's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-733>","Transcription profiling of human macrophages from Crohns disease patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli;","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-733>","Transcription profiling of human macrophages from Crohns disease patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli;","disease","ileal Crohn's disease"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","cell type","mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 27.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","time","0 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Compound treatment","diclofenac"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","58 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","organism part","peripheral blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 29.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","53 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 28.4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Compound treatment","placebo"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","time","10 days"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 29.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","57 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 30.9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","41 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 15"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","60 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 18"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","54 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 26.1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 29.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 9"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","19 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 28.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","56 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 17"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 27.3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","42 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 11"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 27.6"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 27.5"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","52 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","35 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 12"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 26.7"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 10"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","20 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 29.2"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 13"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 19"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 28"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","Clinical info","BMI: 26.8"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","age","50 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-740>","Transcription profiling of PBMCs from slightly obese human males given diclofenac or a placebo to study modulation of inflammation","individual","Subject 14"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","disease","chronic lymphocytic leukemia"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","organism part","blood"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL trisomy 12 high zap IGHV unmutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","cell type","peripheral blood mononuclear cell"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL normal karyotype low zap IGHV mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL 11q deletion high zap IGHV unmutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL 13q deletion low zap IGHV mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL 17p deletion high zap IGHV unmutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL trisomy 12 low zap IGHV mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-763>","MicroRNA profiling of peripheral blood mononuclear cells from CLL patients to identify a signature for specific chromasomal abnormalities","genotype","CLL 17p deletion low zap IGHV mutated"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","growth condition","control"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","disease","healthy"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","disease","ulcerative colitis"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","growth condition","heat-killed Escherichia coli"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-734>","Transcription profiling of human macrophages from ulcerative colitis patients or healthy control individuals, either unstimulated or stimulated with heat killed E. coli","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","organism part","lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","sample type","tissue"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","disease staging","4"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","21"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","disease","peripheral T-cell lymphoma, not otherwise specified"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","67"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","disease","angioimmunoblastic T-cell lymphoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","54"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","59"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","56"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","organism part","from lymph node"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","sex","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","disease staging","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age years ","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","sample type","sorted cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","71"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","69"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","disease staging","1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","65"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","62"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","35"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","50"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","32"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","disease staging","3"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","64"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","57"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","77"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","83"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","53"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","75"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","45"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","74"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","81"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","66"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","63"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","68"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","organism part","n/a"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-783>","Transcription profiling of human non anaplastic T-cell lymphoma","age","42"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-782>","miRNA profiing of human THP-1 cells treated with resveratrol","cell line","THP-1"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-782>","miRNA profiing of human THP-1 cells treated with resveratrol","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-782>","miRNA profiing of human THP-1 cells treated with resveratrol","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-782>","miRNA profiing of human THP-1 cells treated with resveratrol","Compound treatment","resveratrol"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","21 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism status","postmortem"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism","Pongo pygmaeus"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism part","kidney"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","sex","male"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","11 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism part","liver"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","43 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism part","prefrontal cortex"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","28 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","18 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism","Macaca mulatta"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism","Pan troglodytes"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","12 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","25 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","organism part","heart"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","sex","female"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","36 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","39 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","8 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","46 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","15 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","49 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","16 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","22 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","23 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","44 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age",">40 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","24 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-84>","Transcription profiling by array of brain in humans, chimpanzees and macaques, and brain, heart, kidney and liver in orangutans","age","5 years"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","cell type","THP-1 monocytic cells"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","genotype","GAM overexpression"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","genetic modification","transfection"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","Compound treatment","lipopolysaccharide 100 nanograms per milliliter"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","genotype","wild type"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","Compound treatment","none"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-868>","Transcription profiling of human THP-1 cells wild type vs overexpressing GAM or siRNAs directed against GAM (siGAM) challenged by LPS","genotype","siGAM"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-898>","Transcription profiling of human glioblastomas (56 tumor samples)","disease","glioblastoma"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-898>","Transcription profiling of human glioblastomas (56 tumor samples)","clinical treatment","Response to chemiotherapy: 'No', Response to radiotherapy: 'NA'"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-898>","Transcription profiling of human glioblastomas (56 tumor samples)","organism","Homo sapiens"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-898>","Transcription profiling of human glioblastomas (56 tumor samples)","clinical treatment","Response to chemiotherapy: 'NA', Response to radiotherapy: 'Yes'"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-898>","Transcription profiling of human glioblastomas (56 tumor samples)","clinical treatment","Response to chemiotherapy: 'NA', Response to radiotherapy: 'No'"
"<http://rdf.ebi.ac.uk/resource/atlas/E-TABM-898>","Transcription profiling of human glioblastomas (56 tumor samples)","clinical treatment","Response to chemiotherapy: 'Yes', Response to radiotherapy: 'NA'"
